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Methylation reactions are important for the establishment and 
maintenance of epigenetic methylation tags on DNA and histone molecules that 
are critical for the development and life-long function of an organism. While 
epigenetics has been studied extensively during embryological development and 
age-related disease such as cancer, little is known about whether epigenetic 
methylation enzyme expression change in normally aging or long-living 
mammals. Because growth hormone (GH) plays an important role in determining 
the lifespan of many organisms, we have focused our studies on the long-living 
growth hormone deficient model the Ames dwarf mouse. We focused our studies 
on epigenetic methylation in the liver, because of its role in GH signaling, IGF-1 
signaling, and it’s responsiveness to changes in the methionine pathway which 
govern DNA and histone methylation.  
Our studies showed that DNA methyltransferase 1 (DNMT1) protein is 
basally expressed less in the Ames dwarf compared to their wild-type 
counterparts, despite higher or equivalent transcription, suggesting that some 
form of post-transcriptional regulation is taking place. Global DNA methylation 
levels in dwarf mice resisted age-related changes compared to wild type mice. 
Histone methylation of key regulatory transcriptional markers, and total histone 
H3 expression were also altered in dwarf mice. 
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We demonstrated that the protein abundance of a potential regulatory 
protein of DNMT1 (DEAD-box helicase 20) significantly higher in Ames dwarf 
mice at 3, 12, and 24 months of age. Metallothionein1 (MT1) mRNA expression 
was much higher in dwarf mice especially at 3 months of age. Also there were 
differences in the methylation of putative CpG islands of the MT1. Growth 
hormone administration influenced DNA methyltransferase and DDX20 protein 
expression in dwarf mice and areas of methylation in the predicted MT1 CpG 
island. MicroRNA 140-3p which pairs with DDX20 for post-transcriptional 
regulation of DNMT1 was also studied. 
Studies using growth hormone receptor knockout mice and over-expressing 
growth hormone transgenic mice DNMT transcription and interspersed repeat 
methylation were also studied to discover continuities with previous experiments in 
Ames dwarf mice. Taken together, this study offers valuable insight about the 
changes in the epigenetic methylation mechanisms and markers due to aging.






Even though every cell type in the mammalian organism contains the 
same genome, each cell type expresses its own sets of genes and proteins 
which are necessary for function in complex multicellular organisms such as 
humans. Epigenetic refers to heritable forms of gene expression that cannot 
be attributed to a change in the DNA sequence (Robin Holliday, 2006). 
Epigenetic modifications on DNA and proteins contribute to cell differentiation, 
function, and gene expression and influence the observable phenotype of 
mammalian organisms. Epigenetic studies started with observations of 
heritable phenotypic traits that were passed on from mother to daughter cells 
during cell division. During embryological development, these traits 
determined cell type, organ formation, and eventually a multi-organ organism 
(Tost, 2010). It was understood as early as the 1950s that there were 
mechanisms responsible for the timing and regulation of gene expression and 
DNA packaging which were key to development (Robin Holliday, 2006). 
Epigenetics in this context led to the study of the epigenome, a heritable 
regulatory mechanism consisting of markers on DNA or proteins associated 
with DNA, that affects DNA packaging and expression of genes, non-coding 
RNA, and retroviral elements.  
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Epigenetics came into the social and scientific forefront following the 
publication of a few landmark studies. Nutritional insufficiencies were found to 
affect the phenotype of human offspring even to the second generation through 
the "Dutch famine studies" and Dr. Bygren's  Swedish studies (Bygren et al., 
2001; Heijmans et al., 2008). These reports changed the debate from nature 
(genetic control) versus nurture (environmental control) in phenotype expression 
to nature and nurture having equal importance on the phenotypic plasticity and 
fitness of an organism even during development (Jang & Serra, 2014).  Maternal 
administration of demethylating agents such as bisphenol A or methyl-rich diets 
demonstrated that environmental maternal factors had an obvious and persistent 
impact on offspring phenotype (Jang & Serra, 2014; Morgan et al., 1999). Agouti 
mice are also prone to diabetes and cancer (Calvanese et al., 2009; 
Schellenberg et al., 2011). This challenged  the rejection of Lamarck’s principles 
of inheritable adaption and environmental influence that are continually being 
rethought, revised and reintroduced to the scientific community through the study 
of epigenetics (Gravina & Vijg, 2010; Robin Holliday, 2006; Jablonka & Lamb, 
1989). 
As early as the 1960’s, it was thought that epigenetics may influence 
aging, but epigenetic regulation of human aging really came to the forefront with 
studying the phenotypic discordance among aging human monozygotic twins 
(Berdyshev et al., 1967; Fraga et al., 2005; Poulsen et al. 2007). Many of the 
most well-known epigenetic changes controlling gene expression have been 




Alzheimer’s disease. Yet much remains to be done to understand how these 
changes are beneficial or detrimental to an aging organism and how this could be 
translated into medical treatments to enhance longevity and a higher quality of 
function during aging. Before these changes and their effects on gene expression 
and genome integrity can be discussed in detail, the mechanisms and markers 
related to these epigenetic changes must first be introduced and defined. 
Epigenetic markers and mechanisms 
  There are several epigenetic markers including methylation, 
hydroxymethylation, which are covalent DNA modifications, and histone 
modifications that include but are not limited to methylation, phosphorylation, 
acetylation, ubiquitination, and sumoylation in mammals (Chia & Rotwein, 2010; 
Guibert & Weber, 2013; Strahl & Allis, 2000). Epigenetic markers are responsible 
for regulating the expression of the genome in each cell or cell-type. Without 
epigenetic regulation, the differentiation of cells and development of multicellular 
organisms wouldn’t be possible. One well-studied epigenetic modification in 
somatic cells is DNA methylation. This marker consists of a covalent insertion of 
a methyl group onto the five prime carbon of the nucleotide cytosine typically 
preceding an adjacent guanine on the same strand known as a CpG 
dinucleotide. These dinucleotides make up around 1% of the total genome and 
are most densely packed in gene regions known as CpG islands (Bestor, 2000; 
Ehrlich et al., 1982; Tost, 2010). Gene regions make up approximately 2-3% of 
the entire genome and CpG islands, which are regions of CpG dinucleotides of 




regions. CpG islands are thought to regulate transcription positively or negatively 
depending on the gene but are generally hypomethylated in differentiated cells 
(Singal & Ginder, 1999). High levels of  DNA methylation at the CpG island or 
promoter regions are mostly associated with the repression of gene expression, 
X chromosome inactivation, genomic imprinting, and the repression of repetitive 
elements that contain ancestral retroviral sequences able to transpose 
themselves into other areas of the genome if expressed (Shin et al., 2011; Tost, 
2010). High levels of methylation are also typically associated with proteins that 
bind DNA into heterochromatin, a tightly packed form of DNA that is sequestered 
from transcriptional proteins such as transcription factors and RNA polymerases. 
DNA methylation is catalyzed by DNA methyltransferases, or DNMTs, which 
consist of three catalytically active families, DNMT1, DNMT3a, and DNMT3b. 
DNMT3L which is included in this family, contains homogeneity in sequence but 
lacks catalytic sequences and activity. However, DNMT3L affects the affinity of 
other DNMTs for their substrates and thus remains an important cofactor for 
DNMT activity (Bestor, 2000; Cheng & Blumenthal, 2008). DNA 
methyltransferases catalyze the removal of a methyl group from the substrate S-
adenosylmethionine (SAM), which is the major methyl donor for every 
methyltransferase reaction in a cell, and transfers it to specific cytosines on the 
DNA molecule. This reaction relies on the availability of SAM in the nuclear 
compartment (Wallace & Fan, 2010). DNA methyltransferases have specific 
activity for methylating either hemi-methylated DNA, or can form de novo 




affinity for hemi-methylated DNA that is used as a template and is more 
abundant during cell division and DNA synthesis, it has been termed a 
maintenance methyltransferase  (Bestor & Verdine, 1994; Robertson et al., 
1999). DNMT1 is considered the most active and abundant DNA 
methyltransferase in mammalian cells. DNMT3a and 3b are de novo 
methyltransferases not requiring a template strand for methyl marker replication. 
They preferentially methylate heterochromatin and are required for the 
methylation of repetitive DNA (Bachman et al., 2001; Liang et al., 2002a). 
However, DNMTs associate with different genomic areas upon differentiation and 
may play different roles (Challen et al., 2012; Jones & Liang, 2009). For instance, 
DNMT3a is enriched in intergenic heterochromatin, whereas DNMT1 and 
DNMT3b are more associated with intragenic regions and areas of transcription 
after induced differentiation of pluripotent cells with retinoic acid (Jin et al., 2012).  
In addition, different isoforms of each family of DNMT exist and are specific to 
certain periods of embryonic development or certain cell types that result in 
possible functional differences adding to the complexity of DNMT regulation 
(Bestor, 2000; Chen et al., 2002; Keith D Robertson, 2002). All three DNMTs 
have different isoforms and have gene expression regulatory effects independent 
of DNA methylation, adding yet another possible layer of function that has yet to 
be fully investigated (Bachman et al., 2001; Jin et al., 2012; Lan et al., 2010; 
Milutinovic et al., 2004). There are fewer CpG dinucleotides in the mammalian 
genome than statistically expected. This may be caused by nucleotide mutation 




the other is an enzymatically catalyzed deamination of methylated cytosines. 
Both processes render a new base, uracil, which is converted to thymine if no 
DNA repair enzymes intercede (Lindahl, 1974; Singal & Ginder, 1999). As a 
result, methyl binding proteins, which protect methylated cytosines from 
deamination, are thought to play a major role in the maintenance of methylation 
patterns and may be one mechanism of transcriptional repression (Hendrich & 
Bird, 1998; Lan et al., 2010).  
If DNA in the human body were laid out in a string from each of the 46 
chromosomes, it would measure about two meters long. This large amount of 
DNA must be packaged to fit into a nucleus which is only about six microns in 
diameter (Alberts et al., 2008). Most of our DNA is wrapped around and bound to 
proteins that produce a complex layered hierarchy of packaging that is known in 
its most condensed form as chromatin.  DNA, and its associated proteins, plus 
the proteins that anchor chromatin to the inside of the nuclear membrane, make 
up the nuclear architecture, which provides compartmentalization for transcription 
and the sequestration of repetitive DNA in the nucleus. DNA methylation also 
impacts how DNA is packaged. DNA can be gathered into tightly wound 
prohibitive structures and around proteins that inhibit transcription factor and 
polymerase binding to suppress gene expression (heterochromatin) or less 
prohibitive structures that allow or even facilitate gene expression (euchromatin). 
Both utilize histones, and non-histone proteins. There are two types of 
heterochromatin, facultative and constitutive. Both types of heterochromatin 




Constitutive heterochromatin occurs at repetitive DNA that localize principally 
near telomeres and centromeres of chromosomes. This structure keeps 
chromosomes separated, and stabilizes the genome by preventing transposition 
events or mutations in the DNA sequence by keeping it silenced. 
Compartmentally it localizes to the nuclear periphery and historically, has been 
considered fixed and irreversible, but recently has been discovered to  change 
with aging (Kreiling et al., 2011; Oberdoerffer & Sinclair, 2007; Sedivy et al., 
2008).  
Facultative heterochromatin (or inducible chromatin) is largely responsible 
for, the phenotype of a cell during differentiation, X- chromosome inactivation, 
and the phenotypic response of a cell to a changing environment. This type of 
heterochromatin is localized to promoter regions and is dependent on 
transcriptional repressors and silencing protein complexes, which may include 
non-coding RNA. Interestingly, senescent cells associated with aging phenotypes 
in culture, show alterations in facultative heterochromatin that disallow cell cycle 
re-entry. (Sedivy et al., 2008; Sinclair & Oberdoerffer, 2009) 
Histones are proteins that, in binding DNA, form the most basic repeating 
unit of structure in chromatin known as a nucleosome. Nucleosomes are 
octameric structures made up of dimers of four families of core histone proteins 
labeled H2A, H2B, H3, and H4.  Histones are highly basic and able to bind DNA 
due to its negatively charged backbone making it a very stable complex (Li et al., 
2007). At its smallest repeating unit, approximately 147 base pairs of DNA are 




associated with linker DNA, the DNA between each nucleosome and the 
nucleosome itself facilitating the next level of more compact nuclear 
condensation known as the 30-nm fiber. This structure is then looped and coiled 
into a higher order of condensation  which is typical of transcriptionally repressive 
heterochromatin by non-histone proteins such as condensins, DNA 
topoisomerase, and heterochromatin protein 1 (HP1). Other non-histone proteins 
are chromatin remodeling proteins associated with the disruption of histone 
binding to DNA in order to promote the transcription of gene encoding sections of 
DNA (Alberts et al., 2008). 
 Histones contain large N-terminal tails of amino acids which are subject to 
covalent modifications that further regulate how tightly DNA is wrapped and 
sequestered from transcriptional proteins or other elements in the nuclear milieu. 
Histone modifications are reversible and include acetylation, methylation, 
ubiquitination, sumoylation, along with an abundance of other post-translational 
modifications  to which large databases such as HIstome have been dedicated in 
cataloguing (Khare et al., 2012; Shin et al., 2011). These modifications appear to 
carry out specific patterns of transcriptional regulation that are synergistic or 
antagonistic depending upon the combination of markers in each histone at any 
given time. The acetylation marks and some facultative histone methylation 
marks are thought to be more dynamic and responsive to intrinsic or extrinsic 
regulation than DNA methylation and more "stable" constitutive heterochromatin 
marks  which are heritable across cell generations (Barth & Imhof, 2010; Dunn, 




modifications and forms a large part of the regulatory “histone code” that has 
been consistently observed as either activating or repressive to transcription 
(Strahl & Allis, 2000).  
Table 1: A list of histone methylation modifications. 
Adapted from (Li et al., 2007). 
Histone methylation also uses the universal methyl group donor, SAM, 
similar to DNA methylation. A list of well-known methylation markers and 
functions is shown in Table 1. Repressive and silencing markers such as the tri-
methylation of Histone H3 lysine 9, Histone H4 lysine 20, and histone H3 lysine 
27 contribute to constitutive and facultative heterochromatin. These markers are 
concentrated in areas of DNA that normally are heavily methylated throughout 
adulthood and are resistant to changes in methylation. These include areas of 
repetitive DNA, e.g. retroviral ancestral elements, that are thought to contribute 
transcriptional “noise”, genomic mutation through retrotransposon insertions, and 
cellular dysfunction when expressed (Christensen et al., 2009). Other tri-
Modifications Histone and Position Transcriptional Function 
Lysine Methylation  H3 K4 
 
Activation 
 H3 K9 
 
Repression, activation 
 H3 K27 
 
Repression 
 H3 K79 
 
Activation 
 H4 K20 
 
Silencing 
Arginine Methylation  H3 R2 Activation 
 H3 R17 Activation 
 H3 R26 Activation 




methylation marks such as on Histone H3, lysines 4, 36 and 79, are associated 
with transcriptional activation, relaxing the tightly bound DNA allowing access of 
regulatory elements by transcriptional proteins. Just as there are variants of each 
protein in the DNMT family, there are histone variants of H3, H2, and H1 that are 
conducive to transcription or repression. These variants can also participate in 
other processes such as DNA repair and cell cycle regulation (Jin et al., 2011). 
There are many known histone H1 linker variants in somatic mammalian cells 
that stabilize the genome into heterochromatin states and higher compaction. Six 
variants of H1 (H1.0- H1.5) are found in somatic mammalian cells while two 
variants are specific to testes and oocytes. Histone H1.0 is the most abundant 
subtype in terminally differentiated cells while the other subtypes are associated 
with cell division and vary depending on cell type (Sancho, Diani, Beato, & 
Jordan, 2008). Histone H2 variants reside in heterochromatic areas and promoter 
regions poised for transcription (Histone H2A.Z) or  areas of active transcription 
(H2ABbd) ( Li et al., 2007). Histone H3 variants vary in abundance according to 
tissue type and may play a role in determining and maintaining cellular 
differentiation (Garcia et al., 2008). However, histone variant H3.3 differs in four 
amino acids from canonical histone H3, and deposition is associated with 
increased transcription. During transcription histones must be temporarily evicted 
for transcriptional machinery access to the DNA elements. Subsequent to histone 
methylation marks on histone H3K36 and H3K4, DNA is opened up and histones 
are displaced by RNA Polymerase II and chromatin remodeling proteins. Special 




placements (Li et al., 2007). There are many enzymes for adding and subtracting 
histone post-translational methylation and the enzymes are methylation marker 
specific (Rice & Allis, 2001). Histone post-translational modification is intrinsically 
linked to DNA methylation by DNMT association with histone deacetylases 
(HDACs), histone methyltransferases (HMTs), chromatin remodeling complexes, 
and other transcriptional corepressors altering chromosome structure in tandem 
with DNA methylation (Cheung & Lau, 2005; Cockerill, 2011; Shin et al., 2011). 
Similar to the complex function of DNMTs, many histone enzyme, histone 
variant, and associating protein functions are complex adding more facets to an 
already intricate mechanism of regulation. 
Recently, a third form of epigenetic regulation has been discovered and 
involves the small non-coding RNAs (snRNA). Two types of snRNAs have been 
studied, small interfering RNAs (siRNAs) and microRNAs (also known as miRs or 
miRNAs). Both siRNAs and miRNAs are involved in mRNA or transcriptional 
control. Small interfering RNA is produced by RNA polymerase III, is transcribed 
from repetitive DNA, and is involved in heterochromatin formation. MicroRNAs 
are primarily transcribed in gene regions by RNA polymerase II and are involved 
in mainly posttranscriptional regulation (Nakahara & Carthew, 2004; Yu et al., 
2014).  MicroRNAs are approximately 22 nucleotides long and regulate post-
transcriptional expression via targeted degradation or translational suppression. 
MicroRNA transcripts are highly conserved among different species of mammals 
demonstrating the evolutionary importance of this form of regulation (Chuang, 




and are processed with a guanine cap and polyadenylated tail before editing. 
The discovery of new miRNAs transcripts has increased in surprising numbers, 
from 450 transcripts in 2007 to over 1100 transcripts in 2010, with more being 
continually discovered and predicted in databases such as rna22 and miRBase 
(Chuang, 2007; Kozomara & Griffiths-Jones, 2014; Miranda et al., 2006; Sato et 
al., 2011). 
MicroRNAs are processed after transcription by RNA polymerase II and 
are composed of long stem loop RNA structures known as pri-miRNA. These 
molecules then associate with RNase III endonuclease, Drosha, and DGCR8 that 
make up the microprocessor complex where it is cleaved into an approximately 
70 base pair fragment which is now known as pre-miRNA. From here a complex 
of other proteins stabilize and export the pre-miRNA from the nucleus to the 
cytosol for further processing by associating with Dicer and Transactivation 
Responsive RNA-binding Protein 2 (TARBP2). Dicer has RNase III activity which 
facilitates double strand RNA cleavage. The final miRNA double stranded RNA 
strand, of approximately 22 base pairs is attached to Argonaut (Ago) which in 
participates in miRNA processing to a single stranded RNA.  This complex is 
then loaded onto RISC (RNA induced silencing complex) for posttranscriptional 
regulation of mRNAs. This regulation can occur either through the 
complementary base pairing of mRNA transcripts to the miRNA where RISC 
degrades the mRNA transcript or through an incomplete complementation 
between the miRNA and the 3' UTR region of an mRNA molecule where other 




degradation (Bian et al., 2013; Chuang Jody C., 2007; F. Sato et al., 2011). 
However, miRNA biogenesis, localization, turnover, and activity are all regulated 
by RNA binding proteins (RBPs) which can intercede at different processing 
stages. DEAD-box helicases, (DDXs) also known as Gem-associated proteins 
(Gemins), are a family of putative RNA helicases with a specific amino acid 
consensus sequence, which complexes with Ago to guide the miRNA onto RISC. 
These are potentially important regulators of miRNA to mRNA targeting and post-
transcriptional control. The expression of DEAD-box helicases can be  altered in 
certain disease states (Van Kouwenhove, Kedde, & Agami, 2011; Wilker et al., 
2010). MicroRNA has the capability of controlling the expression of other 
epigenetic factors, such as the DNMTs, histone modifying enzymes, and methyl 
binding proteins (Bian et al., 2013; Denis, Ndlovu, & Fuks, 2011; F. Sato et al., 
2011). MicroRNA can be controlled by epigenetic mechanisms through DNA 
methylation of miRNA coding regions and in the cytosol by RNA binding proteins.  
Genetic and epigenetic stability, aging, and aging pathology 
Aging is considered a temporally based physiological decline that occurs 
through the accumulation of cellular damage causing cellular dysfunction 
accompanied by inappropriate responses of cells to external or internal stimuli 
(Gravina & Vijg, 2010; López-otín et al., 2013). However, in genetic and 
epigenetic terms, the focus is the damage to molecules in the nucleus and the 
disruption of the genome and the epigenome whose regulation is interconnected. 




and miRNA expression, with effects that ripple outward to create excesses or 
deficiencies in cellular protein expression and function.  
Proper gene expression of a somatic cell relies on the fidelity of gene 
sequences during replication, along with all of their regulatory elements, so that 
they may be properly transcribed and translated in concert, providing functional 
proteins affecting the overall function of a cell at any given time and condition. 
DNA sequence damage and mutations, which involve insertions or deletions, can 
cause genetic instability, changing the ability of the cell to function and respond 
to internal or external stimuli (Gravina & Vijg, 2010; López-Otín et al., 2013; 
Wolters & Schumacher, 2013). Extrinsic DNA sequence damage can be caused 
by mechanical, biological, and chemical stressors. Examples of extrinsic forces 
include ultraviolet radiation and mutagenic substances. Intrinsically caused DNA 
damage can occur through oxidative stress via the production of reactive oxygen 
species, spontaneous hydrolytic, deamination, or alkylating reactions, and DNA 
replication or repair errors of the cell (Hoeijmakers, 2009; Lindahl, 1974; Shin et 
al., 2011; Singal & Ginder, 1999; Wolters & Schumacher, 2013). Genetic 
instability accumulates with aging in humans and mice (Vijg & Suh, 2013). It also 
occurs in human accelerated aging diseases such as Werner syndrome, Bloom 
syndrome, and Hutchinson-Gilford Progeria syndrome (HGPS) and many of 
these mutations cause cancer susceptibility associated with aging (Moskalev et 
al., 2013; Wolters & Schumacher, 2013). Werner syndrome and HGPS stem 
from a mutation in the nuclear lamin A/C gene, from which translated nuclear 




expression. These mutations display phenotypes that correlate with both genetic 
and epigenetic instability and many markers of aging.  Disruption of DNA repair 
mechanisms through mutation causes many aging phenotypes including retinal 
degeneration, progressive kyphosis, ataxia, photosensitivity, and 
neurodegeneration (Barzilai et al., 2008; Burtner & Kennedy, 2010; Laugel et al., 
2010) Cellular mitotic or DNA replication errors producing chromosomal 
aneuploidies and variable copy-numbers also increase with aging (Faggioli et 
al.,2012;Forsberg et al., 2012) . Repetitive DNA, unlike genes which make up a 
small percentage of DNA, makes up 40 to 50% of the genome in mice and 
humans respectively (Shapiro & Von Sternberg, 2005; Waterston et al., 2002). 
Repetitive elements are also known as interspersed repeats, retroviral elements, 
and DNA transposons.  Transposable elements (TEs) are a class of repetitive 
elements found in mammals including mice and humans which are able to copy 
and subsequently insert themselves in different areas of the genome when 
expressed (Tomilin, 2008).  Transposition of these elements increases with aging 
in mouse tissue (De Cecco et al., 2013). 
There are four classes of transposable elements in mammals, three of 
which appear to be important in cellular differentiation and can be altered in DNA 
methylation and expression due to nutritional stressors and age (De Cecco et al., 
2013; Martens et al., 2005; Pogribny et al., 2009). The first class, known as long 
interspersed nucleotide elements (LINEs), is independently capable of 
transposition. They are considered non-retroviral elements and contain coding 




an RNA intermediate, create DNA copies via RT, and insinuate themselves into 
the host genome via an endonuclease. Short interspersed nuclear elements 
(SINEs) do not contain RT or endonuclease coding regions, therefore these 
elements require LINE transcription to provide these enzymes. Interestingly, 
LINEs are located in A-T rich regions in gene poor regions and SINEs are 
located in C-G and gene rich areas (Alberts et al., 2008; Waterston et al., 2002). 
A third class of transposable element is the retroviral-like retrotransposon. These 
repeats are more like the retroviral ancestors from which they probably came. 
These include the intracisternal-A particles long terminal repeats (IAP-LTRs) 
whose transcription causes small particles to accumulate in the endoplasmic 
reticulum during embryogenesis and in tumors (Hojman-Montes de Oca et al., 
1983). LTRs contain RT and integrase coding regions. Their transcription 
produces a DNA copy, similar to LINEs, and an integrase implants the DNA into 
a new area of the genome (Alberts et al., 2008).   
Telomeres are repetitive sequences at the ends of chromosomes that are 
rich in guanine and protect DNA from degradation and recombination. Telomere 
loss is strongly associated with aging, progeria, and increases vulnerability to 
genomic instability (Londoño-Vallejo, 2010; López-Otín et al., 2013; Shin et al., 
2011; Sinclair & Oberdoerffer, 2009; Wolters & Schumacher, 2013). Telomere 
sequences attract special proteins that loop the DNA and protect it from damage. 
Due to these proteins, DNA replication and repair enzymes have difficulty 
accessing these regions which consequently decrease in size over time until they 




(Londoño-Vallejo, 2010). Cellular senescence is the cellular state where a cell 
has permanently left the cell cycle and cannot proliferate even upon exposure to 
stimulatory growth factors. Senescent cells also display an aberrant hyperactive 
expression and secretory state and  aging tissue is thought to accumulate these 
types of cells (Blagosklonny, 2011; Campisi & d’Adda di Fagagna, 2007).  
During adulthood, epigenetics plays an important role in maintaining cell 
differentiation, gene expression, genetic stability, and contributes to the ability of 
a somatic cell to change its functions or its state in response to a variable 
environment. This is termed phenotypic plasticity. Epigenetic changes are likely 
to occur in a group of cells responding to the same stimulus unlike genetic 
changes defined by the maintenance of a single cell’s genetic integrity during 
DNA synthesis and cellular division, or exposure to chemical, environmental, or 
biological stressors (Gravina & Vijg, 2010; López-Otín et al., 2013; Shin et al., 
2011). Epigenetic (unlike genetic changes) are dynamic, which allow phenotypic 
plasticity for cellular responses to a stimulus, or reversal of cellular responses 
upon the stimulus cessation. Epigenetic stability involves maintaining the fidelity 
of DNA and histone markers and replications over time but also the plasticity of 
epigenome marker addition, subtraction, or replacement, to changes in intrinsic 
and extrinsic cellular signaling. If parts of the epigenome are no longer able to 
appropriately change according to the condition in which these cells exist, cell 
genome and protein expression can become unresponsive or hyper-responsive, 
meaning that necessary genes either are not expressed or are over-expressed in 




& Vijg, 2010). This concept is what is currently proposed to happen during aging 
through several mechanisms contributing to epigenetic and genetic instability. 
Because genome and epigenome instability are both present in aging cells, it is 
currently debated which event precedes the other as a potential early biomarker 
of cell dysfunction (Pegoraro & Misteli, 2009). When do epigenetic changes start 
to coincide with aging pathology? As yet, there are no firm answers to this 
question however, there is surprising evidence that DNA methylation changes 
occurring early in the life of mammals (i.e. zero to one month in mice) are 
amplified during adulthood and the aging process (Takasugi, 2011). This begs 
the question as to which of these DNA methylation changes could be predictive 
for later detrimental age-related changes or are part of normal aging 
development. Epigenetic stability can be threatened in several ways. The 
environment has a well-established effect on epigenetic markers, especially DNA 
methylation. Chronically present intrinsic or extrinsic stressors, such as altered 
nutritional intake can make lasting differences in epigenetic markers which can 
permanently influence signaling in cells (Pogribny et al., 2006). In addition to 
environmental inputs or insults, epigenetic markers can be affected by random or 
stochastic changes over time which may be defined as epimutations, epigenetic 
drift, or even epigenetic recombination. These can result in observable 
phenotypic traits that cannot be explained by genetics or the environment that 
cause divergent transcriptomes over time (Fraga & Esteller, 2007; Gravina & 
Vijg, 2010; R Holliday, 1987; Poulsen et al., 2007). In addition, just as in genetic 




proliferating cells, errors can make a significant contribution to epigenetic aging 
(Laird et al., 2004). This can promote epigenetic heterogeneity between 
monozygotic twins and in in-bred animal strains that are exposed to similar 
environments and nutritional access (Wong, Gottesman, & Petronis, 2005).  
There are several mechanisms by which the epigenome protects or 
enhances genome function in a cell that can go awry during aging causing 
genetic instability and ultimately cell dysfunction. Many parts of the DNA 
sequence are protectively sequestered from mutations and undesired 
transcription by DNA methylation and epigenetic proteins, such as methyl-
binding, histone, and non-histone proteins. Areas of normally heavily methylated 
DNA regions in adult somatic cells are interspersed repeats and oncogenes. Two 
major events appear to be important factors in aging and aging pathologies via 
DNA methylation. The first is global hypomethylation in CpG dinucleotides and 
concurrent hypomethylation in repetitive elements (Asada et al., 2006; Berdasco 
& Esteller, 2012; V Bollati et al., 2011; De Cecco et al., 2013; Jintaridth & 
Mutirangura, 2010; Mustafina, 2013; Singhal, Mays-Hoopes, & Eichhorn, 1987; 
Thompson, Atzmon, & Gheorghe, 2010). The second event is the 
hypermethylation of tumor suppressor genes and other normally expressed 
genes such as housekeeping genes (Burzynski, 2005; Christensen et al., 2009; 
Chuang Jody, 2007; Fraga & Esteller, 2007; Gentilini et al., 2012; Gravina & Vijg, 
2010; López-otín et al., 2013; Sedivy et al., 2008; Teschendorff et al., 2010).  
While interspersed repeat expression is postulated to threaten genomic stability 




unwarranted cellular proliferation, and appears to be concurrent with silencing of 
tumor suppressor genes by increased methylation, laying the foundation for 
cellular transformation and tumorigenesis during aging.  Global loss of DNA 
methylation is thought to contribute to chronic inflammation and autoimmune 
diseases by making DNA more immunogenic to surrounding cells. Therefore 
more “self” reactivity can occur resulting in less apoptosis of aberrant cells and 
increasing necrosis during aging (Agrawal et al., 2010). DNA methylation 
changes during aging have been demonstrated to polarize T cell differentiation 
patterns and alter receptor expression contributing to autoimmune diseases such 
as systemic lupus erythematosus and rheumatoid arthritis (Goronzy et al., 2010).  
Age-related DNA hypomethylation, transcription, translocation, or even partial 
translation of endogenous retroviral elements may contribute to the development 
of autoimmune diseases (Balada et al., 2010; Perl, 2003). Brains of Alzheimer’s 
patients show global changes in DNA methylation, changes in DNA methylation 
at repetitive elements, gene specific methylation changes, and changes in 
metabolic pathways that affect DNA methylation (Bollati et al., 2011; Coppieters 
et al., 2014; Groen, 2010). Gene specific changes in DNA methylation are also 
associated with osteoarthritis (Barter et al., 2012). Global DNA hypomethylation 
has been associated with aging and is a widespread phenomenon; however 
there are exceptions to the accepted paradigm. In vivo tissue does not always 
show global hypomethylation with age or in progeroid tissues (Osorio et al., 
2010). As a result, the aging epigenome paradigm might be different for different 




Chromatin structure, histones, and histone modifications can also play 
large roles in protecting the cell from genetic and epigenetic instability. As stated 
earlier, chromatin structure, histone alterations, and DNA methylation work 
cumulatively or synergistically to regulate gene function and DNA accessibility. 
There is a strong reorganization of chromatin structure during aging that impacts 
global RNA expression. In aging drosophila there is a loss of heterochromatin 
and a gain of ribosomal RNA expression associated with aging. In murine tissue, 
there is a gain of heterochromatin and loss of total RNA correlated with aging (De 
Cecco et al., 2013). Senescent cell types also exhibit changes in 
heterochromatin formation at normally euchromatin associated areas (Sedivy et 
al., 2008). 
Histone proteins play a role in genomic stability. For instance, DNA 
damage repair triggers H2AX phosphorylation, which is a histone H2 variant that 
senses DNA damage and helps negatively regulate the cell cycle for DNA repair. 
This mechanism helps maintain genomic stability and proper cell function and is 
associated with cellular senescence in aging tissues and progerias (Campisi & 
d’Adda di Fagagna, 2007; Gravina & Vijg, 2010; Hanasoge & Ljungman, 2007; 
Wang et al., 2009). It is also a convenient marker for global DNA damage 
because of this role (Pogribny et al., 2010). Histone methyltransferases and 
DNMTs form complexes and both attain methyl groups from SAM, the universal 
methyl donor. Therefore, it’s not especially surprising to discover that there are 
many histone methylation modifications that change with age, just as there are 




The constitutive heterochromatic markers, histone H3K9 methylation, H3K27 
methylation, and protein HP1 decrease in elderly human cells, senescent cells, 
and progeroid cells (Pegoraro & Misteli, 2009; Sedivy et al., 2008; Shin et al., 
2011). Histone H3K27 tri-methylation levels decrease while messenger RNA 
increases with age in nematodes but not flies (Han & Brunet, 2012). Histone 
H4K20 tri-methylation is also  a heterochromatic transcriptionally repressive 
histone marker that increases in senescent cells, rat liver, and progeroid cells but 
is  decreased in cancer (Fraga & Esteller, 2007; Shin et al., 2011). Loss of 
histone H3K4 methyltransferase, which produces the transcriptionally active tri-
methylation marker, extends lifespan in nematodes. In addition, loss of the 
demethylase for the same marker decreases lifespan for both nematodes and 
drosophila. However, in murine and human brain tissue, histone H3K4 tri-
methylation is decreased with aging (Cheung et al., 2010; Kuzumaki et al., 
2010a). Thus some of the histone markers involved in aging appear to be 
specific to mammalian aging and disease. Histone acetylation, which is a more 
transient marker, shows some differences in age such as increases in H4K16 
acetylation in yeast.  In theory, stochastic changes in histone modifications can 
occur just as in DNA methylation, which would correlate with increased 
stochastic gene expression with age (Gravina & Vijg, 2010). Global acetylation of 
histones H4 and H2A also occur in progeroid mice (Osorio et al., 2010). 
Cognitive decline in mice is associated with the loss of chromatin plasticity via 




 Non-coding RNAs have recently been discovered to alter their expression with 
age in nematodes, with a decline in total microRNA expression and an increase in 
specific miRNA transcripts (Boehm & Slack, 2005; Ibáñez-Ventoso et al., 2006). 
However, no specific miRNA over- or under-expression effects have been discovered 
to modulate aging directly in mammals, though many have been identified for the 
regulation of aging pathways and in cross-sectional studies of aging mammals that 
may be potential targets (Bates et al., 2010; Grillari & Grillari-Voglauer, 2010; Maes, 
An, Sarojini, & Wang, 2008). Some of these targets are shown to have effects on 
DNA methylation regulation, cancer and autoimmune regulation as well (Bian et al., 
2013). Other miRNA transcripts are regulated by other epigenetic mechanisms and 
are involved in many different types of cancer, apoptosis, neurogenesis, 
neurodegenerative disease, senescence, and genomic imprinting all of which are 
affected by, or are correlated with, aging. (Grillari & Grillari-Voglauer, 2010; Sato et al., 
2011). Histone H2AX expression is involved in the DNA damage response and 
cellular senescence. This histone variant is also regulated by miRNA expression and 
is implicated in DNMT expression as well (Denis et al., 2011; Grillari & Grillari-
Voglauer, 2010; Ugalde et al., 2011). However, though some bioinformatical and 
predictive queries have been started, miRNA expression and functional crossovers 
between aging, aging diseases, and epigenetics are still lacking (Inukai & Slack, 
2013). Finally, the transcription of repetitive elements, possibly into small interfering 
RNA, has been suggested to potentially serve some function in the mammalian cell 
and aging in particular, since transcription of some of these families increases with 




The methionine pathway, methylation, and epigenetic s 
The methionine pathway is central to many important biochemical 
reactions and regulation of cellular function. All of the myriad methylation 
reactions of a cell and the nucleus are connected to the methionine pathway, 
also known as one carbon metabolism or thiol metabolism, through the 
production of the methyl donor molecules S-adenosylmethionine (SAM or 
AdoMet). As discussed previously, DNA methylation is very important to 
transcriptional regulation. Histone methylation and it’s “code” for transcriptional 
activation or repression is well studied. Histone methylation marks are more 
stable posttranslational modifications than either acetylation or phosphorylation 
and have specific measurable markers that contribute to all forms of chromatin 
(euchromatin, facultative heterochromatin, and constitutive heterochromatin) 
(Barth & Imhof, 2010). The first step of the methionine pathway involves the 
conversion of methionine to SAM by methionine adenosyltransferase (MAT). This 
step requires ATP and is the rate limiting step of this pathway due to a 
triphosphate intermediate (Wallace & Fan, 2010). SAM is then converted to SAH 
by many different methyltransferase enzymes unless it is shunted to a salvage 
pathway and polyamine synthesis where it is decarboxylated (Cavuoto & Fenech, 
2012). S-adenosylmethionine on its own can act as a riboswitch involved in 
translation inhibition and transcriptional termination by binding RNA affecting 
cellular function. However for methylation reactions, in which it is mostly involved, 
SAM is converted to S-adenosylhomocysteine (SAH) by methyltransferase 




methyl groups is second only to the use of ATP in the cell and is used for the 
methylation of DNA, RNA, histones and other proteins, polyamines, and lipid 
methylation as well as the methylation of some small molecules, demonstrating 
the diverse number of uses for methionine that contribute heavily to cellular 
metabolism and homeostasis (Loenen, 2006). The availability and competition for 
SAM as a substrate affects methyltransferase activity and expression and 
consequently DNA methylation. For instance, induced or inhibitory alteration in 
glycine-N-methyltransferase activity, which competes for methyl groups with 
DNMT, causes alterations in DNA methylation and DNMT activity (Huang et al., 
2007; Martínez-Chantar et al., 2008; Rowling et al., 2002; Ulrey, et al., 2005; 
Wang et al., 2011).  The methionine pathway is also subject to nutritional 
supplementation or deficiency of methionine, or other nutrients, cofactors, and 
hormones as well. These molecules include choline, vitamins B6 and B12, folate, 
insulin, glucagon, growth hormone and glucocorticoids (Aida et al., 1997; Brown-
Borg, Rakoczy, & Uthus, 2005; Ulrey et al., 2005). Diets that are methyl-deficient 
alter the availability of SAM and usually lack one or a combination of choline, 
methionine, or folate. These diets are thought to alter the ratio of SAM: SAH 
abundance which is widely accepted as a reference for methylation capacity 
(Brown-Borg et al., 2005; Cantoni & Chiang, 1980). Nutritional deficiencies or 
supplementation of folate, choline and vitamin B12 have been shown to alter the 
expression of several methionine metabolic enzymes, which in turn induced 
changes in SAM:SAH, global DNA methylation, and histone modifications in 




al., 2005). Altered SAM and SAH levels are known to contribute to human 
disease (Loenen, 2006). S-adenosylhomocysteine is also capable of inhibiting 
methyltransferase activity and possibly DNA methylation (Davis & Uthus, 2004; 
De Cabo, Santos, & Fernández-Piqueras, 1995).  
How is the methionine pathway affected by aging? One of the most 
studied hormones involved in aging is growth hormone (GH). Growth hormone is 
known to regulate components of the methionine pathway. Several murine 
studies, in diverse background strains, show mutant animals deficient in GH 
signaling live significantly longer than their non-mutant siblings (Brown-Borg, 
2009). Furthermore, there are reports that GH administration to GH deficient 
mutants shortens lifespan to wild type levels and greatly affects the enzyme 
activities in the methionine pathway, including many methyltransferases (Brown-
Borg et al., 2005; Panici et al., 2010). 
Growth hormone, methionine pathway, and aging 
Growth hormone is a protein hormone that is released by somatotrophs in 
the anterior pituitary in a pulsatile fashion (Hartman et al., 1993; Vijayakumar et 
al.,2011). Several factors diminish or stimulate its release in humans and mice 
including exercise, sleep, starvation, steroid hormones, and stress (Cornford et 
al., 2011; Hartman et al., 1993; Weltman et al., 2006). GH secretion is affected 
by estrogens and androgens and therefore exhibits sexual dimorphism (Ohlsson 
et al., 2009). Growth hormone also affects DNA methylation of many genes 
based on gender (Takasugi et al., 2013). One molecule of growth hormone from 




facilitates the phosphorylation of the Janus family of tyrosine kinases (JAK2) and 
the serine threonine phosphorylation of the GH receptors. A phosphorylation 
cascade is initiated which can stimulate the Signal Transducers and Activators of 
Transcription (STATs) and many other pathways such as ERK1/2 and MAPK 
(Bartke et al.,2013; Vijayakumar et al., 2011). STAT localizes to the nucleus 
where it can act as a transcription factor through STAT responsive elements on 
many different genes involved in proliferation. GH signaling affects other  
pathways including the phosphotidylinositide 3-kinase/Akt pathway (PI3K/Akt) 
which is primarily responsible for regulating cellular proliferation, cell survival, 
and differentiation (Herrington et al., 2000; Rawlings et al., 2004; Schumacher et 
al., 2008) and GH administration to GH deficient dwarf mice affects many 
components of this pathway in liver tissue (Masternak et al., 2010; Miquet et al., 
2010).  During aging, GH levels decline starting after the age of twenty years in 
humans, and since GH stimulates IGF-1 production and secretion from the liver, 
this hormone declines as well. IGF-1 is important to somatic and central nervous 
system development and brain function (Aberg et al., 1998; Muniyappa et al., 
2007; Ye & D’Ercole, 2006). Though most IGF-1 is produced in the liver, some is 
produced by local tissues with autocrine/paracrine effects (Ohlsson et al., 2009). 
IGF-1 can also affect GH secretion (Bartke et al., 2013; Vijayakumar et al., 
2011). Insulin shares similar pathway mechanisms with IGF-1 signaling and has 
also been implicated in aging across species, including worms, flies, and mice  
(López-Otín et al., 2013). Overexpression of growth hormone in mice leads to 




et al., 1993). In humans there are a number of indicators that the GH, IGF-1 and 
insulin signaling pathways are involved in aging from Laron dwarfs, deficient in 
GH signaling, to centenarians. The lack of many age-related diseases such as 
cancer and diabetes in Laron dwarfs, and delayed cancer among centenarians, 
indicates potential promising cross-over between mice and humans (Bartke et 
al., 2013; Guevara-Aguirre et al., 2011; Heemst, 2010; Longo & Finch, 2003; 
Salvioli et al., 2009; Suh et al., 2008). However, Laron dwarfism (GH receptor 
defect) does not offer any decided prolongation of lifespan in humans as it does 
in mice (Aguiar-Oliveira et al., 2010). Although there is a difference between 
humans and mice in aging phenotypes, some bioinformatics inquiries are tackling 
the species specific similarities and differences in the murine and human 
genomes to help guide the scientific community to more translatable paradigms 
and hopefully a better understanding of somatotropic signaling and human aging 
(Yuan et al., 2011).  
  The liver as an organ of study for aging and methyl ation 
In some mammalian tissues, cells continue to readily divide in a fully formed 
adult organism, such as intestinal wall or skin cells, whereas others are terminally 
differentiated and have lost the capacity to divide, such as neurons. One 
exception is liver cells, which upon insult or partial removal can reenter the cell 
cycle from a quiescent differentiated state to proliferate and replace lost tissue 
(Pennisi et al., 2004; Schmucker & Sanchez, 2011). The liver loses volume, 
blood flow, and the ability to regenerate with age. Also more Kupffer cells are 




associated with aging (Hilmer et al., 2007; Sheedfar et al., 2013). The liver is 
responsible for the first pass metabolism of many pharmaceuticals that can 
increase drug half-life and drug toxicity in aged humans (Klotz, 2009; Pond & 
Tozer, 1984). Therefore, the liver is a very important organ in aging and there is 
an excellent reservoir of scientific evidence demonstrating that epigenetic 
changes occuring in this organ are related to the methionine pathway and methyl 
availability.  
 Many diseases such as hepatitis steatosis (fatty liver), cirrhosis from 
alcoholism, and vascular diseases and inflammation can be correlated with an 
altered production of S-adenosylmethionine (SAM) and its corresponding 
byproduct after methyl group subtraction, S-adenosylhomocysteine (SAH). Liver 
disease and risk of hepatocellular carcinoma increases in humans and animals 
with age as well (Sheedfar et al., 2013). The most abundant methyltransferase in 
the liver, glycine-N-methyltransferase (GNMT), displays diminished expression in 
human hepatocellular carcinoma and GNMT knockout mice show a propensity 
for hepatocellular carcinoma accompanied by differences in DNA and histone 
methylation (Martínez-Chantar et al., 2008). Experimentally increased or 
decreased expression of GNMT in hepatocytes alters DNMT methylation and 
activity, which can further be affected by adding another variable, methionine 
supplementation ( Wang et al., 2011). The activation of GNMT using retinoic acid 
also causes global hypomethylation in rats (Rowling et al., 2002). GNMT is one 
of the methyltransferases in the methionine pathway mentioned earlier, and 




methyltransferases (Yeo & Wagner, 1994). By altering separate nutritional 
components of the methionine pathway, such as choline, and methionine itself, 
many differences can observed in the expression of epigenetic markers and 
mechanisms in murine hepatocytes (in vitro) and murine liver (in vivo).  Methyl-
deficient diets induce miRNA expression changes in mice that are associated 
with diseases and aging (Choi & Friso, 2010). However, common groups of 
miRNAs which simultaneously regulate aging pathways, the methionine pathway, 
and the regulation of the epigenome, still remain to be discovered. Methyl-
deficient diets also alter repetitive element expression which is associated with 
genetic instability, hepatic steatosis, and hepatocellular carcinoma (Asada et al., 
2006; Hsieh et al., 1989; Pogribny et al., 2009). Methyl-deficient diets 
significantly alter DNA and histone methylation in long-lived inbred strains of 
mice compared to short-lived strains and show some interesting differences 
(Pogribny et al., 2009). However, none of these epigenetic modifications have 
been studied in mutant long-lived mouse models compared to their wild type 
siblings, exposing a large gap in the scientific knowledge between aging, the 
methionine pathway, and epigenetic mechanisms. 
 As stated earlier, the liver is very responsive to growth hormone 
and primarily responsible for IGF-1 secretion in the body (Bartke et al., 2013; 
Brown-Borg, 2009). Liver fibrosis, a condition that increases with aging, displays 
differences in DNA methylation and miRNA expression. DNA methyltransferase 1 
negatively regulates the phosphatase and tensin homologue (PTEN), that 




stimulated by GH through JAK/STAT pathways (Bian et al., 2013). The protein 
PTEN is also associated with increased lifespan in many organisms (López-otín 
et al., 2013; Salminen & Kaarniranta, 2010; Scrable et al., 2010). However the 
connection between GH pathways and DNMT expression has not yet been 
demonstrated. Aging mouse liver show higher amounts of γ-H2AX, a marker of 
DNA damage demonstrating decreased genomic stability (Wang et al., 2009). 
Liver tissue from old mice exhibits multinucleated hepatocytes that increase in 
size but without cytokinesis (known as polyploidy). This phenomenon is not well 
understood but is similar to senescence in other cell lines and occurs with aging 
(Lebel, De Souza-Pinto, & Bohr, 2011).  
Ames dwarf mice as a model for epigenetic study and  aging 
 Ames dwarf mice result from a single nucleotide polymorphism in the 
Prophet of Pit-1 gene (prop-1) rendering a loss of function mutation that is unable 
to stimulate Pit-1 gene expression (Andersen et al., 1995; Schaible & Gowen, 
1961; Sornson et al., 1996). This results in an underdeveloped anterior pituitary 
gland devoid of secreting somatotropes, lactotropes, and thyrotropes causing the 
absences of plasma growth hormone, prolactin, and thyroxine stimulating 
hormone, respectively (Bartke, 1964; Sornson et al., 1996). Ames mice exceed 
wild type sibling lifespans by 49-68%, with females showing the largest gain 
(Brown-Borg et al., 1996). Ames dwarf mice have many physiological and 
developmental phenotypic differences from wild type mice including, smaller size,  
lower body temperature, female infertility, delayed incidence of neoplastic 




maintain a juvenile appearance in adulthood (Bartke et al., 2001; Bartke et al., 
2013; Brown-Borg et al., 1996; Hunter et al., 1999; Ikeno, Bronson et al., 2003; 
Schaible & Gowen, 1961). Other important biochemical characteristics related to 
aging in Ames dwarf mice include heightened insulin sensitivity even in old age, 
lower glucose levels, very low IGF-1 plasma levels, enhanced resistance to 
oxidative stress, and an atypical methionine pathway with altered basal 
expression and activity of many enzymes ( Brown-Borg & Rakoczy, 2003; Brown-
Borg, 2009; Chandrashekar & Bartke, 1993; Louis et al., 2010; L. Y. Sun et al., 
2011; Uthus & Brown-Borg, 2003, 2006). GH is known to oppose the actions of 
insulin and contributes to insulin resistance. Another interesting feature of dwarf 
mice is that sexual liver dimorphism gene expression seen in wild type mice 
disappears between male and female dwarf mice (Amador-Noguez et al., 2005; 
Takasugi et al., 2013). When Ames dwarf mice are treated with GH beginning at 
2 weeks of age for 6 weeks, their lifespan becomes shorter and more similar to 
wild type mice. Thyroxine injections however have no effect on lifespan, only 
body weight, illustrating the effects of longevity in dwarf mice is mostly due to a 
lack of GH (Panici et al., 2010).  
While many of the phenotype differences are interesting, the enzymatic 
differences within the methionine pathway have a large potential to alter 
epigenome methylation in Ames dwarf mice, and thereby change phenotypic 
gene expression.  GNMT is an important regulator of methyl donor availability 
and dwarf mice show increased activity and expression of this enzyme. There 




production of methionine into SAM, the universal methyl donor (Uthus & Brown-
Borg, 2003). Ames dwarf mice have a reduced SAM:SAH ratio, that is usually 
associated with reduced methylation capacity, but lack the increased disease 
pathology seen in other mice or in humans (Chen et al., 2010; Elmore & 
Matthews, 2007). However, Ames mice show greater activity in methylation 
enzymes responsible for SAM to SAH conversion, and higher rates of 
transmethylation and transulfuration, demonstrating that they most likely do not 
have a reduced methylation capacity (Uthus & Brown-Borg, 2006). Also, due to 
the fact that the administration of GH in dwarf mice can reverse methionine 
enzyme activity and expression to wild type levels suggests growth hormone may 
be a powerful factor in epigenomic stability and aging.   
The presence of GH diminishes the ability to resist oxidative stress 
(Brown-Borg, 2009). Ames dwarf mice also exhibit a high resistance to 
oxidative stress from reactive oxygen species and an increased expression 
and activity of many antioxidant enzymes including superoxide dismutases 
(SODs), catalase, glutathione, peroxidase, and  on enzymatic antioxidants 
such as glutathione, and metallothionein (Amador-Noguez et al., 2004; Brown-
Borg & Rakoczy, 2000; Brown-Borg & Rakoczy, 2002; Brown-Borg et al., 
2005; Meyer et al., 2003; Sharma et al., 2010; Sun et al., 2011; Swindell et al., 
2010).  While glutathione expression is regulated through enzymes connected 
to the methionine and transulfuration pathways, the heavy metal and free 
radical scavenger, metallothionein can be regulated by the DNMTs through 




Majumder, Ghoshal et al., 1993). This is yet another reason why the Ames 
dwarf mouse may have the potential for important epigenetic alterations 
contributing to aging and longevity. 
There are other models deficient in GH signaling, such as Laron dwarf 
mice, which lack a functional growth hormone receptor and binding protein 
resulting in a mouse resistant to GH (GHRKO mice) (Zhou et al., 1997). These 
mice show increased life spans (38-55% longer) along with many other 
phenotypic similarities with Ames dwarf mice including small body size, delays 
in sexual maturation, oxidative stress resistance, enhanced insulin sensitivity 
and an altered expression of methionine enzymes including GNMT and MAT ( 
Brown-Borg et al., 2009; Brown-Borg, 2009). However, while these mice 
display low levels of plasma IGF-1, they also express high levels of plasma 
GH and normal levels of thyroid stimulating hormone and typically prolactin 
(Al-Regaiey et al., 2005; Coschigano et al., 2000; Coschigano et al., 2003; 
Hauck & Hunter, 2001; Zhou et al., 1997). As the Ames dwarf mice exhibit 
multiple endocrine deficiencies, growth hormone receptor knockout mice are 
thought to be a good model to validate GH effects of aging. However, GHRKO 
mice are created on inbred laboratory strains, whereas Ames dwarf mice 
come from a genetically heterogeneous background. Epigenetically speaking 
there is great variation between laboratory strains alone and in response to 
nutritional stressors such as methyl-deficient diets, so this caveat must always 




Another model used to study the effects of GH and aging are the GH 
overexpressing transgenic mice (GH Tg). These mice live approximately half as 
long as their wild type littermates (Steger et al., 1993). Phenotypically these mice 
are much larger than wild type counterparts, hyperglycemic, insulin resistant, 
sexually mature earlier, and have increased cellular oxidative stress and 
oxidative damage due to increased metabolic activity (Brown-Borg, 2009). Also 
GH transgenic mice show differences in methionine enzyme expression and 
metabolite differences of the methionine pathway (Brown-Borg, unpublished 
data).  
There are human epigenetic differences attributable to longevity. It’s been 
reported that centenarians and their offspring tend to maintain higher DNA 
methylation levels than people without a family history of longevity demonstrating 
additional scientific reasons studying the epigenetic differences of normal and 
long living organisms (Gentilini et al., 2012). One of the most highly conserved 
(top ten) gene sequences among centenarians is DNMT3a, demonstrating a 
potential conservation of important methylation mechanisms. However there are 
more heterozygous IGF-1R mutations in centenarians that may alter the IGF-1 
pathway in these individuals (Suh et al., 2008). Centenarians also have genetic 
telomerase variants that allow retained telomere length contributing to genetic 
stability (Atzmon et al., 2010). Human centenarians are known to have delayed 
cancer and in liver, the very elderly (>75 years of age) exhibit a reduction in 
hepatosteatosis and incidence of hepatocellular carcinoma (Salvioli et al., 2009; 




not been studied in the context of epigenetic changes due to methyl-donor 
capacity and aging. Most aging research in epigenetics is in a developmental or 
diseased context, such as in embryonic stem cells and immortal cell lines derived 
from cancers. However, given that there are differences in “normal aging” and 
“longevity” such as between average life spanned and long-lived humans and 
mice, the context of epigenetic information and discovery with aging is 
enormously incomplete. The methionine pathway is strongly correlated with 
epigenetic differences in mice due to mutational or nutritional stressors, thus we 
were interested in potential differences in well-known methylation mechanisms 
and markers between GH deficient signaling mice (Ames dwarf and GHRKO 
mice) and GH transgenic mice and begin to catalogue important differences due 
to GH and aging.  We expect to see differences in epigenetic markers that show 
increased epigenetic stability indicative of the already greater genetic stability 
noted in long-lived models such as Ames dwarf mice (Brown-Borg et al., 2001; 
Salmon et al. 2008; Sanz et al., 2002). We also expect to see increased 
maintenance of the heterochromatin and DNA methylation and a reduction or 
reversal of changes in markers that are considered to promote or correlate with 
aging. This research is extremely novel and should have profound implications 
and impacts on the study of epigenetics of aging and potential therapeutic targets 




  CHAPTER II 
MATERIALS AND METHODS 
 We designed our cross-sectional age studies to examine DNA methylation 
enzyme activity, expression, and DNA methylation in growth hormone signaling 
deficient mice and GH overexpressing mice. We investigated interspersed repeat 
mRNA expression and methylation in these mice as a tool to investigate genetic 
stability and DNA methylation in gene-poor versus gene-rich regions.  We also 
treated Ames dwarf mice with GH and looked for differences in DNMT and repeat 
expression. Primary hepatocytes from Ames mice were isolated and treated with 
growth hormone to validate our in vivo DNMT and DNA methylation studies as a 
possible future model of pathway investigations. We treated GHRKO (Laron 
dwarf) mice with IGF-1 to examine the effects down-stream of GH signaling 
through mRNA expression of DNMTs. We also studied a putative post-
transcriptional pathway involved in DNMT1 regulation via miRNA expression, 
protein expression, and used methylation specific PCR analysis to probe the 
methylation difference of gene regions reported to be regulated by DNMT1 in 
Ames dwarf and age-matched wild type mice, and mice treated with growth 
hormone or saline. We began the characterization of histone methylation 
modifications cross-sectionally between Ames dwarf mice and their wild type
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 Siblings by immunoblotting of histone extract and included an mRNA expression 
pilot study to locate histone modification enzyme targets.                         
Experimental animals 
All mutant and age-matched wild type mice were taken from colonies at 
the University of North Dakota animal facility. Ames dwarf mice (df/df) result from 
crossing heterozygous (df/+) or homozygous (df/df) male mice with carrier 
females (df/+) that are on a heterogenous background. The growth hormone 
receptor knockout mice (Laron dwarf or GHRKO) that were originally generated 
on an OLA/Balb/cJ background and used in our studies were kindly provided by 
Andrzej Bartke (SIU) (Zhou et al., 1997). They were developed by crossing 129 
OLA/Balb/cJ wild type (GHR+/-) animals with mice derived from C57BL/6J and 
C3HJS strains. These mice were maintained in a closed colony (Panici et al., 
2009). Wild type siblings of both the Ames dwarf and GHRKO mice have median 
lifespans of approximately 2 years (24 months) of age and this age was chosen 
to represent the oldest group for both strains in cross-sectional studies. Three 
months of age was chosen to represent young adult development and twelve 
months was chosen for middle-aged adult mice. The GH transgenic (GH Tg) 
mice used in these studies were derived from a single male founder (strain 
B6SJL) produced by microinjection of the phosphoenolpyruvate carboxykinase 
(PEPCK) promoter region (300 bp)/bGH hybrid gene into the male pronucleus of 
single-cell embryos. The production and characterization of transgenic animals 
(transgenic males crossed to C57Bl/6J x 3C3H/J F1 females) has been 
previously described (McGrane et al., 1988; Steger et al., 1994). The GH Tg line 
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has a median lifespan of  approximately 12 months and at this age we and others 
have observed large numbers of liver tumors (Steger et al., 1993; Brown-Borg, 
unpublished data). Therefore, to avoid using pathological tissue in our studies, 
the oldest group of GH Tg mice used was 10 months of age. Young adult mice at 
three months of age and 6-month-old mice (GH Tg middle aged) with age-
matched wild type controls were used for cross-sectional studies. All of the mice 
were kept under standard laboratory conditions with a twelve hour light/dark 
cycle, room temperature of 22°C, and fed ad libitum (8640 Teklad 22/5l: 22.6% 
crude protein, 5.2% fat, Harland Laboratories) with free access to water. Only 
males of GHRKO, GH Tg and their respective wild type siblings and only wild 
type males of the Ames dwarf line were used to avoid any variability caused by 
sex steroid effects. Groups of Ames dwarf mice groups contained both female 
and male mice. Female dwarf mice are infertile and exhibit biochemical 
characteristics similar to males in many studies. In addition, it has been reported 
that there is a loss of sexual liver dimorphism gene expression in these mice 
(Amador-Noguez et al., 2005). All procedures involving animals were reviewed 
and approved by the UND Institutional Animal Care and Use Committee in 
accordance with the NIH guidelines for the care and use of laboratory animals.  
 For cross-sectional basal expression studies, liver tissue was collected 
from mice at 3, 6, 12 and 24 months of age. Liver tissue was then divided into 
portions, rapidly frozen, and stored at -80°C. Live r tissues were utilized to 
evaluate mRNA and miRNA expression, DNA methylation and methylation 
enzymes, histone methylation, and protein abundance.  
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In vivo GH treatment of Ames dwarf mice and IGF-1 treatmen t of GHRKO 
mice 
 Porcine growth hormone (GH) (NIDDK, National Hormone and Peptide 
Program, Torrance, CA,USA) was administered to 4-6 month old Ames dwarf 
mice and IGF-1 was administered to 6 month GHRKO mice using methods 
published previously to determine whether GH and IGF-1 affects protein 
expression, miRNA and mRNA transcripts, and methylation of our enzymes of 
interest in the liver listed in later sections (Brown-Borg & Rakoczy, 2003; 
Rojanathammanee, Rakoczy, & Brown-Borg, 2013).  Porcine GH in alkaline 
saline mixed with 50% polyvinylpyrrolidone (pH 9, 1:1, saline–PVP) was injected 
subcutaneously twice daily (25 µg in 50 µl /injection) into one group of dwarf mice 
(n= 8-12). The vehicle, saline-PVP was injected subcutaneously (50 µl/injection) 
into another group of dwarf mice (n=8-11) and age-matched wild type mice (n=8-
11) in two separate experiments. Insulin-like growth factor 1 was dissolved in 
saline solution and one group of GHRKO mice (n=8-12) were administered 13µg 
of IGF-1 in 50 µl/injection (Catalogue # CYT-216, ProSpec, Ness-Ziona, Israel). 
The vehicle, saline, was injected subcutaneously (50 µl/injection) into another 
group of GHRKO mice (n=8-12) and age-matched wild type mice (n=8-12) similar 
to the GH administration for Ames dwarf mice. All mice were injected two times 
daily (8:00 a.m. and just before lights out at 8:00 p.m.) for 7 days (total of 13 
injections).  This is done to more closely mimic the pulsatile manner in which GH 
is secreted, which consequently is responsible for the secretion of IGF-1 from the 
liver (Panici et al., 2010; Waxman et al., 1995). On the morning of the seventh 
day, one hour following the last injection of saline-PVP or GH, liver tissue was 
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collected from each group of mice, weighed, frozen, and stored at -80°C until 
analysis.  This experimental protocol has been shown to raise IGF-1 plasma 
levels in the dwarf mouse and the somatic changes due to GH are apparent by a 
gain in body weight  of 1-4 grams (Chandrashekar & Bartke, 1993). To confirm 
GH action in the dwarf, the body weight of each mouse was recorded prior to 
starting the experiment, during, and following the last GH injection to validate 
weight gain in GH-treated animals compared to untreated animals. Liver weights 
were also recorded and compared.  Liver was collected similarly for GHRKO 
treated and untreated GHRKO and wild type mice.   
Hepatocyte isolation and GH treatment in vitro 
 Primary hepatocyte cultures were prepared with liver tissue isolated from 5 – 
6 month old Ames dwarf and wild type mice using previously published pre-
perfusion, collection, and culturing methods (Brown-Borg & Rakoczy, 2003; 
Kreamer et al., 1986). Briefly, each animal was anesthetized with 2.5% 
tribromoethanol (i.p. 100 µl/10 g body wt), the inferior vena cava was cannulated, 
and the liver was perfused with 37°C calcium-free H EPES pre-perfusion buffer 
(160.8 mM NaCl, 3.15mM KCl, 0.7 mM Na2HPO4-7H2O, 33 mM HEPES, and 
0.5mM; pH 7.6) containing 1% penicillin-streptomycin for 15 min followed by 
perfusion with a 37°C collagenase solution (pre-per fusion buffer and 1.0 mM CaCl) 
until livers displayed a swollen appearance and were altered in color indicating blood 
loss and liver digestion (0.033% collagenase [Worthington, Lake Park, NJ]). 
Collagenase separates the lobular parenchyma of the liver to release hepatocytes. 
Following perfusion, livers were removed, placed into warm transfer buffer and 1% 
 
 42   
 
pen/strep (37°C), and the outer membrane of the liv er was carefully excised into a 
petri dish with warm media under a sterile hood. The remaining connective tissue 
was agitated by hand until the media became cloudy indicating the presence of 
freed hepatocytes and the connective tissue (extracellular matrix and epithelial 
tissue) was discarded. The cells were transferred to a conical centrifuge tube and 
pelleted for 3 min at 600 rpm at 4°C and washed thr ee times with ice-cold 
hepatocyte wash buffer containing 1% penicillin-streptomycin until the supernatant 
was clear (Gibco® Life tecnologies, Grand Island, NY). The final cell pellet was 
resuspended in ice-cold serum-free HepatoStim Media containing 1% penicillin-
streptomycin (Becton Dickinson, Mountain View, CA, USA). Trypan blue dye 
exclusion was used to assess cell viability and integrity. Cell collections with ≥ 95% 
viability were used. Cells for each genotype were pooled (n=2-5 mice/genotype), 
resuspended in attachment medium containing 1% pen/strep  and 15% fetal bovine 
serum (to aid in cellular adhesion) and seeded (2 × 106) into MatriGel coated dishes 
(Life Technologies, Grand Island, NY, USA). Following cell attachment (2 hours at 
37°C and 5% CO 2), the medium was exchanged for serum-free HepatoStim media 
(Life Technologies) containing 1% pen/strep and 2 mM glutamine. Serum-free 
media favors differentiation and suppresses growth and proliferation. Following 
overnight recovery, fresh serum-free media was added and the cells were allowed to 
equilibrate (2 hrs.) before GH treatment (0.1, 1.0, 10 and 20 µg porcine GH per ml 
media). Twenty-four hours following treatment (37°C  and 5% CO2), cells were 
collected by washing with cold (4°C) HEPES and appl ying MatriSperse (BD 
Biosciences, Franklin Lakes, NJ, USA) for 1 hour on ice.  
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Dishes were aspirated to remove dead cells and media, scraped, and cells were 
pelleted and washed with ice-cold phosphate buffered saline (PBS) via 
centrifugation. Cell pellets were stored at -80°C o r homogenized immediately for 
downstream assays (see immunoblotting).  
Immunoblotting 
Liver tissue and hepatocyte samples were analyzed using standard 
immunoblotting procedures previously published (Brown-Borg & Rakoczy, 2003). 
Liver tissue was homogenized in lysis buffer (10 mM Tris, 0.15 M NaCl, 5 mM 
EDTA, 1% Triton X) containing serine, cysteine, threonine and trypsin protease 
inhibitors (1mM phenylmethylsulfonyl fluoride (PMSF), 25 mg/ml leupeptin, and 25 
mg/ml aprotinin, or HaltTM Protease and Phosphatase Inhibitor Single-Use Cocktail, 
Catalogue # 78442, Thermo Scientific, Rockford, IL,  at 10µl per milliliter of lysate) at 
4° C using the 24 sample Bullet Blender (Protocol f or Hepatic (Liver) Tissue 
Homogenization, Next Advance Inc. Averill Park, NY). Protein abundance was 
determined using the Bradford assay (Bradford, 1976). Briefly, a protein standard, 
bovine serum albumin, with a starting concentration 80 µg/ml was serially diluted in 
sterile water produce a standard curve of six concentrations (80, 60, 40, 20, 10, 5 
µg/ml). Sample liver lysates were diluted in sterile water at a 1:700 dilution to gain 
absorbance measurements close to our central concentration, 40 µg/ml, for best 
detection. Standards (in triplicate) and samples (in duplicate) were loaded at 50 µl 
per well of a 96-well plate. Bradford Reagent (Catalogue # 500-0006, BioRad, 
Hercules, CA) was diluted with sterile water according to manufacturer directions 
and 150 µl per well was loaded to the standards and samples. The plate was read 
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on a spectrophotometer 96-well plate reader (BioTek Instruments, Winooski, VT) at 
a wavelength of 595 nm. Standard curves of R2≥ 0.95 were used. Protein dilution 
was calculated by comparison to the standard curve. Equivalent protein samples (50 
µg per 10 µl volume) were assembled using Laemmli Buffer solution and β-
mercaptoethanol was added according to manufacturer’s directions (Catalogue # 
161-0747, BioRad, Hercules, CA). Before loading samples were briefly centrifuged 
and heated in a dry-bath at 95-100°C for 5 minutes and 10 minutes for target 
proteins >100kDa. Loading samples were centrifuged again and loaded at 50-75 µg 
per lane, unless otherwise specified. Loading samples were resolved by SDS-PAGE 
(CriterionTM TGXTM Precast Gels Any kDTM, BioRad, Hercules, CA) running at 100 
volts for 3.5-4 hours for proteins >100 kDa (40 minutes to 1 hour for smaller 
proteins). PVDF (polyvinylidine diflouride) membranes for transfer were activated in 
100% methanol for at least 1 hour before transfer. Proteins were transferred to 
PDVF membrane in cold transfer buffer at 100 volts for 30 minutes in cartridges 
backed by filter paper and sponges soaked in cold transfer buffer in a transfer case 
(CriterionTM, Hercules, CA). Transfer buffer contained 10% methanol for larger 
proteins (>100 kDa) and 20% methanol for smaller proteins. After transfer, the blots 
were rinsed briefly in tris-buffered saline containing Tween 20 (25mM Tris-Cl, pH8.0; 
125mM NaCl; 0.1% Tween 20) and blocked in 5% nonfat dry milk in 0.1% T-TBS for 
1 hour at room temperature. Blots were incubated for DNA methyltransferases 
DNMT3b and DNMT1, staining in primary antibody in 1% milk/0.1% T-TBS and in 
primary with antibody in 5% milk/0.1% T-TBS for all other antibodies. All blots were 
rotated overnight at 4° C. Primary antibody (Abcam ®, Cambridge, MA, USA) 
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concentrations were as follows: DNMT3a 1:1,000 (ab14291), DNMT1 1:400 
(ab13537), DNMT3b 1:250 (ab13604), and DEAD-box helicase 20  1:1000 
(ab166913) and glycine-N-methyltransferase (Santa Cruz Biotechnology Inc. Santa 
Cruz, CA, USA, sc-166834). After incubation with the primary antibody blots were 
washed 4-6 times for 10 minutes to reduce background signaling. Blots were then 
incubated and probed for 1.5 hours rotating at room temperature in the appropriate 
horse radish peroxidase  or alkaline phosphatase conjugate secondary between 
1:2000 to 1:5000 dilutions as necessary for each optimized antibody (BioRad, 
Hercules, CA). Solutions for secondary antibody probes were 1% milk/0.1%T-TBS 
for Dnmt1 and Dnmt3b blots and 5% milk/0.1% T-TBS for all other blots. Blots were 
washed 5-6 times in 0.1% T-TBS for 10 minutes to reduce background. Blots were 
developed with chemiluminescent substrate for 5 minutes rotating at room 
temperature and mean optical density was measured and used for comparative 
analysis (UVP Bioimaging system (Upland) with Labworks 4.5 analysis software and 
also Omega Lum™ G imaging system (Aplegen™) with UltraQuant Analysis Software 
version 13.04.05). Ponceau S staining was used to assess equivalent loading.   
Nuclear extraction and DNMT activity assay 
 Liver nuclear extracts were prepared from frozen liver tissue according 
to manufacturer’s directions using an Epiquick Nuclear Extraction Kit 
containing premixed proprietary buffers, dithiothreitol (DTT),  a positive DNMT 
enzyme control, and a protease inhibitor cocktail mix (OP-0002, Epigentek, 
Farmingdale, NY, USA). Briefly, liver was homogenized at 4° C (Bullet 
Blender, Next Advance Inc. Averill Park, NY) in a nuclear pre-extraction buffer 
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containing DTT to lyse the cellular membrane and release intact nuclei from 
the cells. Lysate was then incubated on ice for 15 minutes and centrifuged for 
10 minutes at 12,000 rpm at 4°C. The supernatant (c ytosolic fraction) was 
either kept for negative control in fresh tubes or discarded. To the remaining 
nuclear pellet, nuclear extraction buffer, DTT, and a protease inhibitor cocktail 
was added. The nuclear extraction was incubated on ice and vortexed for 5 
seconds every 3 minutes during incubation for a total 15 minutes. The 
suspension was then centrifuged for 12 minutes at 13,200 rpm at 4°C and the 
supernatant containing nuclear proteins was transferred to a fresh 
microcentrifuge tube. Protein abundance was measured using the Bradford 
assay as previously mentioned (Bradford, 1976). Protein was immediately 
aliquoted for DNMT activity assessment and the remaining nuclear lysate was 
stored at -80°C until further use. Activity of DNMT  was measured using 
Epigentek DNA methyltransferase Activity/Inhibition Assay Ultra Kit following 
manufacturer's directions. This assay contains proprietary buffers, colorimetric 
solutions, SAM substrates, antibodies, and 8-well microplate strips containing 
cytosine-rich DNA substrate that can be used in a 96 well format frame for 
spectrophotometry. (P-3009, Epigentek, Farmingdale, NY, USA). These 
assays are colorimetric similar to ELISA assays that use color changing 
reactions, such as 3,3',5,5'-tetramethylbenzidine, that react to horse radish 
peroxidase to yield a blue color when detecting HRP. Then an acidic solution 
is applied turning the reaction yellow with a maximum absorbance of 450 nm. 
Optimization was determined to be 20 µg of lysate per well by serial dilution of 
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sample to detect an appropriate magnitude of absorbance for maximum 
detection. Previously aliquoted protein was diluted to a final concentration of 
6.67 µg/µl.  Assay buffer was aliquoted into each well (24 µl per well) and 3 µl 
of protein solution was added. Blank wells were assayed in buffer alone and 
positive wells contained 50 ng of DNMT control and assay buffer. S-
adenosylmethionine substrate was diluted to a 1:5 solution and 3 µl added to 
each well (final volume of 30 µl per well). Wells were incubated at 37°C for 1.5 
hours and the plate was mixed during incubation so the cell sample DNMT 
could methylate the coated plate substrate cytosine residues. Wells were 
aspirated and washed 3 times with wash buffer and 50 µl of the 5’-
methylcytosine capture primary antibody (1:1000 wash buffer dilution) was 
added. The plate was incubated at room temperature (22°C) for 60 minutes on 
an orbital shaker. Wells were aspirated and washed 4 times with wash buffer 
and 50 µl of the detection secondary antibody (1:1000 wash buffer dilution) 
was added and incubated at room temperature for 30 minutes. Wells were 
then aspirated and washed 5 times with wash buffer. Developer solution was 
added to each well (100 µl) and incubated at room temperature for 2-10 
minutes (with the plate protected from light) until a medium blue hue was seen 
indicating a reaction between the solution and the secondary antibody. An 
acidic stop solution was added turning the reactions yellow.  Samples were 
run in triplicate, included one blank well, and one positive control well and 
analyzed using dual-wave spectrophotometric analysis (630nm and 450nm). 
The amount of methylated DNA is proportional to the enzyme activity and is 
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calorimetrically quantified by an ELISA-like reaction.  Dnmt activity which is 
measured in optical density/hour/milligram was calculated by subtracting the 
negative control optical density from the optical density of the reaction. This 
value was then divided by the amount of sample protein added in micrograms 
that was multiplied by the initial incubation time in hours. This dividend was 
then multiplied by 1000 to convert micrograms to milligrams for the final value.  
Messenger RNA expression via one-step RT-PCR 
Total RNA was isolated using Ultraspec® RNA (Catalogue # BL-10050, 
Biotecx, Houston, Texas), based on a previously described method and 
measured with a spectrophotometer for quality and purity using the optical 
density ratio of 260nm/280nm from 1.8-2.0 (Brown-Borg et al., 2009; 
Chomczynski & Sacchi, 1987). The RNA was then diluted and used to 
measure expression of genes of interest in 3, 12, and 24 month old Ames 
dwarf and GHRKO mice and also 3, 6, and 10 month old GH Tg mice and 
compared to age-matched wild type controls. Ames dwarf and wild type 4-6 
month old mice used in the GH administration experiments were also studied 
for mRNA expression. Genes of interest are listed along with the primers used 
for these experiments (Table 2). Primers were obtained from previous 
literature (Chen et al., 2005; Ray et al., 2006; Sharma et al., 2010; Uthus & 
Brown-Borg, 2006), screened against the whole mouse genome for 
unintended targets using NCBI primer blast, and optimized. Reaction 
substrates were contained in the QuantiTect SYBR® Green RT-PCR Kit 
(Catalogue # 204243, Qiagen, Valencia, CA). 
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Primer 5’ - 3’ Annealing  
Temperature 
β2M NM_00975 For - AAGTATACTCACGCCACCCA 60°C 
  Rev - AAGACCAGTCCTTG  
Histone 
H4 
 For- ACAACATCCAGGGCATCACG 60°C 
  Rev- GAAGACCTTCAGCACACCGC  
GNMT NM_010321 For - GCTGGACGTAGCCTGTGG 60°C 
  Rev - CACGCTCATCACGCTGAA  
DNMT1 NM_010066 For - AAAGTGTGATCCCGAAGATCAAC 60°C 
  Rev -
TGGTACTTCAGGTTAGGGTCGTCTA 
 
DNMT3a NM_007872 For – TGCTACATGTGCGGGCATAA 58°C 
  Rev- GGAGTCGAGAAGGCCAGTCTT  
DNMT3b NM_0010039
61 
For – CCCAAGTTGTACCCAGCAATTC 59°C 
  Rev – TGCAATTCCATCAAACAGAGACA  
DDX20 NM_ 017397 For - ACATGCATCGGATTGGCAGA  60°C 
  Rev - CCCAGGCGTTCTTTGAGACT  
MT1 NM_013602 For - CCTTCTCCTCACTTACTCC 60°C 
  Rev -TCCATTCCGAGATCTGGTGAA  
MT2 NM_008630 For - TCCTAGAACTCTTCAAACCGATCT 
 
65°C 
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The reaction mixtures contained SYBR green, forward and reverse primers, 
and QuantiTect RT mix, a Taq DNA polymerase, and assayed using a 
SmartCycler instrument (Cepheid, Sunnyvale, CA) or a CFX 96TM Real-Time 
PCR Detection System (BioRad, Hercules, CA). Polymerase chain reactions 
included an initial reverse transcription step of 50° for 30  minutes, a taq 
polymerase activation and denaturation step at 95°C  for 15 minutes, PCR 
cycling of 95°C for 15 seconds and an annealing tem perature of 50-60°C 
(Table 2) for 30 seconds. These reactions were run for 40-45 cycles. Melt 
curve analysis and standard curve optimization was used for quality control 
of the PCR reaction and detection. No template controls and no reverse 
transcriptase treated template controls were used to check for cross-
contamination and genomic DNA contamination respectively. Data was 
analyzed using the ∆∆Ct, also known as the comparative Ct method, which 
calculates in reference to the control (the genomic DNA control specific to 
mouse, the reverse transcription control from the cDNA reaction in triplicate, 
and the positive PCR control in triplicate). The amount of tested gene cDNA 
relative to a control gene (β2-microglobulin) was determined using the ∆∆Ct 
(comparative Ct method) as previously published (HM Brown-Borg et al., 
2009; Lupberger et al., 2002). The Ct value is the number of cycles it takes 
for a sample to reach the level where the rate of amplification is the greatest 
during the exponential phase and the value is inversely proportionate to the 
amount of RNA or cDNA in the sample. ∆Ct for each mouse type is 
calculated as ∆Ct = Ct (gene of interest)–Ct (average of β2m RNA). ∆∆Ct is calculated as 
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∆∆Ct = ∆Ct (Ames experimental) - ∆Ct (wildtype control) of the same age group and the 
fold change in expression will be calculated as 2 (-∆∆Ct). A one-fold change 
indicates no change in transcription, a greater than one-fold change 
suggests increased transcription, and a less than one-fold change indicates 
decreased transcription (Heid et al., 1996). 
miRNA expression via two-step RT-PCR 
The miRNA 1st-Strand cDNA Synthesis Kit (600036, Agilent Technologies, 
Wilmington, DE) was used on isolated total liver RNA (1 µg per reaction) to 
polyadenylate and elongate miRNA at the 3’ end of the transcript in the sample 
with a bacterial polyadenylate polymerase (PAP). A no PAP control was included 
to screen for contamination. All steps were done with samples on ice except 
during incubation periods. Then the miRNA is reverse transcribed using a 
genetically engineered Moloney murine leukemia virus reverse transcriptase into 
cDNA according to the manufacturer’s directions. RNase inhibitors are also 
included to prevent miRNA degradation during the process. The RT portion of the 
kit also provides a proprietary “RT adaptor primer” which anneals to the 3’ end of 
the poly A tail and creates a universal sequence tag during the amplification that 
is incorporated into the 5’ region of the transcripts. This tag allows the use of a 
proprietary universal reverse primer to be used during real-time qPCR 
amplification (Agilent Technologies, 600037, Wilmington, DE). Forward primer 
sequences for miR-140-3p and the 5S rRNA control  were verified for use in 
mouse using miRBase and NCBI GenBank (Table 3; Takata et al. 2012; Bates et 
al. 2010). For miRNA expression validation a commercially prepared validated 
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control for U6 splicoeosomal RNA (RNU6) (MiScript Primer Assay,Catalogue # 
MS00033740, Qiagen, Valencia, CA). RNU6 is an approximately 100 basepair 
non-coding RNA that complexes with RNA splicing proteins for mRNA 
processing. RT-PCR was performed using the PerfeCta® SYBER® Green 
SuperMix (Catalogue # 95054, Quanta Biosciences, Gaithersburg, MD), forward 
and reverse primers, nuclease free water and polyadenylated cDNA. Reactions 
were run using CFX 96TM Real-Time PCR Detection System (BioRad, Hercules, 
CA), reactions beginning with denaturation step of 95 ° C for 3 m inutes, followed 
by cycling conditions of 95 ° C for 15 seconds, 60°  C for 30 seconds, for 45 
cycles. Controls for cross-contamination and genomic DNA contamination were 
utilized. Melt curve analysis was used for quality control of the PCR reaction and 
detection. The amount of tested gene cDNA relative to a control gene, 5S rRNA, 
was determined using the ∆∆Ct (comparative Ct method). 
Interspersed repeat transcription two-step RT-PCR 
Total RNA was treated with DNase I according to the manufacturer’s protocol to 
eliminate genomic DNA contamination through a non-specific endonuclease 
action, which degrades DNA in the RNA samples (Catalogue #M0303S/L, New 
England Biolabs, Ipswich, MA). All steps were performed with samples on ice 
except during incubation. Briefly, 10 µg of RNA was suspended in DNase I 
reaction buffer which includes enzyme activating cations such as Ca2+ to a final 
volume of 100 µl. Two units of DNase I were added to each sample mixture and 
were mixed thoroughly by inverting samples roughly 20-30 times. Reactions were 
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briefly centrifuged and put into a dry bath at 37°C  for 10 minutes. To terminate 
the reaction, 1 µl of 0.5M EDTA was added and the samples were then heat 
inactivated for 10 minutes.  RNA  was converted to cDNA by use of Protoscript 
M-Mulv Taq RT-PCR reagents from New England Biolabs, Ipswich, MA) along 
with control reactions to verify cDNA  synthesis and the absence of gDNA 
contamination (Filkowski et al., 2010; Martens et al., 2005; Pogribny et al., 2009). 
DNase I treated RNA (1 µg ) was put into a mix with a random primer mix (2 µl, 
60 µM), a deoxynucleotide (dNTP)  solution mix (1 µl, 10mM), and nuclease free 
water to a final concentration of 16 µl (Catalogue #S1330S, #N0447S/L, New 
England Biolabs). The random primers mix is designed to allow the reproduction 
of the complete complement of messenger RNA to complimentary DNA in a 
sample. This mix was briefly centrifuged and put in a dry bath at 70°C for 5 
minutes after which the samples were promptly chilled on ice. Then, to each 
reaction 2 µl of 10x RT buffer, 20 units of Murine RNase inhibitor, 200 units of 
Moloney Murine Leukemia Virus reverse transcriptase (M-MuLV), and 0.5 µl of 
nuclease free water were added. Samples were again briefly centrifuged and 
incubated at 25°C for 5 minutes then incubated at 4 2°C for one hour. To 
terminate the reaction and inactivate the enzyme, the samples were then 
transferred to a dry bath at 80°C for 5 minutes. Nu clease free water was added 
to bring the final volume to 50 µl and the reactions were placed on ice. 
Successful reaction were validated by PCR using a control primer set (β2-
microglobulin)  and running a negative control (reactions without the reverse 
transcriptase added) alongside reverse transcriptase treated samples on a 2% 
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agarose gel.  Complementary DNA (cDNA) products were used immediately or 
stored at -20°C for downstream PCR applications. Ta ble 3 lists the primers used 
which were taken from previous publications or designed via NCBI primerblast 
(Lane et al., 2003; Martens et al., 2005). All primers were verified via NCBI 
primerblast and/or Repbase, which is a database established purely for repetitive 
sequences. Reactions were performed using the QuantiTect SYBR® Green PCR 
Kit. The reaction mixtures contained, forward and reverse primers, and 
QuantiTect SYBR Green PCR Buffer, a taq DNA polymerase, and assayed using 
a SmartCycler instrument (Cepheid, Sunnyvale, CA). Polymerase chain reactions 
included an initial taq polymerase activation and denaturation step at 95°C for 15 
minutes, PCR cycling of 95°C for 15 seconds, an ann ealing temperature of 60-
63°C (Table 3) for 30 seconds, and an extension ste p of 72°C for 30 seconds. 
These reactions were run for 40 cycles. Standard curves were performed 
between the transcripts of interest and β2m, RNA and primer concentration and 
reaction conditions were optimized, and standard RT-PCR controls, similar to the 
aforementioned experiments, were used. The amount of tested gene cDNA 
relative to a control gene (β2m) was determined using the ∆∆Ct (comparative Ct 
method) as previously mentioned for one step RT-PCR experiments (Bates et al., 
2010; Brown-Borg et al., 2009; Heid et al., 1996). 
McrBC-qPCR DNA methylation assay 
 McrBC is an endonuclease which cleaves DNA containing 5-
methylcytosine or 5-hydroxymethylcytosine or N4-methylcytosine on one or both 
strands of genomic DNA. McrBC will not act upon unmethylated DNA and 
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depends on the presence of guanosine tri-phosphate (GTP) for cleavage 
(Sutherland, Coe, & Raleigh, 1992). This allows for the enrichment  of  non-
methylated genomic DNA which can then be compared to non-digested genomic 
DNA following qPCR using the absolute standard method (Filkowski et al., 2010; 
Martens et al., 2005; Pogribny et al., 2009). 
 TABLE 3: Primer pairs utilized for McrBC-PCR and miRNA two-step RT-PCR. 
 
DNA was extracted from the liver using a Gentra® Puregene® Tissue Kit 
(Catalogue # 154667, Qiagen, Germantown, MD, USA) and was homogenized 
using the Bullet BlenderTM. Briefly, 10-15 mg of liver tissue was homogenized in 
100 uL of Cell Lysis solution from the Gentra Puregene kit on ice. After the initial 
homogenization another 200 µl of Cell Lysis solution from the Gentra Puregene 
kit was added to each sample (on ice) and run in the Bullet Blender at a lower 






Primer 5’ - 3’ Annealing  
Temperature 
LINE1 3’UTR D84391 
 
For - TTGATCACAGGGCTCCCAATGGAG  60°C 
  Rev - GTACCGGGGCACACAAAGTCTGCG   
IAP-LTR M17551 
 
For - TGCGCATATGCCGAGGGTGGTT  63°C 






For - GTGGCGCACGCCTTTAATC 63°C 
  Rev -GACAGGGTTTCTCTGTGTAG 
 
 
SINE B2 J00630 
506-700 bp 
 
For –GAGATGGCTCAGTGGTTAAG 60°C 
  Rev- CTGTCTTCAGACACTCCAG  
miRNA 140 -
3p 
NR_029553 For – TACCACAGGGTAGAACCACGG 59°C 
5S rRNA NR_046144 For-CAGGGTCGGGCCTGGTTAGTACTTG 60°C 
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spectrophotometrically using OD of 260nm/280nm for purity and samples 
measuring 1.8-2.0 were used for the assay (Epoch Micro-Volume 
Spectrophotometer System, BioTek Instruments,Inc., Winooski, VT). DNA was 
aliquoted into 25-50 µl and kept in -80º C until needed. Genomic DNA was 
diluted in TE buffer (10 mM Tris, 1 mM EDTA, at pH8) and sonicated using the 
UCD500-Bioruptor XL® (Life Research ©, Scoresby, Victoria, Australia) user 
manual version 2.1 to increase the efficiency of downstream restriction enzyme 
digestion. After genomic sonication was complete samples were run on a 1% 
agarose gel to validate DNA fragment sizes of 3-5 kilobase pairs. Restriction and 
mock restriction reactions were set up with nuclease free H20, buffer provided by 
New England Biolabs, a GTP substrate, bovine serum albumin, and 1µg of 
genomic DNA. Lastly, 3 µl (30 U) of McrBC was in a 50% glycerol solution for 
restricted gDNA and for mock restrictions 3 µl 50% glycerol in nuclease free 
water. Plasmid DNA was also provided as a positive control for enzyme activity. 
(Catalogue # M0272S or M0272L, Ipswich, MA). Final reaction volumes were 
100 µl. Sample reactions were gently mixed by tapping the tube lightly, or 
inverting the tube gently several times, and incubating overnight at 37 °C 
(Holemon et al., 2007; Martens et al., 2005). Reactions were inactivated by 
heating the samples to 65°C for 20 minutes. The pos itive control plasmid DNA, 
mock restricted, and restricted samples were verified through electrophoresis on 
a 1% agarose gel. Table 3 shows all primers that were used which are the same 
primer sets used for two-step RT-PCR transcriptional analysis of the interspersed 
repeats as previously mentioned. Reactions for mock-restricted and restricted 
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samples were assembled and run together in duplicate. Reagent contents, 
primers, and thermocycling conditions were equivalent to the previously stated 
qPCR measurement of interspersed repeat transcription parameters. As in 
previous publications, the absolute quantification analysis of qPCR was used 
where the threshold cycle (Ct) is defined as the fractional cycle number that 
passes the fixed threshold. Ct values for each repetitive element were converted 
into the absolute amount of input DNA using the absolute standard curve 
method. An increased amount of input DNA after digestion with McrBC compared 
to mock-restricted DNA is indicative of hypomethylation, whereas a decreased 
amount of input DNA is indicative of hypermethylation (Filkowski et al., 2010; 
Pogribny et al., 2009) 
Global methylation assay 
 Global methylation of isolated genomic DNA (see above in the McrBC-qPCR 
methylation assay) was determined using the MethylampTM Global DNA 
Methylation Quantification Ultra Kit (Catalogue # P-1014B, Epigentek, Farmingdale, 
NY, USA) according to the manufacturer’s instructions. This kit is a colorimetric 
assay similar to ELISA reactions that probes for 5’-methylcytosine using antibodies. 
The kit includes proprietary buffers including wash buffer, binding buffer, blocking 
solution and antibodies, developer and stop solutions and also unmethylated DNA 
(negative control, 100 ng per well) and fully methylated DNA (positive control, 10 ng 
per well ). The DNA sample (200 ng per well), positive control and negative control 
DNA are aliquoted into wells coated with a DNA affinity substance and the DNA 
binding solution is added to a final volume of 30 µl per well. The plate was gently 
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shaken and incubated uncovered at 37°C for 40 minut es in room air. Afterwards the 
samples were incubated at 60°C for 35-40 minutes ev aporating all the solution and 
drying the wells. If the wells were not completely dry, wells were aspirated of the 
remaining solution with 10 or 20 µl pipette tips or incubated at 60°C for 5-10 
minutes more according to manufacturer directions. Blocking solution was then 
added at 150 µl per well and incubated at 37°C for 30 minutes. Wells were 
aspirated and washed three times with 150 µl of wash buffer at room temperature. 
The capture antibody was added in a 1:1000 dilution (1 µg/ml, 50 µl/well) in wash 
buffer. The wells were covered and incubated at room temperature (22°C) for 1 
hour. Wells were aspirated and washed four times with 150 µl of wash buffer at 
room temperature. The detection antibody was added in a 1:5000 dilution (0.08 
µg/ml, 50 µl/well) in wash buffer. The wells were covered and incubated at room 
temperature (22°C) for 30 minutes. Wells were then aspirated and washed five 
times with 150 µl of wash buffer at room temperature. A signal enhancer was 
added in a 1:5000 dilution (50 µl/well) in wash buffer. Wells were again, aspirated 
and washed five times with 150 µl of wash buffer at room temperature. A developer 
solution was added (100 µl/well) and incubated at room temperature (22°C) for 1 to 
5 minutes (protected from light). As in the DNMT activity assay previously 
mentioned, color development was monitored and stop solution (50 µl/well ) was 
applied after the reactions had reached a medium blue color. Samples and controls 
were run in triplicate and analyzed using dual wave spectrophotometric analysis 
(630 nm and 450 nm). To calculate the percent methylation of the samples, the 
negative control absorbance was subtracted from the sample absorbance. This 
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number was then divided by 0.42 because there is a 42% DNA GC content in 
mouse DNA. This number was then divided by the difference between the positive 
control minus the negative control multiplied by 20 since there is a 20 fold 
difference in concentration between the sample genomic DNA and the fully 
methylated positive control. This number is then multiplied by 100 to obtain a 
percentage calculation of methylated DNA. Methylation was normalized to the 3 
month wild type mice for GH signaling deficient mice, where in 2 assays, the 
positive and negative controls were similar in absorbance and had the same lot 
numbers, were averaged (within 2 standard deviations) between assays and thus 
were used for subsequent cumulative analysis. For GH Tg assays, differences 
between the control absorbance measurements between the two plates were too 
large (58% difference), therefore the first assay was normalized to 3 month old wild 
type mice, and the second assay was normalized to 6 month wild type mice.  
Methylation-specific PCR analysis  
 Genomic DNA was isolated from dwarf and wild type liver tissue (Gentra 
Puregene Tissue Kit; Qiagen, Germantown, MD), and bisulfite treated using the 
BisulfFlashTM DNA Modification Kit (Catalogue # P-1026, Epigentek, Farmingdale, 
NY). Bisulfite treatment of genomic DNA results in the deamination of cytosines 
not protected by methylation, to uracil. Upon PCR amplification of this product, 
uracil is converted to thymine thus 2 sets of primers are used to probe for 
methylated and unmethylated cytosines of CpG dinucleotides to assess the 
methylation status of the target region. This kit contains a proprietary conversion 
buffer, a conversion enhancer solution, and a denaturation enhancer which 
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protects DNA from degradation and keeps it denatured during the bisulfite 
conversion. These three agents are first mixed together and 200 ng of genomic 
sample DNA was added to each reaction and subsequently used for methylation-
specific PCR (Herman, Graff, Myöhänen, Nelkin, & Baylin, 1996). Primers (Table 
4) were designed for predicted methylated and unmethylated sequences of CpG 
dinucleotide islands using the MethPrimer program (Li & Dahiya, 2002). 
Thermocycling conditions and primer concentrations were optimized using RT-
PCR and PerfeCta® SYBR® Green SuperMixTM (Catalogue # 95054, Quanta 
Biosciences, Gaithersburg, MD) to ensure end products for agarose gel analysis 
were produced during the exponential phase of the reaction for methylation 
comparison. This mix contains the same AccuStartTM taq DNA polymerase as the 
AccuStartTM II PCR SuperMix used for the MS-PCR experiment reactions 
(Catalogue #95127, Quanta Biosciences, Gaithersburg, MD). Reactions contained 
AccuStartTM II PCR SuperMix, the forward and reverse primers for each 
methylation state (methylated versus unmethylated; 1 µM), and 1µL of bisulfite 
treated DNA (10 ng) for a total volume of 15µl. Thermocycler (Eppendorf 
Mastercycler) conditions consisted of an initial denaturation step at 95°C for 15 
minutes, PCR cycling of 95°C for 15 seconds, an ann ealing temperature of 55°C 
for 30 seconds, and an extension step of 72°C for 3 0 seconds. Reactions were 
held at 4°C. Samples were run on a 2% agarose gels,  stained with ethidium 
bromide and band intensities of methylated PCR products were compared to 
unmethylated PCR products using Omega LumTM G imaging system (AplegenTM, 
Pleasanton, CA) and UltraQuant version 13.04.05.   
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177-328  For - TTTTAGGGAGTTTTGTATTTCGTTC 55°C 
  Rev - AACAACCTACCCTCTTTATAATCGTT  
MT1 
unmethylated 




  Rev - AACAACCTACCCTCTTTATAATC TT  
MT1 methylated 465-570  For - GAATATTAAGTTGGGATCGTAGAGC 55°C 
  Rev - AAAACGAATTCTAAAAAAAACCGA  
MT1 
unmethylated 




  Rev - AAAACAAATTCT A AAA A CA A  
MT2 methylated 105-280 For - TTGTTTTACGAGTAAAAAGAGGTC 55°C 
  Rev -TAACGAAAAATATTAAATCGAACGC  
MT2 
unmethylated 
105-280 For - TTGTTTTACGAGTAAAAAGAGGGTC 
 
55°C 
  Rev- ATAACGAAAAATATTAAATCGAACG 
 
 
LINE1 3’ UTR 
methylated 
150-324 For- GGATTAGAGGATAGGTGTTCGTTC 60°C 
  Rev- TACCTCAATACCTCTATACTTCCGC  
LINE1 3’UTR 
Unmethylated 
150-324 For- GGATTAGAGGATAGGTGTTTGTTTG 60°C 
  Rev- ACCTCAATACCTCTATACTTCCACC  
LINE1 3’UTR 
Methylated 
528-676 For- GTTGAGGTAGTATTTTGAGTGGGTC 60°C 
  Rev- AAACTAATTTCCTAAATTCGACGAA  
LINE1 3’UTR 
Unmethylated 
528-676 For- GTTGAGGTAGTATTTTGAGTGGGTT 60°C 
  Rev- AAACTAATTTCCTAAATTCAACAAA  
IAP-LTR   UTR 
Methylated 
105-298 For- TTATGTGTTTTGTTTTTTTCGTGAC 60°C 
 
 
 Rev- CACAAACCAAAATCTTCTACGAC  
IAP-LTR   UTR 
Unmethylated 
105-298 For- ATGTGTTTTGTTTTTTTTGTGATGT 60°C 
  Rev- ACCACAAACCAAAATCTTCTACAAC  
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Histone extraction and immunoblotting 
Histones were extracted from 3, 12, and 24 month old Ames dwarf and wild 
type age matched livers using the EpiQuik™ Total Histone Extraction Kits 
(OP-0006, Epigentek, Brooklyn, NY, USA) according to the manufacturer’s 
protocol. Briefly, weighed pieces of tissue sample were homogenized in a 
pre-lysis buffer then centrifuged at 3000 rpm for 5 minutes at 4°C. After 
discarding the supernatant, the cellular pellet was re-suspended in lysis 
buffer and incubated on ice for 30 minutes. Samples were then centrifuged 
at 12,000 rpm for 5 minutes at 4°C and the supernat ant fraction containing 
the acid-soluble proteins was transferred into a new microtube. A balance 
buffer containing DTT solution was added to the supernatant immediately 
and chromatin was quantified using a spectrophotometer using the 
Bradford method. Histone extracts (50 µg/ lane) were be separated via 
electrophoresis, transferred to PVDF membrane, and specific proteins 
detected using standard immunoblotting techniques and 
chemiluminescence. Antibodies to pan-Histone H3 (07-690) 1:2000 dilution, 
trimethyl-Histone H3Lys4 (07-473), trimethyl-Histone H3Lys27 (07-449), 
trimethyl-Histone H3Lys9 (07-442), trimethyl-Histone H4Lys20 (04-079, 
Millipore, Temecula, CA) were used. Densitometric analysis was conducted 
using an Omega Lum™ G imaging system (Aplegen™) and UltraQuant 
Analysis Software version 13.04.05. GelCode® Blue Stain reagent 
(ThermoScientific, Rockford, IL, USA) was used to assess equivalent 
protein loading (Kingston, 2010) 
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Histone chromatin modification enzyme RT-PCR pilot study 
 Histone modification enzyme mRNA expression was probed in 3-month-old 
Ames dwarf and age-matched wild type mice to look for differences in expression of 
these enzymes. For this study the murine Epigenetic Chromatin Modification 
Enzymes RT2 Profiler PCR Array was used (Catalogue # PAMM-085A, Qiagen, 
Valencia, CA) which contains a 384 well plate coated with mRNA amplification 
primers for 4 sets of 84 genes, allowing 4 samples to be assayed at one time (n=2 
mice/genotype). The 384 (4 replicate x 96 well) option contains 4 replicate primer 
assays for: each of 84 genes in the pathway (DNA methyltransferases, histone 
acetylases, deacetylases, methylases, methyltransferases, phosphorylases, 
kinases, and ubiquitination enzymes), primer assays for 5 housekeeping genes, for 
genomic DNA controls, 12 wells for reverse-transcription controls, and 12 wells 
contain positive PCR controls. Purified RNA was used to perform a reverse 
transcription reaction with the RT2 First Strand Kit. Complimentary DNA is used with 
the RT2 SYBR Green mix. The reaction mixtures contained SYBR green, forward 
and reverse primers, a Taq DNA polymerase, and assayed using a Bio-Rad 
CFX384™ (BioRad, Hercules, CA). Briefly, reagents of the RT2 First Strand Kit were 
thawed on ice and tubes from the kit were centrifuged (10–15 seconds) to bring the 
contents to the bottom of the tubes. A genomic DNA elimination mix for each RNA 
sample was prepared containing, a proprietary buffer and RNase-free to a final 
volume of 10 µl.  The reaction was mixed gently and briefly centrifuged. The 
genomic DNA elimination mix was incubated for 5 min at 42°C then placed 
immediately on ice. The reverse-transcription mix was prepared with proprietary 
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buffers, a reverse transcriptase, RNase-free water to a total volume of 40 µl for 4 
reactions. For the RT reaction 10 µl of the reverse-transcription mix was added to 
each tube containing the 10 µl genomic DNA elimination mix (containing sample or 
a positive control RNA). This was mixed gently and incubated at 42°C for exactly 15 
min. All reactions were stopped simultaneously by incubating at 95°C for 5 min. 
RNase-free water (91 µl) was added to each reaction which were gently mixed and 
placed on ice. The PCR components mix were prepared in a 5 ml tube, containing a 
SYBR Green master mix, the cDNA synthesis reaction, RNase-free water to total 
volume of 1300 µl for each sample. The remaining 9 µl cDNA synthesis reaction 
was stored at –20°C, for quality control analysis o f the RT reaction. The mixed 
components were dispensed into the RT2 Profiler PCR Array 10 µl/ well for 96 wells 
per sample. Special covers were provided by the manufacturer for ease of pipetting 
and prevention of sample cross-contamination. Thermocycling conditions were 
provided by the manufacturer as a program which consisted of 10 min at 95°C for 
Taq polymerase activation, followed by 40 cycles of 15 s 95°C, and 30 seconds at 
55°C, 30 seconds at 72°C. Data was analyzed using P CR Array Data Analysis 
Software (Excel based) provided by Qiagen which automatically performs all ∆∆Ct 
based fold-change calculations from the uploaded raw threshold cycle data. 
Statistical analysis 
Real-time quantitative PCR, interspersed repeat hypomethylation, immunoblotting or 
MS-PCR data among three or more groups, and global methylation data were 
analyzed with one-way ANOVA or two-way ANOVA (factors: genotype and age; 
GraphPad Prism 5.0) with Bonferroni's or Dunnett's post hoc tests as appropriate 
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with a p< 0.05 adjusted significance level. Global methylation of in vivo GH 
administration did not pass Levene’s test for equal variances and was analyzed 
using a Kruskal-Wallis test and Dunn’s multiple comparison post-test. 
Immunoblotting, end-point MS-PCR, and DNMT activity data between genotypes 
were analyzed using Students t-test (GraphPad Prism 5.0). All data are shown as 
mean ± standard error of the mean (SEM). Sample values (n) are listed in the figure 
legends.    






Ames dwarf liver exhibits alterations in components of the methionine pathway in 
the liver. In hepatocellular carcinoma cells and in animal models these alterations 
are known to change DNA methylation. Most epigenetic studies are either in 
abnormally proliferating cells, such as cancers, or in pre-disease or diseased 
states, such as methyl-deficient diets causing hepatosteatosis. To offer a fresh 
perspective on epigenetic mechanisms in aging, we examined the epigenetic 
methylation mechanisms and markers in Ames dwarf mice that are known to 
outlive their wild type counterparts, which is attributable to GH deficiency. We 
studied DNA methyltransferase expression basally in cross-sectional studies (3, 
12, and 24 months), and with the addition of growth hormone, to study this 
hormone, and its effects on epigenetic mechanisms. We also examined global 
methylation, histone methylation, and studied as whether one pathway that 
regulates DNMT1 in hepatocellular carcinomas, also regulates DNMT1 in dwarf 
mice. We ended our studies by performing similar experiments in another GH 
signaling deficient long-living mouse, the growth hormone receptor knockout, and 
a growth hormone over-expressing short-lived model. We were evaluating these 
mice for differences and similarities between the strains that might show patterns 
of epigenetic methylation related to aging and growth hormone. 
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GNMT transcription and translation is higher in dwa rf mice 
Glycine-N-methyltransferase regulates SAM in the liver and the over- or 
under-expression of this enzyme has been linked to changes in DNA 
methylation. Our lab has previously shown that GNMT mRNA expression 
and activity is increased in Ames dwarf mice compared to wild type mice. 
However, changes in GNMT expression due to aging had not been 
determined, which could affect DNA methylation over the lifespan of an 
animal. Given that GNMT is linked to DNA methylation and possible DNA 
methyltransferase activity via the methionine pathway, we investigated 
GNMT expression in dwarf and wild type mice in our cross-sectional studies.  
Similar to previous findings, GNMT liver mRNA is more abundantly 
expressed across all three age groups in the Ames dwarf compared to wild 
type mice with significance at 3 and 12 months of age (Figure 1). The GNMT 
mRNA expression is influenced by genotype (p=0.0001) and age (p=0.0176).  
Protein levels of GNMT are also higher in dwarf mice at 12 months of age 
when compared to age-matched wild type controls (p=0.0408).  
DNA methylation enzyme basal expression and activit y is significantly 
altered in Ames dwarf mice compared to wild type mi ce 
 
Next we examined mRNA expression of DNMT1, DNMT3a, and DNMT3b using 
RT-PCR analysis of isolated liver RNA. Surprisingly, we found that dwarf mice 
show a much higher mRNA expression of both DNMT1 (105%) and DNMT3a 
(238%) at 3 months of age (p<0.0001; Figure 2).  
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FIGURE 1. GNMT mRNA and protein expression are higher in Ames dwarf mice compared to 
their wild type siblings. a) Liver GNMT mRNA expression is shown for dwarf (gray bars) and wild 
type mice (open bars) at 3, 12, and 24 months of age (n=7-8). b) GNMT protein levels at 3 (n=10-
11, p=0.7248) and c) 12 months (n=8-10, p=0.0408) and d) 24 months of age (n=6-8, p=0.6618). 
Mean optical densities are shown ± SEM. *p<0.05 and **p<0.01. Ponceau S was used for equal 
loading. 
Gene expression of DNMT3b mRNA was similar between genotypes at all age 
groups studied. Age appeared to be an important factor in the expression of 
all three DNMTs.  A significant effect of genotype was detected for DNMT1 
and DNMT3a however, the genotype by age interaction was significant 
confounding the independent effects. The DNMT expression overall shows an 
interesting U-shaped pattern with the lowest levels at 12 months of age in 
both genotypes compared to the linear decrease in GNMT mRNA expression 
(Figure 1). Previous literature noted DNA methyltransferase RNA expression 
declined with age and when the expression was normalized to histone H4, 
which was used to rule out a more or less proliferative background (Ray et al., 
2006). We compared histone H4 to β2m mRNA expression to detect any 
effects of background cellular proliferation that might influence DNMT 
transcription results and determined no discernable differences. Therefore 
β2m was considered an appropriate transcript for all mRNA normalization in 
the liver (Figure 3). 
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Figure 2. DNMT1 and DNMT3a mRNA expression are higher in Ames dwarf mice at 3 months of 
age. Liver DNMT mRNA expression is shown for wild type (open bars) and dwarf mice (gray 
bars) at 3, 12, and 24 months of age (n=7-8) for DNMT1, DNMT3a, and DNMT3b. Mean relative 
changes in expression are shown ± SEM. ****p<0.0001. 
 
Figure 3. Average Ct counts for H4 or β2m transcripts showed similar biological expression 
between all age groups and genotypes. Age groups compared are 3, 12, and 24 months (wild 
type mice, open bars; dwarf mice, grey bars).  β2m normalization was therefore used for all 
transcriptional studies. Bars represent  mean± S.D. 
 
Protein levels of DNMT1, DNMT3a, and DNMT3b were also compared 
between dwarf and wild type mice at 3, 12 and 24 months of age (Figure 4). 
To maximize the genotypic comparisons, independent immunoblots for each 
age were assayed.  Very low levels of DNMT1 protein were observed in the 
liver tissue of dwarf mice compared to wild type mice at each age group 
examined.  
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 Figure 4. DNMT protein levels are expressed differently in Ames dwarf and wild type liver tissue 
at 3, 12, and 24 months of age.  Wild type mice represented by open bars and dwarf mice by gray 
bars. DNMT1 protein expression was much lower that wild type mice at 3 months (n=10-11, 
p<0.0001), 12 months (n=9, p=0.0427) and 24 months (n=7-9, p=0.0015). DNMT3a protein was 
significantly higher in dwarf mice at 3 months (n=10-11, p<0.0001), statistically equivalent at 12 
months (n=12, p=0.2464) and much lower in dwarf mice at 24 months (n=8, p=0.0172). DNMT3b 
protein was not different between the genotypes at 3 months (n=10, p<0.4000), 12 months (n=11-
12, p=0.6244) or  24 months (n=9-10, p=0.5621). Mean optical densities are shown ± SEM. 
*p<0.05, **p<0.01, and ***p<0.001.  
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The variability of protein levels between animals was more pronounced in wild 
type DNMT1 and DNMT3a as compared to dwarf mice. DNMT3b expression 
was variable in both genotypes at every age. Due to a high variability of 
DNMT protein expression among in vivo groups, each immunoblotting assay 
was done independently for each group to increase murine sample sizes. DNA 
methyltransferase 3a protein levels were higher (193%) in the dwarf mice at 3 
months of age (p<0.001), similar at 12 months of age (p=0.2464), and 
significantly lower (54%) at 24 months of age (p=0.0172). Compared to wild 
type controls, DNMT3b levels were not different between genotypes at any 
age, similar to mRNA findings at each age group. We also asked whether 
there were differences due to aging in DNMT1 and DNMT3a within genotypes. 
We evaluated expression at all three ages within each genotype where we 
were limited to a sample of 8 per age group (24 well gel capacity, Figure 7). 
We doubled the amount of our dwarf liver lysate and re-optimized for the 
detection of DNMT1 since the basal signal was so low. We observed an 
increase of DNMT1 expression in the dwarf mouse (p=0.0012) and in the wild 
type mouse (p=0.0512) with age. DNMT3a however, had opposite expression 
patterns over all three ages when comparing genotypes. Remarkably, dwarf 
mice displayed higher DNMT activity in young and similar DNMT activity in 
middle aged (3 months, p=0.0214; 12 months, p=0.1704) liver compared to 
wild type mice but lower activities in old Ames dwarf liver (24 months, 
p=0.0491) (Figure 6).  The DNMT activity in the liver more closely resembles 
DNMT3a protein expression than DNMT1 or DNMT3b.  
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Figure 5. DNMT expression genotype differences due to age run in separate gels. The figures on 
the left wild type mice show an increase in DNMT1 and in DNMT3a (One way ANOVA p=0.0512 
and p=0.1056 respectively, n=6-8).  Dwarf mice also show a significant increase from 3 to 24 
months of age in DNMT1 but a no significant decrease in DNMT3a (One way ANOVA p=0.0012 
and p=0.0926 respectively, n=6-8). However, for DNMT1 in the dwarf the amount of liver protein 
used for dwarf tissue was doubled (and immunoblotting conditions re-optimized) in comparison to 
the wild type tissue to generate enough signal to detect by immunoblotting. Bars represent 
mean±SEM, ****p<0.0001. 
Overall DNMT activity was measured with an ELISA-based colorimetric 
assay using nuclear lysates extracted from liver tissue, as DNMT isoform 
specific activity assays are not available. Independent assays comparing 
dwarf versus wild type for each age group were performed. All samples were 
performed in triplicate for accuracy. In conclusion, it appears that DNMT1, 
DNMT3a, and GNMT mRNA and protein expression are not directly 
correlated with each other though both show significant effects of age and 
genotype in transcription.  
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DNMT1 protein expression is greatly diminished in dwarf mice at every 
age and DNMT3a protein appears to follow DNMT activities, which are all 
novel findings. DNMT3b shows no genotype differences in transcription or 
protein; however an age difference was noted in transcription.  
Figure 6. DNMT activity is higher in Ames dwarf mice at 3 months and lower at 24 months than 
age-matched wild type siblings matching the pattern of DNMT3a protein expression. ELISA-
based colorimetric activity assay of nuclear liver lysate showing differences in total DNMT activity 
in 3 month (n=11, p=0.0214),12 month (n=8-11, p=0.1704) and 24 month old (n=9-12, p=0.0491) 
wild type (open bars) and Ames dwarf mice (gray bars). Mean activities expressed as optical 
density per mg per hour are shown ± SEM. *p<0.05. 
 Global DNA methylation is higher in dwarf mice at e very age and 
resists changes due to age 
 Global DNA methylation in liver tissue is subject to DNMT activity 
alterations and abundance, SAM availability, and alterations of enzyme 
expression or activity in the methionine pathway. Because we observed such 
interesting differences in DNMT activity and expression, we measured global 
methylation using an ELISA-based method with antibodies for methylated 
cytosines across all three age groups (Figure 7). Comparison of dwarf versus 
wild type mice showed independent factors of genotype (p=0.0635) and age 
(p=0.0534) approaching significance. At 3 and 12 months of age, dwarf mice 
retained higher methylation than age-matched wild type mice, becoming 
equivalent at 24 months of age. Because much of the global loss of DNA 
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methylation with aging is thought to take place in interspersed repeats, also 
known as repetitive elements and transposable elements, transcription of 
these elements is thought to increase and contribute to genetic instability. We 
measured the hypomethylation status and transcription of these repeats 
between Ames dwarf and wild type mice in another cross-sectional study to 
see if this was indeed the case.   
 
Figure 7. Global DNA methylation of Ames dwarf mice is higher at 3 and 12 months of age. 
ELISA-based colorimetric activity assay of nuclear liver genomic DNA showing global DNA 
methylation in wild type (open bars) and Ames dwarf mice (gray bars). Percentage methylation 
was derived using control and sample optical densities, which were then normalized to 3 month 
wild type mice± SEM.  
 We used a well-published technique called the McrBC-qPCR 
method. McrBC is an endonuclease that restricts methylated DNA and 
degrades it. The treated DNA sample is compared to “mock restricted” sample 
of the same genomic DNA which does not contain the restriction enzyme but 
has been processed in the same way at the same time. Genomic DNA that is 
restricted is enriched for unmethylated DNA, therefore DNA that is less 
methylated shows greater abundance levels during quantitative PCR (Figure 
8, left panels). Both intracisternal A-particle long transposable repeat (IAP-
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LTR) and short interspersed nuclear element B2 (SINE B2) are increasingly 
hypomethylated with age in the wild type mouse. Hypomethylation in SINE B2 
also increases in the dwarf mice with age. Long interspersed nuclear element 
1 (LINE1) hypomethylation approached significance for genotype differences 
(p=0.0753) displaying higher levels of hypomethylation in dwarf mice that 
decreases over time, whereas wild type mice appear to maintain or only 
slightly gain methylation levels. This lack of difference in methylation of wild 
type mice is consistent with the most recent literature. Differences in IAP-LTR 
hypomethylation between dwarf and normal mice also show genotypic 
differences moving toward significance (p=0.0656) where dwarf mice have 
more methylation at 3 months and 24 months compared to wild type mice. The 
repetitive element SINE B2, which is rodent specific, exhibited statistically 
different levels of hypomethylation affected by age and genotype 
independently (p=0.0140, p=0.0415, respectively).  Short interspersed nuclear 
element B2 was clearly more methylated in dwarf mice at every age compared 
to wild type, yet both genotypes demonstrated a linear increase of 
hypomethylation with age. Short interspersed nuclear element B1, which is 
homologous to the human Alu repeat, did not display differences in 
methylation due to age or genotype, but remained relatively similar at all three 
ages studied. 
 While methylation does regulate transcription in many cases, for the 
four interspersed repeats studied, transcription and methylation appear 
unrelated or uncoupled. However, there are transcriptional differences 
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attributable to age or genotype (Figure 8, right panels). All four repetitive 
element transcripts were significantly affected by age, whereas only SINE B1 
displayed a significant genotype difference, most likely due to the increase of 
transcription in dwarf mice at 24 months of age compared to wild type mice. 
Remarkably, transcriptional expression of repetitive elements resembles the 
u-shaped curve of expression similar to DNMT transcription. For IAP-LTR this 
pattern of mRNA expression due to aging has been noted in mouse liver 
before (Gaubatz, Arcement, & Cutler, 1991).It also appears the transcriptional 
expression of repetitive elements is greatest at 3 months of age in wild type 
mice but not dwarf mice, which can regain an equivalent or increased amount 
of transcription in LINE1, SINE B1, and SINE B2.  
 Since LINE1 makes up approximately 20% of the 40% of genomic DNA 
comprised of interspersed repeats in the murine genome, we decided to use 
LINE1 and MS-PCR to validate our hypomethylation results (Figure 9). Two 
primer sets were used, however, only the set with CpG island prediction 
between base pairs 150-324 showed any unmethylated CpGs. The other 
LINE1 primer set that probed between base pairs 525-676 only showed highly 
methylated products with no difference between dwarf and wild type mice at 
any age (data not shown). However, the loss of methylation at 3 months of 
age corresponds with our hypomethylation data using the McrBC-qPCR 
technique.  At 24 months of age, dwarf mice appear to have increased 
methylation compared to wild type mice (p=0.0586). 
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Figure 8. Ames dwarf mice show differences in hypomethylation and transcriptional expression of 
repetitive elements that may contribute to genetic stability. Using the McrBC-qPCR technique 
differences in liver genomic DNA hypomethylation of four interspersed repeats are shown for 
dwarf (gray bars) and wild type mice (open bars) (left panels, n=6-8). Liver IR mRNA expression 
is shown using two step RT-PCR at 3, 12, and 24 months of age (right panels, n=7-8). Mean 
relative changes in expression or hypomethylation are shown ± SEM. **p<0.01. 
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Figure 9. Methylation patterns of LINE1 are different in Ames dwarf mice. Ames dwarf mice 
display lower methylation at 3 months of age (gray bars, p=0.0351), equivalent methylation at 12 
months of age, but higher at 24 months of age (p=0.0586). Wild type mice are represented by 
open bars.  Mean relative changes in expression and optical densities are shown ± SEM. 
*p<0.05.  
DNA methylation enzyme expression is significantly affected in growth 
hormone treated dwarf mice 
 Our next question was whether growth hormone, which also alters methionine 
pathway enzymes such as GNMT, could significantly affect DNMT expression and 
DNA methylation in the dwarf liver. To begin, porcine GH was administered to one 
group of 5-6 month old Ames dwarf mice while saline vehicle was administered to wild 
type mice and an additional group of dwarf mice as controls. Animals received GH or 
saline twice daily for seven days and was replicated with a second experiment. 
Growth hormone treated dwarf mice gained 3-4 grams of body weight over the course 
of one week compared to saline-treated dwarf mice which is typical of this protocol 
(Students t-test; Experiment1:+4.19 ± 0.06 g; p<0.0001, Experiment 2: +3.153±0.2184g, 
p<0.0001, Figure 10). Wild type mouse body weights were not different pre- and post-
saline injection. Liver weights were recorded as an additional indicator of GH action 
and the mean liver weights of GH injected dwarf mice were approximately 60-76% 
higher than saline injected dwarf mice [Experiment 1: 0.70 ± 0.13 g and 0.44 ± 0.05 g 
respectively (p<0.0001); Experiment 2: 0.60 ±0.08 g and 0.34 ± 0.09 g  respectively 
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(p<0.0001)]. The expression of DNMTs was compared between GH and saline-
treated Ames dwarf and wild type controls. Liver DNMT1 and DNMT3b mRNA levels 
were higher in saline-treated dwarf mice than saline-treated wild type mice and 
increased further after GH administration (Figure 11). Transcription of DNMT3a 
mRNA abundance was higher in saline-treated dwarf mice compared to saline-treated 
wild type mice, and no change was observed after GH treatment. 
Figure 10. Body weight is increased by one week of growth hormone injections in Ames dwarf 
liver. Liver weight in grams is shown for wild type mice injected with saline (n=9-11, open bars), 
dwarf mice injected with saline (n=8-11, gray bars), and dwarf mice injected with growth hormone 
(n=8-12, black bars) at 5-6 months of age. One-way ANOVA for body weight p<0.0001 for both 
left (Experiment 1) and right graphs Experiment 2). *p<0.05, and ****p<0.0001 using Bonferroni's 
Multiple Comparison test. Bars represent means ± SEM. 
 
 
Figure 11. Liver DNMT mRNA expression For DNMT1 and DNMT3b is increased upon GH 
administration.  Shown for wild type mice injected with saline (n=10-11, open bars), dwarf mice 
injected with saline (n=10-11, gray bars), and dwarf mice injected with growth hormone (n=10, 
black bars) at 5-6 months of age.  mRNA expression is normalized to β2- macroglobulin. One-
way ANOVA for DNMT1 p=0.0054, for DNMT3a p=0.1202, and for DNMT3b p=0.0129.  Bars 
represent means ± SEM. *p<0.05 and **p<0.01. 
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We next examined DNMT protein. Protein levels of DNMT1 were significantly 
lower in saline-treated dwarf than in the saline-treated wild type mice similar to our 
aforementioned findings (Figure 12).  However with GH treatment, protein expression 
of DNMT1 increased in dwarf mice (p<0.05) though not to wild type levels. DNMT3a 
protein levels were significantly decreased following GH treatment in Ames dwarf 
mice (p<0.05). Yet again, transcriptional differences did not correlate with protein 
expression, indicating a post-transcriptional pathway that may be influenced by growth 
hormone. DNMT3b protein in growth hormone treated mice was not assessed due to 
the absence of genotype differences from previous experiments between dwarf and 
wild type mice.  
   
Figure 12. DNMT protein expression is susceptible to growth hormone treatment in Ames dwarf 
mouse liver. One-way ANOVA for DNMT1 protein p=0.0021 and for DNMT3a protein 
p=0.0367(n=5-8). *p<0.05 and **p<0.01 using Bonferroni's Multiple Comparison test. Bars 
represent means ± SEM. 
 
DNA methylation enzyme expression is significantly altered in hepatocytes 
following growth hormone treatment 
For in vitro study of GH administration effects on DNMT protein expression, we 
isolated hepatocytes from 4-6 month old mice and treated them for 24 hours with 
different concentrations of porcine GH growth hormone (Figure 13). For this study 
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our goal was to demonstrate and verify that the in vitro hepatocytes reflected the in 
vivo results for future pathway studies of DNMT regulation that remain to be 
elucidated. Significant differences were detected for DNMT1 due to increasing GH 
concentrations in dwarf (p=0.0026) and wild type (p=0.0014) mouse hepatocytes. 
Ames dwarf mice showed a significant increase in DNMT1 protein expression 
following 1.0 and 10µg of GH per plate compared to a media only control. Though 
the higher concentration of GH (20 µg) also showed visibly greater protein 
expression, only 2 samples were present for quantification and thus statistically 
difficult to compare. Protein expression of DNMT1 in hepatocytes from wild type 
mice did not show a significant increase compared to a media only control until a 
dose 10 times higher than that used in dwarf mice (10 µg GH per plate). The levels 
of DNMT3a protein were decreased in primary dwarf hepatocytes following GH 
treatment (One-way ANOVA, p=0.0464) independent of GH concentration. Wild 
type hepatocytes showed little to no protein expression of DNMT3a and no 
difference following GH treatment that could be quantified by our methods.  
 
Figure 13. Ames dwarf hepatocytes are more sensitive to growth hormone treatment which alters 
DNMT expression. DNMT1 expression in wild type (One-way ANOVA,p=0.0014) and dwarf (One-
way ANOVA,p=0.0026) hepatocytes with increasing concentrations of growth hormone (0, 
0.1,1.0, 10, and 20 µg/ml). DNMT3a expression in dwarf (One-way ANOVA, p=0.0464) 
hepatocytes with increasing concentrations of growth hormone (0, 0.1, 1.0, 10, and 20 µg/ml). 
DNMT3a not present in wild type hepatocytes.*p<0.05 and **p<0.01 using Dunnett's Multiple 
Comparison Test to a media only control. Error bars represent means ± SEM. 
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 Since growth hormone appears to affect DNMT expression, we were 
interested to see if the altered expression of methylation mechanisms could 
affect global methylation. Thus, we next examine  global DNA methylation by the 
same ELISA colorimetric methods as described for the cross-sectional studies 
(Figure 14). Dwarf mice treated with growth hormone for one week lost 
approximately 15% of global DNA methylation. Because of the dramatic loss of 
methylation we next asked whether growth hormone administration could disrupt 
the methylation of interspersed repeats observed in many methyl-deficient diets 
which affect the methionine pathway. 
 
Figure 14. Growth hormone administration alters global DNA methylation in dwarf mice. 
Methylated cytosine by ELISA-based colorimetric assay shown for wild type mice injected with 
saline (n=10-11, open bars), dwarf mice injected with saline (n=10-11, gray bars), and dwarf mice 
injected with growth hormone (n=10, black bars) at 5-6 months of age (Kruskal-Wallis test, 
p=0.0392). *p<0.05 using Dunn's Multiple Comparison Test.  Error bars represent means ± SEM.  
 We used MS-PCR to examine LINE1 in dwarf mice that had been treated 
with growth hormone as well as our saline injected wild type and dwarf controls 
(Figure 15). We found the GH administration did not seem to alter LINE1 
methylation, although there was a large amount of deviation between the means 
for wild type and GH injected mice. Dwarf mice were consistent in mean 
methylation to each other. 
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Figure 15. Growth hormone treatment did not change methylation patterns of LINE1 in Ames 
dwarf mice. LINE1 was probed with MS-PCR for  wild type mice injected with saline (WT, open 
bars), dwarf mice injected with saline (DW, gray bars), and dwarf mice injected with growth 
hormone (DW+GH, black bars) at 4-6 months of age (One-way ANOVA p=0.6584, n=6). Mean 
relative changes in expression and optical densities are shown ± SEM.  
DNMT1 post-transcriptional regulation in Ames dwarf  mice 
A recent line of investigation observed that DDX20 (a DEAD-box helicase) 
contributes to transcriptional up regulation of metallothionein 1 (MT1) and 
metallothionein 2 (MT2) via the repression of DNA methylation by DNMT1. 
Purportedly, DDX20 assists in pairing miRNA 140-3p with the DNMT1 mRNA 
transcript and in conjunction with RISC complex, allows for either degradation of 
the mRNA transcript or de-capping the mRNA transcript repressing translation 
(Takata et al., 2013; van Kouwenhove et al., 2011). 
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Interestingly, our lab and others showed that Ames dwarf mice express 
more metallothionein protein and mRNA in liver as well as other tissues 
(Amador-Noguez et al., 2004, 2005; Meyer, M.M., Swinscoe, J.C., Brown-Borg, 
H.M., Carlson, 2003; L. Y. Sun et al., 2011; Swindell et al., 2010). Coupling the 
high MT levels with altered DNMT1 expression in Ames mice, we investigated 
the expression DDX20 and miRNA 140-3p involvement in a potential novel 
regulatory pathway and whether it may be utilized by dwarf mice to repress 
DNMT1 translation in the liver.    
Figure 16. Liver DDX20 mRNA expression is affected by age but not genotype and DDX20 
protein is more abundant in dwarf mice. Grey bars represent dwarf mice and open bars represent 
age-matched wild type mice at 3, 12, and 24 months of age. For mRNA n=7-8 per group and for 
protein studies n=6-10 per group. Mean optical densities are shown ± SEM. *p<0.05, 
**p<0.01, and ****p<0.0001.  
We first looked at DDX20 transcriptional and protein expression in dwarf 
mouse liver to see if there were basal differences (Figure 16). While we found no 
differences to DDX20 transcriptional expression due to genotype, our study 
showed age was a significant factor for both genotypes of mice. Dwarf and wild 
type mice appear to lose transcription abundance of DDX20 with age somewhat 
reminiscent of GNMT mRNA levels, with a more linear loss observed in wild type 
mice. The basal expression of DEAD-box helicase 20 protein levels is more 
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abundant at all three age groups in dwarf mice. This correlates with the decrease 
in DNMT1 abundance suggesting that this may be a potential pathway for 
DNMT1 post-translational regulation. We next asked if basal expression of miR-
140-3p was also changed in dwarf mice and could be contributing to DNMT1 
regulation (Figure 17). 
 
Figure 17. Dwarf mice display decreased expression of miRNA 140-3p at 3 and 24 months of age 
but also loss of 5S rRNA transcription at 24 months of age, compared to age-matched wild type 
mice. The top left panel displays age and genotype related differences in miRNA 140-3p 
expression between dwarf and wild type mice at 3 and 12 months of age, n=6-8. Using Student’s 
t-test miRNA 140-3p expression is greater at 24 months in dwarf mice when normalized to 5S 
rRNA (Top middle panel, n=7-8, p=0.0207) but upon validation by normalization with RNU6, 
transcription of miRNA 140-3p is significantly decreased (Top right panel, n=6-8, p=0.0104). 
Differences in transcription can be seen in 5S rRNA Ct values for two separate experiments 
(Bottom panels, n=8, p=0.0002 and p<0.0001 respectively). . Error bars represent means ± SEM. 
*p<0.05, ***p<0.001and****p<0.0001. 
 
We utilized 5S rRNA for normalization of miRNA 140-3p as suggested in 
previous literature (Bates et al., 2010). This ribosomal RNA is part of the 
translational machinery of ribosomes. We found that miRNA 140-3p was 
significantly decreased at 3 months and increased at 24 months of age. 
 
 86   
 
However, upon validation with another miRNA normalization transcript, U6 
splicoeosomal RNA (RNU6), we showed opposing results, where miRNA 140-3p 
was actually decreased, for the 24 month group dwarf only. RNU6 is a small non-
coding RNA that is part of the RNA splicing machinery (spliceosome) that 
processes pre-messenger RNA in the nucleus. As a result of this finding, we 
investigated the normalization Ct values of 5S rRNA and found they were similar 
except at one age group in one group of mice.  
Our dwarf mice show decreased abundance in 5S rRNA compared to wild 
type mice at 24 months of age, which is indicated by higher Ct values.  We 
replicated this Ct difference with a different set of 24 month old liver samples 
from wild type and dwarf mice (Figure 17 Bottom panels, Experiments 1 and 2). 
This is a novel finding as increased rRNA expression has been linked to a loss of 
heterochromatin in drosophila (Larson et al., 2012).  
DDX20 and miRNA-140 suppress DNMT1 translational repression and 
affect metallothionein (MT) expression via loss of methylation in CpG regions of 
the MT gene and promoter regions in hepatocytes. Ames dwarf mice exhibit 
increased basal expression of MT1 and MT2. However, no age-related 
differences in MT expression had been studied in the liver. Therefore, we 
examined metallothionein transcriptional expression and methylation in dwarf 
and wild type mice to determine age-related changes in metallothionein 
expression and identify whether methylation of the metallothionein gene and 
promoter region in dwarf mice correlated with increased DDX20 protein. We 
observed that liver MT1 expression exhibited age-related decreases in dwarf 
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mice after 3 months of age (Figure 18). However, there is an approximate 8-fold 
increase in wild type transcription at 24 months of age. At 3 months of age MT1 
mRNA expression is nearly 150-fold higher in dwarf mice. MT2 transcription was 
not detected in the wild type liver, thus expression levels were normalized to 
dwarf 3-month-old mice (Figure 18). 
 
Figure18. Liver MT1 mRNA basal expression was higher in dwarf mice and affected by age and 
genotype. MT2 was only present in dwarf mice and the linear loss is not significant. MT1 mRNA 
expression for wild type (open bars) and dwarf mice (gray bars) at 3, 12, and 24 months of age 
(Left panel, n=6-8). Liver MT2 mRNA expression is shown for dwarf mice (gray bars) at 3, 12, 
and 24 months of age (Right panel, One-way ANOVA p= 0.1199, n=5-8).  
 Next we examined whether basal levels of DNA methylation in MT1 and 
MT2 gene and promoter regions were different in the Ames dwarf mice 
compared to wild type mice as might be expected from the higher 
transcriptional rates. Since the largest difference in transcription occurred at 3 
months of age, we used tissues from this age group for determining methylation 
differences within predicted CpG islands of the MT1 and MT2 genes.  
Using MethPrimer to predict CpG islands and primers sequences, MT1 
showed a putative CpG island, including its promoter sequence, of 
approximately 600 base pairs in length and thus, two sets of primers were 
designed and used to maximize coverage (Table 5, Materials and Methods). 
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Bisulfite treated DNA is only protected from the cytosine to uracil conversion if 
the cytosine is methylated. Therefore two primer sets were designed, one set 
probed for converted cytosines (unmethylated cytosines) and the other set 
probed for unconverted cytosines (methylated cytosines). Coverage of the 600 
base pair posited an MT1 CpG island between base pairs 177 to 328 that 
showed an equivalent methylation status between dwarf and wild type mice 
(p=0.4422, Figure 19, left panel). This sequence contains several transcription 
factor binding sites including metal response elements a,b,c, and d (MRE) and 
the metal response transcription factor 1 (MTF-1) that is responsible for an 
increase in MT1 due to heavy metal stress, such as the administration of zinc. 
The antioxidant response element (ARE) that is responsible for the oxidative 
stress response of MT1 is also located in this area (S. R. Davis & Cousins, 
2000; Majumder et al., 2002; Park et al., 2013). From base pairs 464 to 570 of 
the MT1 predicted CpG island, dwarf mice exhibited decreased methylation 
compared to wild type mice (Figure 19, middle panel). This sequence covers an 
intergenic region between exons one and two of the MT1 gene. Metallothionein 
2 has a putative CpG island between base pairs 86-395 in the MT2 gene. The 
MT2 gene is highly unmethylated in dwarf and wild type mice alike (Figure 19, 
right panel). Primers designed for this area showed no amplification of 
methylated primer sets in both normal and dwarf mice, therefore a ratio 
comparison could not be made. The area of regulation for MT2 may lie outside 
the gene and promoter regions or may not be subject to methylation regulation. 
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Figure 19. Three month old dwarf liver shows less methylation in MT1 at 464-570 bp of the 
putative CpG island. U is the product from primers designed to probe CpGs in the same regions 
that are unmethylated, M is the product from primers design to probe CpGs  that are methylated. 
MT1 CpG Island methylation sites from base pairs 177-328 are shown for wild type (open bars) 
and dwarf mice (gray bars) at 3 months of age (Left panel, p=0.4422, n=7) and MT1 CpG Island 
methylation sites from basepairs 464-570 at 3 months of age (middle panel, n=6, *p<0.05). The 
right panel shows MT2 equally unmethylated (U) with no methylation (M) detected. Gels shown 
are representative to the mean optical densities of methylated primer products verses 
unmethylated primer products. Graphs represent mean ratios ± SEM.  
 
Figure 20. Protein expression of DDX20 is more abundant in dwarf mice treated with growth 
hormone. Liver DDX20 mRNA expression is shown for wild type mice injected with saline (WT, 
open bars), dwarf  mice injected with saline (DW, gray bars), and dwarf mice injected with growth 
hormone (DW+GH, black bars) at 5-6 months of age (Left panel, One-way ANOVA p= 0.3490, 
n=9-10). DDX20 protein expression for wild type mice injected with saline (WT, open bars), dwarf  
mice injected with saline (DW, gray bars), and dwarf mice injected with growth hormone 
(DW+GH, black bars) at 5-6 months of age. Mean optical densities are shown ± SEM. *p<0.05, 
**p<0.01, and ****p<0.0001.  
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Growth hormone administration affects DDX20, metall othionein expression 
and methylation 
Previously we identified differences in DNA methylation enzyme expression 
following one week of growth hormone administration; therefore we queried whether 
DDX20, MT1, and MT2 expression and possibly metallothionein methylation would 
be affected by GH as well. Growth hormone did not appear to have an effect on 
DDX20 transcription in 5-6 month old Ames dwarf mouse liver (Figure 20). Because 
DNMT1 protein levels are increased due to GH administration, we expected DDX20 
to decrease with growth hormone expression. However, protein levels of DDX20 
unexpectedly increased significantly with GH treatment. 
Figure 21. Liver miR-140-3p expression does not significantly change with GH administration. 
miRNA expression shown for wild type mice injected with saline (WT, open bars), dwarf mice 
injected with saline (DW, gray bars), and dwarf mice injected with growth hormone (DW+GH, 
black bars) at 5-6 months of age normalized to RNU6 (Left panel, One-way ANOVA p= 0.4139, 
n=8) or was normalized to 5S rRNA (Right panel, One-way ANOVA p=0.4631, n=7). 
We examined transcription levels of the putative DNMT1 regulator miRNA 
140-3p to ascertain whether GH administration would induce effects similar to 
that observed with DDX20 protein abundance (Figure 21). We did not see any 
significant effects when normalizing to U6 spliceosomal RNA (RNU6) or 5S 
ribosomal RNA (5S rRNA). Similar to our 3 and 12 month old miRNA studies, Ct 
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values or 5S rRNA were similar at 6 months of age in dwarf and wild type mice. 
The two studies produced very similar results indicating that miR-140-3p is not 
significantly changed following the administration of GH for one week.  
Since DDX20 protein expression was enhanced in dwarf mice treated with 
growth hormone but DNMT1 levels were also increased, we measured the 
response of metallothionein expression and methylation following growth 
hormone treatment (Figure 23). Transcription of MT1 and 2 was increased in 
dwarf mice following one week of growth hormone injections, corresponding to 
the increase in DDX20 protein.  
The methylation of several heavy metal response transcription factor 
binding sites including MRE-a,b,c,d, MTF-1, and ARE that are contained in the 
177-328 base pair region of the MT1 CpG island, became more methylated with 
growth hormone treatment. There was no significant change found in the putative 
CpG island fragment between 464-570 base pairs of the MT1 gene region. There 
are two binding elements for the signal transducers and activators of transcription 
(STAT), one of which is shared with interleukin-6 (IL-6) a cytokine that can 
induce transcription. These binding sites are located within the first 150 base 
pairs of the MT1 gene, and were missed by the primer sets that probed from 166 
to 570 base pairs of CpG dinucleotides we utilized in previous experiments.  
Therefore we designed an MT1 STAT primer pair set to probe this region as it 
may be sensitive to GH administration and thus activate the JAK/STAT pathway 
(Figure 23).  
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Figure 22. Growth hormone treatment increases MT1 and MT2 expression and changes 
methylation patterns in Ames dwarf mice. Upper-left  panel shows MT1 mRNA expression for wild 
type mice injected with saline (WT, open bars), dwarf mice injected with saline (DW, gray bars), 
and dwarf mice injected with growth hormone (DW+GH, black bars) at 4-6 months of age (One-
way ANOVA p<0.0001, n=9-10). Upper-right panel shows MT2 dwarf mice injected with saline, 
and dwarf mice injected with growth hormone at 5-6 months of age (n=8-10). Left-lower panel 
shows MT1 CpG Island: 177-328 bps methylation for wild type mice injected with saline, dwarf 
mice injected with saline and dwarf mice injected with growth hormone at 5-6 months of age 
(One-way ANOVA p= 0.0260,n=6-7). Lower-right panel shows MT1 CpG Island methylation for 
wild type mice injected with saline, dwarf mice injected with saline, and dwarf mice injected with 
growth hormone at 5-6 months of age (One-way ANOVA p= 0.6338,n=7). Mean relative changes 
in expression and optical densities are shown ± SEM. *p<0.05, **p<0.01, and ****p<0.0001. 
 
Figure 23. Panel shows two representative samples MT1 STAT binding CpG Island methylation. 
Samples are ordered as follows: wild type mice injected with saline (WT), dwarf mice injected with 
saline (DW), and dwarf mice injected with growth hormone at 5-6 months of age (n=6-7). 
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Based on the literature, a reasonable expectation would be that methylation should 
be diminished in this area at these two binding sites due to the actions of GH 
(Figure 23). However, using MS-PCR techniques and primer design, methylated 
and unmethylated regions were not quantifiable in relation to each other and thus 
no determinations could be made about methylation status of the STAT binding 
region of MT2.Even though a pattern is visually apparent when observing the 
unmethylated primers of the samples in relation to each other; this result must be 
validated by another technique such as pyrosequencing of the STAT binding site 
regions before this difference can be substantiated as non-artifact. 
Histone markers associated with aging are different ially expressed and 
distributed differently in dwarf mice compared to a ge-matched wild type 
mice 
Like DNMTs, histone modification enzymes also use methyl groups from 
SAM just as DNMT and therefore histone methylation marks are also subject to 
methionine pathway disruptions or alterations in enzyme activities or expression. 
Based on the literature we chose to examine histone methylation markers between 
Ames dwarf mice and age-matched wild type mice. Methylation markers from 
dwarf and wild type liver histone extracts were probed to determine the levels of 
histone H3 methylation. 
Two repressive markers, histone H3 lysine 9 tri-methylation (H3K9me3) and 
histone H3 lysine 27 tri-methylation (H3K27me3), and one marker known for 
transcriptional activation histone H3 lysine 4 tri-methylation (H3K4me3), were 
measured using immunoblotting and coomassie staining (to confirm equal 
loading). Interestingly, histone H3 Pan, an antibody used to determine the total 
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amount of histone 3 was much higher in liver tissue dwarf mice at three months 
of age (~70%), lower at 12 months of age and was equal at 24 months of age 
when compared to age-matched wild type controls (Figure 24,  top three panels). 
 
Figure 24. Histone H3 methylation and pan histone levels are expressed differently in Ames dwarf 
and wild type liver tissue at 3, 12, and 24 months of age.  Wild type mice represented by open 
bars and dwarf mice by gray bars (n=7-10). Mean optical densities are shown ± SEM. *p<0.05, 
**p<0.01, and ***p<0.001.  
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Though used in many manuscripts as a loading control, total histone 
H3, has been shown to change with age, and is therefore dynamic. (Larson 
et al., 2012; Levine, Worrell, Zimnisky, & Schmauss, 2012).  However, with 
each genotype, it appears that histone H3 fluctuates more with age in wild 
type mice than in dwarf mice (Figure 25).  
For the transcriptionally active marker histone H3K4me3, total 
abundance in dwarf mice was equivalent at 3 months of age, significantly 
lower at 12 months, and higher at 24 months of age compared to age-
matched wild type controls. Increases or decreases of this marker through 
mutations of methyltransferases or demethylases have marked effects on 
lower life forms such as C. elegans and Drosophila and have been noted to 
increase with aging (Han & Brunet, 2012). The repressive marker histone 
H3K27me3, is connected with levels of facultative heterochromatin, and 
this histone marker is purported to decrease with age (López-Otín et al., 
2013). When dwarf mice were compared to wild type mice, this marker was 
observed to be decreased at 12 months of age, and significantly increased 
at 24 months of age. The constitutive H3K9me3 marker is significantly 
increased in dwarf mice at three months of age (~ 2 fold) only and only 
slightly higher at 12 and 24 months of age. This marker decreases with 
aging in worms (Berdasco & Esteller, 2012). When histone markers are 
normalized to H3 pan, this exposes the distribution of histone H3 for each 
genotype (Figure 26).  
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Figure 25. Age-related total histone H3 expression within Ames dwarf and wild type genotypes. In 
a separate experiment which compared total liver histone H3 abundance, levels  appeared to 
have stayed equivalent in dwarf mice over all three age groups (left panel, grey bars One-way 
ANOVA p=0.7648, n=7-8) while levels increased  linearly in wild type mice (right panel, open 
bars, One-way ANOVA p= 0.0065, n=8). Mean optical densities are shown ± SEM, **p<0.01.  
 
Figure 26. When normalized to H3 pan,  Histone H3 methylation markers were distributed 
differently in dwarf mice at different ages. Histone tri-methylation expressed as normalized to total 
histone 3 for each age group, dwarf (gray bars) and wild type mice (open bars). Mean optical 
densities are shown ± SEM. *p<0.05, **p<0.01, and ****p<0.0001.  
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 The abundance of H3 tri-methylation markers compared to total histone 
H3 shows that at three months of age, dwarf mice used less total histone H3 for 
the active transcription marker H3K4me3 and the facultative marker H3K27me3. 
However, amounts of H3K9me3 remained similar in dwarf and wild type mice. At 
twelve months of age the distribution of histone H3 to H3K9me3 was much 
higher in dwarf mice whereas the other markers distributions remained similar 
between genotypes. At 24 months of age, histone H3 is significantly increased in 
distribution to the marker H3K4me3 in dwarf liver compared to wild type mice.  
Figure 27. Histone H4 lysine 20 tri-methylation and are expressed differently in Ames dwarf and 
wild type liver tissue at 3, 12, and 24 months of age.  Wild type mice represented by open bars 
and dwarf mice by gray bars. H4K20me3 protein expression was much higher that wild type mice 
at 3 months and lower at  24 months (n=7-10,). Mean optical densities are shown ± SEM. *p<0.05 
and ***p<0.001.  
We also probed liver histone extracts for histone H4K20me3 markers 
via immunoblotting (Figure 27). This transcriptionally repressive marker is 
known to increase with age in rat liver (Sarg, Koutzamani, Helliger, Rundquist, 
& Lindner, 2002). In our study dwarf mice at 3 months age had significantly 
more of the H4K20me3 marker compared to wild type mice (p=0.0005). 
However, at 24 months, the oldest age studied, dwarf mice had less 
H4K20me3 (p=0.0389).  
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 Finally, in a pilot study, we examined 84 genes that included histone 
methyltransferases (HMTs) and lysine demethylases (KDMs) to ascertain 
possible targets for future mRNA and protein studies between dwarf and wild 
type mice (n=2/genotype; Table 5). Since we saw many significant differences at 
3 months of age in epigenetic expression overall, we chose to examine 3 month 
old mice in this study. We observed a fold-increase of >2.5 in mRNA expression 
in many histone modifying enzymes in dwarf compared to wild type mice. Lysine 
demethylase 5b (Kdm5b) and histone methyltransferase Setdb2, highlighted in 
Table 5, are involved in demethylation of H3K4 tri-methylation and tri-methylation 
of H3K9, respectively. Both proteins have the potential to be repressors of 
transcription if more abundantly expressed at the translational level and are thus 
potential targets that help to explain our results in Figure 24.  Whether GH 
modulates these enzymes, as suggested by the genotype differences, remains to 
be determined. 








Function  Fold -change (Dwarf/ Wild 
type) 
Ciita Acetylation 2.65 
Kat2a Acetylation  2.59 
Ncoa6 Acetylation  3.74 
Hdac4 Deacetylation 2.98 
Kdm5b  Demethylation  2.91 
Prmt7 Methylation 2.70 
Setd6 Methylation 2.83 
Setdb2  Methylation  3.20 
Nek6 Phosphorylation 2.74 
Dzip3 Ubiquitination 2.89 
Mysm1 Ubiquitination 2.86 
Ube2a Ubiquitination  2.86  
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DNA methylation enzymes are differentially expresse d in other mutant 
mouse models with deficient or excessive GH signali ng 
To further explore the role of GH signaling, we examined another GH 
signaling mutant, the GHRKO mouse and the GH Tg mouse that exhibits an 
excess of GH signaling. These mice show respective increases and decreases in 
lifespan related to the absence or excessive GH signaling. This makes them very 
useful to our studies to elucidate any differences or similarities in epigenetic 
methylation or mechanism expression.   
 
Figure 28. GHRKOmice show no genotypic difference in global DNA methylation compared to 
wild type mice. GHRKO represented by open bars and wild type mice by open bars (n=7-12). 
Percentage methylation was derived using control and sample optical densities, which were then 
normalized to 3 month wild type mice± SEM. 
To see if overall DNA methylation was different between the two strains we 
performed the same colorimetric assay that was used for the dwarf line in a 
cross-sectional study. GHRKO mice at ages 3, 12, and 24 months were used 
along with their age-matched wild type counterparts. These mice exhibit high 
plasma levels of GH but are unable to respond to it due to a mutation in the GH 
receptor gene. We first studied global DNA methylation and interspersed repeat 
methylation to detect any similarities or differences with Ames dwarf mice (Figure 
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28). GHRKO mice showed no genotypic differences in global methylation, 
whereas dwarf mice tended to have high levels of methylation consistent across 
all three age groups (Figure 7). Our data also suggested age might be a factor 
(p=0.0870), but we were limited by sample size in the 24 month old group (n=7) 
at the time of this study. To probe for possible differences in interspersed repeat 
expression and methylation across age groups and genotype, we applied the 
McrBC-qPCR technique and measured hypomethylation of the repetitive 
elements IAP-LTR, LINE1, SINE B1, and SINE B2 (left panels, Figure 29). 
Similar to our observations in dwarf mice versus wild type mice, GHRKO mice 
also show some resistance to the hypomethylation of IAP-LTR. Age-related 
differences were also apparent (Figure 29, p=0.0691). In LINE1 there were 
genotype effects, especially at 24 months of age, and age effects of 
hypomethylation were observed however a significant interaction was detected 
that confounds the main effects. The wild type in this strain of mouse shows a 
large pattern of hypomethylation over age that was not observed in the Ames 
dwarf wild type mice and therefore could be influenced by genetic background. 
There was a significant interaction between genotypes and age in 
hypomethylation of SINE B1 in GHRKO and wild type mice. SINE B2 was only 
affected by age and not genotype, as these elements became hypomethylated in 
both genotypes. Similar to dwarf mice, there is higher transcription of IAP-LTR at 
three months of age that is significant between GHRKO mice compared to their 
wild type counterparts (Figure 29, right panels). The transcription of LINE1 is 
affected independently by both age and genotype.  
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Figure 29. GHRKO mice show differences in hypomethylation and transcriptional expression of 
repetitive elements that may contribute to genetic stability. Using the McrBC-qPCR technique 
differences in liver genomic DNA hypomethylation of four IRs are shown for GHRKO(gray bars) 
and wild type mice (open bars, left panels, n=6-8). Liver IR mRNA expression is shown using two 
step RT-PCR at 3, 12, and 24 months of age (right panels, n=6-8). Mean relative changes in 
expression or hypomethylation are shown ± SEM. *p<0.05 and **p<0.01. 
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Overall, transcription in the GHRKO mouse is higher compared to wild type mice. 
For the dwarf mouse strain, primarily age effects were seen for the cross-
sectional study. SINE B1 transcription is significantly higher for GHRKO mice at 
both 12 and 24 months of age, for Ames dwarf mice, this increased transcription 
was only significant at 24 months of age. No age-related differences in SINE B1 
were observed in the GHRKO but genotype significantly affected transcription. 
SINE B2 also showed age-related changes in the GHRKO strain, similar to the 
Ames dwarf strain, although the transcriptional profile is different. Ames dwarf 
mice along with their wild type siblings present a consistent u-shaped 
transcriptional profile between the ages of 3, 12, and 24 months whereas 
GHRKO mice do not. 
 
Figure 30. DNMT1 and DNMT3a mRNA expression are higher GHRKO mice at 12 months of 
age. Liver DNMT mRNA expression is shown for wild type (open bars) and GHRKO (gray bars) at 
3, 12, and 24 months of age (n=5-8) for DNMT1, DNMT3a, and DNMT3b. Mean relative changes 
in expression are shown ± SEM. **p<0.01. 
Twelve month old GHRKO mice exhibited alterations in transcriptional 
levels of GNMT and other methionine related enzymes, thus we measured the 
cross-sectional DNMT expression to determine if there were genotype 
differences in transcription between GHRKO and wild type mice (Brown-Borg et 
al., 2009). The results in Figure 30 show that DNMT1 and DNMT3a gene 
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transcription is higher at 12 months of age in the GHRKO mutant mice compared 
to wild type mice of the same age. Similar to Ames dwarf mice, DNMT3b 
expression was not different between genotypes, but was impacted by age in this 
strain of mouse. However, it is interesting to note that while DNMT3b 
transcription seems to increase with age in the Ames dwarf line, the expression 
in the GHRKO strain decreases with age, demonstrating the importance of the 
genetic background of our mice on epigenetic mechanisms. 
 
Figure 31. Liver DNMT mRNA expression For DNMT1 and DNMT3a is increased upon IGF-1 
administration in GHRKO mice.  Shown for wild type mice injected with saline (n=7-9, open bars), 
GHRKOmice injected with saline (n=7-9, gray bars), and GHRKOmice injected with IGF-1 (n=8-9, 
black bars) at 4-6 months of age. One-way ANOVA for DNMT1 p=0.0056, for DNMT3a p=0.0026, 
and for DNMT3b p=0.0009).  Bars represent means ± SEM. p<0.05 and **p<0.01. 
GHRKO mice express growth hormone but lack a functional receptor, 
therefore secretion of IGF-1 from the liver is absent. This strain of mouse allows 
the unique opportunity of identifying and observing potential independent effects 
of IGF-1 apart from GH. We therefore decided to measure DNMT transcriptional 
expression in GHRKO mice that have been administered IGF-1 in the same 
manner we studied GH in Ames dwarf mice. These mice were also treated at 4-6 
months of age. Interestingly, DNMT1 displayed a small increase in transcription 
in IGF-1 treated GHRKO mice which without treatment, already showed a greater 
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mRNA levels compared to age-matched wild type mice at 6 months of age. This 
finding is similar to that observed in GH injected dwarf mice. DNMT3a 
transcription, was increased in GHRKO mice, was further elevated by IGF-1 
administration, whereas in dwarf mice it was not affected by GH. Surprisingly, at 
6 months of age, GHRKO mice expressed less DNMT3b mRNA compared to 
wild type mice and these levels remained unaltered with IGF-1 treatment. In 
comparison to dwarf mice DNMT3b was more highly expressed basally, and 
increased even more with GH administration. 
 
Figure 32. GH Tg mice show a genotypic difference in global DNA methylation compared to wild 
type mice at 10 months of age. GH Tg mice are represented by black bars and wild type mice by 
open bars (n=7-12). Percentage methylation was derived using control and sample optical 
densities, which were then normalized to 3 (left) or 6 (right) month wild type mice± SEM. 
Growth hormone transgenic mice (GH Tg) are an excellent model to study 
the overexpression of GH in vivo on epigenetic mechanisms. Growth hormone 
transgenic mice express approximately 20-50 fold more growth hormone 
measured by radioimmunoassay compared to wild type control mice (Sotelo et 
al., 1998). GH Tg mice also express more premature aging phenotypes which 
are readily apparent as early as 6 months of age and live approximately half as 
long (12 months) as their wild type counterparts (Steger et al., 1993; Steger et 
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al., 1994). We were interested in evaluating epigenetic differences in GH Tg mice 
compared to their wild type counterparts. Because GH Tg mice exhibit excessive 
liver tumors at 12 months of age, which is near median lifespan, we chose to 
study these animals at earlier ages (3, 6, and 10 months). Unlike the Ames dwarf 
and GHRKO mouse assays, assays were not pooled due to excessive variability 
between 3 and 6 month and 6 and 10 month assays. The mean raw absorbance 
values for the 6 month wild type mice used in the first assay were 
0.1882±0.01240, and the same wild type samples measured 0.1386±0.0092 for 
the second assay (p= 0.0123, Student’s t test). We saw no real differences 
between genotype, although there was a potential age-related difference (Figure 
32). However, at 10 months of age, GH Tg mice exhibited significantly increased 
amounts of global DNA methylation in liver tissue when compared to wild type 
mice, suggesting a large shift in methylation enzyme activity. The assay between 
6 and 10 months also showed a potential age difference between the two groups, 
but effects of age and genotype were interacting confounding any independent 
effects. 
We next studied the hypomethylation of GH Tg mice in interspersed 
repeats probing for possible genetic instability as we had in dwarf and GHRKO 
mice (left panels, Figure 33). Whereas there were lower levels of 
hypomethylation in dwarf mice and similar levels in GHRKO mice at 3 months of 
age, compared to their respective age-matched controls, GH Tg mice start out 
with more hypomethylation, which is essentially less methylation, of these 
elements in young adulthood.  
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Figure 33.  GH Tg mice show differences in hypomethylation and transcriptional expression of 
repetitive elements that may contribute to genetic stability. Using the McrBC-qPCR technique 
differences in liver genomic DNA hypomethylation of four IRs are shown for GH Tg (black bars) 
and wild type mice (open bars) (left panels, n=6-8). Liver IR mRNA expression is shown using 
two step RT-PCR at 3, 12, and 24 months of age (right panels, n=7-8). Mean relative changes in 
expression or hypomethylation are shown ± SEM. **p<0.01. 
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This genotype difference appears linear with age and approaches 
significance (p=0.0575) whereas age is not seen as a factor possibly due to the 
loss of differences seen in the wild type mice which age normally.  In LINE1 
elements GH Tg mice are surprisingly stable in methylation, while in wild type 
mice a significant increase in hypomethylation of this element is detected at 6 
months of age. However, genotype differences are confounded by interactions 
with age effects even though age itself as a factor was not significant. SINE B1 
did not show significant changes in methylation due to genotype or age. SINE B2 
showed a marked difference of hypomethylation in this strain of mouse shared 
between the GH Tg mutants and wild type counterparts which was dependent on 
age, nevertheless, there were interactions between the factor approaching 
significance (p=0.0671). 
 We also examined transcriptional differences in the four repetitive 
elements (right panels, Figure 33). Interestingly, whereas the longer lived mutant 
mice tended to show more transcription of IAP-LTR at 3 months of age, GH Tg 
mice had similar transcription until 10 months of age. At this older age 
transcription dropped noticeably in the GH Tg mice. There were no differences in 
transcription attributable to age in these mice, but an interaction between age 
and genotype was apparent. For the interspersed repeat, LINE1, transcription 
was lower at 6 and 10 months in the GH Tg mice compared to their wild type 
controls. This contrasted with our other mouse lines where dwarf mice were 
similar in expression and GHRKO mice had increased transcription in LINE1. 
Also the GH deficient mutant strains showed age-related differences in 
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expression, whereas this line does not. Still, it must be noted that these studies 
are at relatively young ages for the normal mice of this strain, which may have to 
be studied more thoroughly at a later date for comparison in age to other strains. 
Transcription of SINE B1 did not show any differences attributable to genotype, 
as had been seen previously in both GH deficient signaling strains where 
transcription was increased and age-related differences in expression 
approached significance (p=0.0678). In the repetitive element, SINE B2, we did 
not observe age or genotype related differences in mRNA expression. 
Figure 34. DNMT3b mRNA expression was higher in GH Tg mice at 3 months of age. Liver 
DNMT mRNA expression is shown for wild type (open bars) and GH Tg mice (black bars) at 3, 
12, and 24 months of age for DNMT1, DNMT3a, and DNMT3b (n=6-8). Mean relative changes in 
expression are shown ± SEM. ****p<0.0001. 
 
 
We evaluated DNMT transcription in GH Tg mice at 3, 6, and 10 months in 
a cross-sectional study, similar to our GH signaling deficient mouse strains with 
their age-matched wild types. For DNMT1 there were no genotype differences in 
transcription, in contrast to our previous experiments in GH signaling deficient 
mice. DNMT3a however showed significant genotype differences in transcription 
with higher levels overall in the GH Tg mice at any particular age. Age-related 
effects were not seen for this transcript. However, in stark contrast to both GH 
signaling deficient genotypes, DNMT3b transcription was approximately 2-fold 
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higher in GH Tg mice at 3 months of age. Age and genotype effects were 
significant along with a significant confounding interaction between the two 
factors. We completed our studies with some preliminary data on DNMT protein 
expression in GH Tg mice versus their wild type counterparts. Interestingly, 
DNMT1 expression is decreased in GH Tg mice at 10 months of age, DNMT3a 
expression lower in GH Tg mice at every age compared to age-matched wild 
type mice, and DNMT3b remains to be probed. 
 
 
Figure 35. DNMT protein levels are expressed differently in GH Tg and wild type liver tissue at 3, 
6, and 12 months of age.  Wild type mice are represented by open bars and GH Tg by black bars. 
DNMT1 protein expression was much lower than wild type mice at 10 months (n=5-6, p=0.004). 
DNMT3a protein was significantly Lower in GH Tg mice at 3 months (n=5-6, p=0.0007), at 6 
months (n=5-6, p=0.0397) and lower in GH Tg mice at 24 months (n=8, p=0.0172). DNMT3b 
protein was not different between the genotypes at 3 months (n=10, p<0.4000), 12 months (n=11-
12, p=0.6244) or 24 months (n=9-10, p=0.5621). Mean optical densities are shown ± SEM. 
*p<0.05, **p<0.01, and ***p<0.001.  
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Thus for each parameter evaluated in the GH Tg mice epigenetic markers, 
mechanisms, and elements contrast with expression and methylation observed in  
the GH signaling deficient mice. These findings suggest that GH signaling 
pathways influence DNA methylation patterns and the expression of epigenetic 
methylation mechanisms. 
 




The main hypothesis of this study was that long-living Ames dwarf mice 
exhibit differences in epigenetic mechanisms and markers, specifically DNA and 
histone methylation. The rationale supporting this hypothesis was that Ames 
mice have an altered methionine pathway that is known to contribute to 
epigenetic processes.  Ames mice are GH-deficient and GH has been shown to 
affect expression of components of methionine metabolism.  The second part of 
this hypothesis was that these alterations in epigenetic markers lead to increased 
genetic and epigenetic stability in dwarf mice. Evidence in the literature 
consistent with our findings will be discussed. The epigenetic patterns 
established in the dwarf appear to remain highly stable through the dwarf life 
span, protect the DNA from damage, reduce transcriptional noise, and participate 
in an altered pattern of gene expression that resists damage and diseases 
associated with aging, favoring the longevity of Ames dwarf mice. This is a novel 
hypothesis since as to date, the preponderance of epigenetic studies and 
seminal literature has been studied in diseased or pre-disease states. This 
dissertation lays essential foundational groundwork to elucidate the epigenetic 




how the master hormone, growth hormone, a chiefly metabolic regulator, can 
drastically affect methylation modifications in the epigenetic landscape.  
 The first aim of our study was to examine age-related and genotype 
differences in DNA methylation enzymes and global DNA methylation and 
differences of transposable element methylation and expression that could 
contribute to genetic stability in Ames dwarf mice compared to wild type mice. 
GNMT expression affects DNA methylation so we examined whether GNMT 
expression was positively correlated with DNMT epigenetic enzyme expression 
in a cross-sectional aging study (Martínez-Chantar et al., 2008; Rowling et al., 
2002; Y. Wang et al., 2011). Activation or suppression of the GNMT enzyme has 
been implicated in many studies involved in global DNA methylation changes. 
We also studied whether this potential competitor for methyl groups changed 
expression with age. We found while GNMT mRNA expression was age-related 
in dwarf and wild-type mice, our data did not suggest any correlative relationship 
to DNMT mRNA expression. Then we examined the abundance and activity of 
DNMT protein between three age groups, and global abundance of DNA 
methylation. We found less DNMT1 protein expression in Ames dwarf mice 
compared to wild type controls and also that DNMT3a protein expressional 
differences in dwarf mice were reflected in overall DNMT activity levels. Next we 
evaluated transposable elements (IAP-LTR, LINE-1, SINE B1, and SINE B2) 
whose hypomethylation or expression is thought to affect transcriptional function 
and genetic stability as it relates to aging (Asada et al., 2006; Valentina Bollati et 




In these repetitive areas we found interesting differences due to genotype and 
age when studying Ames dwarf mice versus their wild type counterparts. We also 
employed another technique to investigate the differences found in LINE-1 
between the two genotypes at different ages. 
 Our second aim was to establish whether growth hormone administration 
to a GH deficient mouse model (Ames dwarf) affected DNA methylation and the 
enzymatic mechanisms responsible.  We have looked on a global scale to define 
major differences in possible GH regulation of epigenetic methylation processes. 
A sub-aim was to validate the use of primary hepatocyte culture for specific 
pathway studies by testing whether dwarf mice showed any alterations in DNMT 
signaling at the hepatocyte level similar to the in vivo results. We found that 
hepatocyte primary cultures reflected the differences seen in expression in the in 
vivo experiments.. In addition, we explored one possible and novel pathway of 
DNMT post-transcriptional regulation that has been very recently introduced and 
never studied in the context of a longevity mouse model as an additional sub aim 
based on our findings and whether it was modulated by GH administration.  
 For our third aim, we characterized basal histone methylation marker 
differences in a cross-sectional study between Ames dwarf and age-matched 
wild type mice and identified possible histone modification enzyme targets for 
future study. Our final aim consisted of characterizing other mutant mouse strains 
with altered GH signaling. Within this aim, we utilized the Laron dwarf or growth 
hormone receptor binding protein knockout mouse and the GH transgenic 




(Ames dwarf and GHRKO mice) and a short-lived premature aging model (GH 
Tg mice), and further establish the potential role of growth hormone in processes 
affecting the expression of epigenetic markers and in epigenetic stability. 
Specific Aim 1- To examine GNMT, DNMT expression, D NMT activity, and 
global DNA methylation cross-sectionally in Ames dw arf and age-matched 
wild type mice 
 Several lines of long-living mice display deficiencies in growth hormone or 
growth hormone signaling (Brown-Borg, 2009). Growth hormone influences the 
methionine pathway by decreasing the expression and activity of several 
enzymes, including methionine adenosyltransferase and glycine-N-
methyltransferase, which promote the production of S-adenosylmethionine and 
S-adenosylhomocysteine, respectively.  Glycine-N-methyltransferase is the most 
abundant protein in the liver, about 1% of total protein, and facilitates the 
conversion of SAM to SAH. Thus, GNMT is a major regulator of SAM in the 
liver(Yeo & Wagner, 1994). S-adenosylmethionine is the major methyl donor for 
most methyltransferase reactions in cells. While many methyltransferases, 
including DNMTs, are negatively regulated by rising SAH levels, GNMT is 
thought to regulate DNMT by an unknown mechanism (Wang, Tang, Chen, 
Chen, & Chiang, 2011). Previously, we showed that GNMT activity decreased 
between 3 and 12 months of age in Ames dwarf mice (Holly M Brown-Borg et al., 
2005). In our first aim, we investigated cross-sectional GNMT expression in both 
genotypes, looking for age-related differences, and expanded our findings to 
include protein levels. We found age-related decreases in GNMT mRNA 




in dwarf mice at all three age groups, most significant at 3 and 12 months of age, 
in comparison to wild type mice (Figure 1). Protein levels of GNMT were 
significantly elevated in dwarf mice (12 months) therefore, our GNMT expression 
relates well with current literature and known GNMT activity level differences 
between dwarf and wild type mice (Brown-Borg et al., 2009; Holly M Brown-Borg 
et al., 2005)  
 To determine if alterations in DNMTs were associated with GNMT 
expression, we examined DNMTs in liver tissue of GH-deficient dwarf and normal 
age-matched wild type mice (Figure 2 and 4). Interestingly, all three known 
catalytically active DNMTs (1, 3a, and 3b) showed a significant difference in age-
related transcriptional expression but did not correlate with the linear decrease 
exhibited in GNMT mRNA expression. Though in dwarf mice, DNMT1 and 3a 
expression was significantly higher at 3 months of age and decreased thereafter. 
In both genotypes, the lowest levels of DNMT mRNA were observed at 12 
months of age with a subsequent increase at 24 months, indicating a u-shaped 
pattern of age-related expression. In dwarf mice, the highest levels of DNMT1 
and DNMT3a were expressed in the youngest mice. Consequently, the 
expression of methyltransferases may be related to aging in both long-living and 
normal mice.  
 The elevated DNMT transcription in 3-month-old dwarf mice is a novel 
finding. Compared to the present literature, very few studies have reported age-
related differences in murine DNMT expression.  Similar to our findings, DNMT1-




with age (Ray et al., 2006). However this landmark study used histone H4 as the 
normalizing transcript to rule out increased cellular proliferation skewing the 
findings. We also tested H4 in comparison to our normal standardization 
transcript β2m to see if cellular proliferation could have influenced our results 
(Figure 3). We found that alteration of cellular proliferation was not a factor in our 
results and therefore β2m was used for normalization of all DNMT transcription 
between mice. Folate and methyl-deficient diets altered methionine metabolism 
in rats that, in turn, also decreased DNMT1 and 3a gene expression with age 
(Ghoshal et al., 2006). This evidence corroborates a link between DNMT 
transcription, the methionine pathway, and age-related expression of DNMTs.  
 To determine if DNMT transcription was predictive of DNMT protein 
abundance, immunoblotting for all three DNMT families was implemented. Liver 
protein levels of DNMT1 in dwarf mice were much lower than in their wild type 
counterparts at every age examined, even though transcriptional expression was 
significantly higher in the dwarf (Figure 4). These particular protein assays were 
designed to detect primarily genotype differences and maximize sample numbers 
thus; age-related differences were ascertained later in a different experiment 
(Figure 5).  DNA methyltransferase 3a protein expression in our cross-sectional 
study also yielded novel results. At 3 months of age, dwarf mice had 
considerably more of this enzyme (almost 2-fold), but equivalent amounts as wild 
type mice at 12 months of age. Also at 24 months of age, dwarf mice had 
approximately half of the amount of protein expressed compared to age-matched 




(C57Bl/6) and short-living (DBA2J) mouse strains indicated that liver DNMT1 
decreased in both lines when fed a lipogenic methyl-deficient diet but the longer 
living C57Bl/6 mice showed higher liver DNMT3a protein levels. High levels of 
DNMT3a were thought to be protective against the more pronounced 
demethylation of repetitive elements observed in the DBA2J thereby protecting 
epigenetic stability (Pogribny et al., 2009). Additionally, ablation of DNMT3a in 
the nervous system of mice causes shortened lifespans even though at birth they 
appear healthy and similarly shortens the lifespan of conditional K-ras knockout 
mice (Gao et al., 2011; Nguyen et al., 2007). Our results in addition to previous 
literature suggest that DNMT3a may be important to longevity and aging. 
 Our studies also included DNMT protein expression of DNMT1 and 
DNMT3a within each genotype to determine age related-differences. Re-
optimization of both protein amounts and antibody concentrations was 
conducted based on our previous finding that DNMT1 protein expression was 
extremely low in dwarf mice. We observed DNMT1 protein expression 
increases in both genotypes with age although the change across the three 
age groups was statistically more dramatic in dwarf mice (Figure 5). DNA 
methyltransferase 3a levels increased in wild type mice with age and 
decreased in dwarf mice. However the constraint in sample numbers per gel 
(n=8) may have undermined any statistical significance for this enzyme. 
Mutant mice deficient in DNMT1 expression showed no detriments or benefits 
to longevity (Ray et al., 2006). DNMT1 deficient mice exhibited delayed 




or  exhibited a higher incidence of cancer compared to wild type mice 
depending on the organ studied (Ray et al., 2006). Therefore, DNMT1 does 
not appear to have any independent effects in regards to lifespan. In totum, 
our data indicates that DNMT3a levels in young mice may indeed be 
protective but expressed later in life may be detrimental, thus DNMT3a protein 
abundance during aging may correlate with longevity.  Whether the lower 
expression of DNMT1 is required for this action still remains to be verified. 
Finally, whether Ames dwarf mice exhibit low DNMT1 in other tissues remains 
to be studied but because methylation enzymes and global DNA methylation 
changes with age are tissue specific, we suspect that DNMT1 and DNMT3a 
differences will be tissue-specific in our animals as well (Maegawa et al., 
2010). 
 In general, DNMT1 is considered the main DNMT expressed in adulthood 
(and somatic cells) and is responsible for maintaining DNA methylation therefore, 
it is considered the largest contributor to DNMT activity. Overall, liver DNMT 
activity was comparatively higher in the young and lower in old dwarf mice 
compared to age-matched controls (Figure 6).  The pattern of activity in dwarf 
mice may be significantly affected by the contribution DNMT3a since DNMT1 
protein is present at markedly lower levels in dwarf mice. Increased DNMT 
activity has been widely associated with hepatocellular carcinoma, loss of GNMT 
expression, and methyl-deficient diets (Y. Wang et al., 2011). However, tumor 
initiation and progression are controlled by the magnitude and timing of DNMT 




phenotype (Gao et al., 2011; Kinney et al., 2010; Yamada et al., 2005).  A 
diminished level of DNMT activity concomitant with high GNMT expression in 
dwarf mice during old age might delay cancer and aging in dwarf mice in 
comparison to wild type mice.  It is also possible that DNMT activity is under 
greater inhibition in the liver of 24-month-old dwarf mice due to higher SAH 
levels. Nonetheless, in young dwarf animals, increased DNMT3a may override 
SAH inhibition and GNMT competition for SAM in the liver allowing greater 
DNMT activity. From another perspective, early life over-expression of DNMT3a 
(before and during 3 months of age) may set up a more stable methylation 
pattern for many genes which are maintained and become larger in magnitude 
with age, as some research demonstrates, regardless of DNMT protein or activity 
changes later on (Takasugi, 2011).  
 Global methylation was also examined in Ames dwarf mice to 
determine the impact DNMT expression may have on the global DNA 
methylation landscape (Figure 7). According to current literature, increased 
DNMT activity in the liver due to methyl-deficient diets can lead to global 
DNA hypomethylation, whereas, in hepatocellular carcinoma cells, the 
administration of glucose and insulin can increase DNMT activity and global 
methylation.  The induction of GNMT expression has opposite effects 
(Chiang et al., 2009; Pogribny et al., 2004; Wang et al., 2011). Ames dwarf 
mice retain high insulin sensitivity, high GNMT expression, and low levels of 
DNMT1 throughout aging, making it difficult to predict whether these mice 




through earlier work, we found no differences in DNA methylation between 
18-month-old Ames dwarf and wild type mice (Uthus & Brown-Borg, 2003). 
In this cross-sectional study, DNA methylation in Ames mice was similar or 
higher than that observed in wild type mice at all three ages (Figure 9; 
Armstrong, et al., 2013). Wild type mice exhibited a u-shaped pattern in 
global DNA methylation comparable to their DNMT transcription; however, 
overall DNA methylation in dwarf mice remained relatively stable. Consistent 
with the earlier study using 18 month old mice, the older 24-month-old 
groups did not show any difference between genotype. Also our methylation 
results showing approximately 16% more methylation in dwarf mice at 12 
months of age was consistent with Snell dwarf global methylation 
measurements at 9-12 months of age (Armstrong et al., 2013; Vitvitsky et al., 
2013). Snell dwarf mice are phenotypically identical to the Ames dwarf but 
have a single nucleotide mutation in pit-1. This gene is a transcript acting 
downstream of prop-1 (the mutation in Ames dwarf mice) which is also 
responsible for the development of somatotropes, lactotropes and 
thyrotropes in the anterior pituitary. Snell dwarf mice also do not secrete 
thyroxin stimulating hormone, prolactin, or growth hormone, and live longer 
than their wild type counterparts similar to dwarf mice (Bartke et al., 2001). 
Therefore, the similarity of global methylation between the two dwarf 
populations at similar ages are strong validation for our results, and suggests 




 We did not see a linear progression in hypomethylation in this 
particular strain of mice, which has a heterogenous background, contrary to 
many laboratory strains. In a widely cited landmark study, C57Bl/6 mouse 
liver was shown to lose DNA methylation with age using a linear model 
(Wilson, Smith, Mag, & Cutler, 1987). However, in that same study older 
mice showed large variations in methylation measurements after 20 months 
of age. In addition, another report within the same timeframe found a u-
shaped pattern of global methylation using a different technique in the same 
strain of mice indicating that methylation in the liver does not necessarily 
decrease in a linear fashion with age (Singhal et al., 1987). Despite the 
contradiction in studies that may be due to murine strain background, the 
main finding of this study is that dwarf mice appear resistant to age-related 
methylation changes due to age compared to wild type mice.  
 DNMT1 is required for the activity of de novo methylation of repetitive 
elements that make up a large part of murine and human DNA (Liang et al., 
2002). This, as stated earlier, is important to the maintenance of genetic stability 
that occurs with retroviral transcription and possible transposition. We 
investigated whether the genotype differences discovered in our study contribute 
to epigenetic stability as postulated (Figure 8). Also, studying retroviral element 
methylation may give a different picture of the methylation landscape since LTRs 
and LINEs are found in gene poor regions (rich in A-T sequences) and SINEs are 
found in gene rich regions (higher frequency of C-G sequences) (Tomilin, 2008). 




reduced in expression during induced differentiation (Martens et al., 2005; 
Tomilin, 2008). This indicates they could play a regulatory role even though the 
functions are unknown. Interestingly, we found differences in the methylation 
status of IAP-LTR, LINE-1 and SINE B2 between dwarf and wild type mice due to 
age and/or genotype (some differences were nearly statistically significant). We 
also found transcription of all four retroviral elements to be affected by age but 
found genotype differences only in SINE B1 transcription. Particular transcripts of 
the IAP retroviral element have been known for some time to increase with aging 
in mice and become hypomethylated with age in different mouse strains and from 
methyl-deficient diets (Dupressoir, Puech, & Heidmann, 1995; Mays-Hoopes, 
Brown, & Huang, 1983; Pogribny et al., 2009). We found that the IAP-LTR of wild 
type mice was hypomethylated with age relative to the Ames dwarf, and 
remained less methylated with age. Interestingly, dwarf mice regain some 
methylation at 24 months of age. Age and genotype are independent factors that 
significantly influence the methylation of this transposable element. Transcription 
of IAP-LTR, which by earlier studies was thought to be induced by 
hypomethylation, did not correlate with methylation loss or gain. In fact, we 
observed the u-shaped transcription expression remarkably similar to DNMT 
mRNA expression in all of our retroviral elements for both wild type and dwarf 
mice. Transcription of IAP-LTR was higher in dwarf mice at 3 months of age, 





 LINE-1 is the most abundant transposable element in the murine and 
human genome (Han, Szak, & Boeke, 2004; Waterston et al., 2002). Increased 
LINE-1 expression or hypomethylation with age have been noted in several 
studies  across many species and disease states including rats, mice, humans, 
hepatocellular carcinomas, and methyl deficient diets (Asada et al., 2006; 
Pogribny et al., 2009; Takai, Yagi, Habib, Sugimura, & Ushijima, 2000). LINE-1 
also plays a role in cellular senescence (Baker & Sedivy, 2013). However, age-
related LINE-1 hypomethylation in human studies has had mixed results and 
more recent studies have found Alu repeats are better markers of age-related 
hypomethylation (Valentina Bollati et al., 2009; Langevin et al., 2011). LINE-1 
hypomethylation in our Ames dwarf mice or their wild type controls did not show 
age-related statistical differences. Genotype differences come close to 
significance, with more hypomethylation being present in dwarf mice at 3 and 12 
months of age using a methylation restriction PCR technique (McrBC-qPCR) 
(Figure 8). When LINE-1 was further investigated through methylation specific-
PCR, in which more than one primer set can be designed for better coverage of 
the 5’ UTR region, we found that one area from 150-324 base pairs of this region 
was significantly less methylated, at three months of age (Figure 9). Also this 
area of LINE-1 showed nearly equivalent methylation at 12 months of age, and 
more methylation at 24 months of age in dwarf mice. This validates the changes 
seen at 3 months in the dwarf mice through McrBC-qPCR. It appears for dwarf 
mice LINE-1 methylation is age-related possibly indicating better maintenance of 




observed to disrupt genome stability, transcription, and translation in other 
human and mouse cell types from aging, cellular senescence, or age-related 
diseases (De Cecco et al., 2013; Han et al., 2004; Muotri et al., 2010; Neidhart et 
al., 2000; Oricchio et al., 2007). However, as in IAP-LTR transcription, LINE-1 
transcription did not appear to be regulated by methylation and changed with age 
similarly in dwarf and age-matched wild type controls. Our transcription data 
correlates with a recent publication that examined the transcription of 
interspersed repeats in C57Bl/6 liver at early and late ages (De Cecco, Criscione, 
Peterson, et al., 2013). However, LINE-1 and the other repetitive elements 
diminish transcription at 12 months of age regardless of genotype; this may be 
an indicator of an important period in adult development whose regulatory 
mechanisms are unknown.  
 Murine SINE B1 is homologous to the human Alu repeat which has been 
associated with aging.  SINE B1 in the liver also loses methylation in rodents fed 
methyl-deficient diets. Its transcription can be increased during embryonic 
implantation, by retinoic acid induced differentiation, and cellular or physiological 
stress (Kalkkila et al., 2004; Li et al., 1999; Liu et al.,1995; Martens et al., 2005; 
Ohnishi et al., 2012; Tryndyak et al., 2006).  A subtype of SINE B1 transcripts 
may also have gene insulator effects by cooperating or inducing repressive 
heterochromatin and forming chromatin barriers to transcription (Román, 
González-Rico, & Fernández-Salguero, 2011; Román et al., 2011). In humans, 
Alu repeats are thought to control transcription and RNA splicing and play a role 




stem cells, to date transcriptional differences in Alu in human aging have yet to 
be defined. In our study, hypomethylation of SINE B1 did not differ by age or 
genotype (Figure 8). However, transcription was affected by both age and 
genotype, showing prominence in dwarf mice at 24 months of age. Wild type 
mice showed the highest transcription of SINE B1 at 3 months of age. In 
agreement, a recent study also found an increase of SINE B1 transcription in 
C56BL/6 mice at 24 months of age corresponding to our findings in dwarf mice 
(De Cecco, Criscione, Peterson, et al., 2013). C56BL/6 is one of the longest 
living strains among laboratory mice and this paper also noted that calorie 
restriction, a long studied and well-documented intervention that increases 
longevity in mice, decreased transcription of this SINE B1 as well as LINE-1. 
However, SINE B1 expression may be a positive response if it is increased in 
longevity models compared to shorter living models of mice. 
Specific Aim 2- To examine growth hormone administr ation effects on DNA 
methylation mechanisms, and global DNA methylation.  
 Ames dwarf do not secrete three hormones, thyroxine stimulating 
hormone, prolactin, or growth hormone. However, many studies indicate that 
growth hormone is the hormone responsible for life span extension and 
increased cellular stress resistance, especially during the early part of adult 
development before physiological (reproductive) maturity (Panici et al., 2010). 
Some work has shown that GH can alter chromatin modifications on a specific 
predefined set of genes known to be affected by or regulate growth hormone 




causes changes in the nuclear architecture forming punctate patterns in the 
nucleus indicating a rearrangement of chromatin (Piwien Pilipuk, Galigniana, & 
Schwartz, 2003).  Liver tissue regeneration depends on growth hormone 
secretion more than cytokine secretion for cellular proliferation (Pennisi et al., 
2004). However, the examination of GH’s possible role on epigenetic methylation 
mechanisms, which are affected by the methionine pathway and SAM 
abundance in liver, is undefined and unique.  Growth hormone regulates GNMT 
activity and, though not directly correlative, alterations in GNMT expression and 
activity do coincide with differences in DNMT expression, DNMT activity, and 
DNA methylation in Ames dwarf mouse liver.  In the current study, increases in 
the transcription of DNMT1 and DNMT3b were noted upon one week of GH 
administration in dwarf liver (Figure 11). DNMT3a transcription, while still 
somewhat increased basally in dwarf liver at 6 months of age, showed no 
difference, therefore transcription of this gene may be influenced by another 
pathway downstream or through a related pathway separate from GH, such as 
the insulin pathway. Indeed, there is evidence that the induction of glucose and 
insulin pathways in hepatocellular carcinoma cells are able to induce large 
increases in DNMT3a mRNA but not DNMT1 or DNMT3b (Chiang et al., 2009). 
Glucose and insulin administration also have large effects on the transcription of 
many methionine enzymes such as GNMT and MAT along with the methionine 
salvage pathway and transulfuration enzymes. Both glucose uptake and insulin 
release are greatly influenced by GH signaling in liver (Brown-Borg, 2009; Louis 




longevity (Bartke et al., 2013). Both young and old dwarf mice are naturally more 
insulin sensitive than their wild type counterparts (Bartke et al., 2001; Louis et al., 
2010). It is also possible that differences in DNMT3a transcription do not show 
immediate effects by acute GH administration, but may show effects after many 
weeks of treatment. Interestingly, our DNMT hepatocyte data does not 
correspond to those found in rat primary hepatocytes (Vinken et al., 2010). 
However, both species and culture condition differences likely account for this 
discrepancy.  For instance, DNMT1 is regulated by glucocorticoid receptor 
stimulation by dexamethasone and corticosterone (Yang et al., 2012). Rat 
hepatocyte culture protocols require these compounds for primary hepatocyte 
cultures contrary to murine protocols. 
 Measurements of relative protein quantities following in vivo and in vitro 
GH administration to GH-deficient dwarf mice displayed a marked increase in 
DNMT1 and decreased DNMT3a levels (Figures 12 and 13). A lower 
concentration of GH was required by dwarf hepatocytes to stimulate DNMT1 
expression when compared to wild type cells suggesting increased sensitivity in 
the GH-deficient state.  This supports earlier findings that dwarf liver is more 
sensitive to GH stimulation than wild type tissue in pathways related to stress 
response and cellular proliferation (Brown-Borg & Rakoczy, 2003; Miquet et al., 
2010). As previously noted, wild type cells did not produce enough DNMT3a 
protein for us to detect by immunoblotting and may be a consequence of 




 We next examined whether GH alters global DNA methylation in dwarf 
mice. GH-treated dwarf mice showed significantly lower global DNA methylation 
compared to saline injected wild type and dwarf mice (Figure 7). This novel 
finding may be indicative of global chromatin changes and globally increased 
gene expression. Therefore determining the genomic location of these DNA 
methylation changes would provide insight on the magnitude of gene expression 
alterations and possible heterochromatic architectural changes between dwarf 
and wild type mice. We examined whether global methylation changes occurred 
in the most abundant and highly methylated repetitive element LINE-1, to look for 
changes in gene poor regions of the genome due to GH (Figure 9). Previous 
publication has shown, decreases in liver LINE-1 methylation are induced by 
methyl-deficient diets, which also show alterations in SAM and SAH abundance 
(Pogribny et al., 2009). However, in our study, no changes in DNA methylation 
were noted in the LINE-1 region either basally between dwarf or wild type mice at 
4-6 months of age, or with the addition of growth hormone in the liver. This leads 
us to conclude that the majority of DNA hypomethylation related changes due to 
GH may be found in gene rich areas of expression or at repeat regions 
associated with these areas.   
 GH administration did not appear to have large effects on mRNA 
expression. In addition Ames dwarf mice had higher levels of DNMT1 
transcription yet lower levels of protein, especially at 3 months of age. This 
suggested that DNMT1 was somehow being post-transcriptionally regulated. 




regulation in hepatocellular carcinoma cells and mouse liver (Takata et al., 2013). 
They demonstrated a regulatory role for a DEAD-box helicase (DDX20) in 
decreasing DNMT1 levels post-transcriptionally via the regulation of microRNA-
140-3p, which has some complementarity to the 3’ untranslated region (UTR) of 
the DNMT1 mRNA sequence. According to miRBase, the miR-140-3p is highly 
conserved between species (Kozomara & Griffiths-Jones, 2014). DNMT1 
negatively regulates the expression of metallothionein (MT) through promoter 
methylation. In human hepatocellular carcinoma lines knockdown of DDX20 
decreases metallothionein expression (Takata et al., 2013). 
 DDX20 is also known as Gemin 3, and is a dead-box helicase that plays a 
major role in transcriptional repression through attachments to microRNAs and 
other proteins forming a ribonucleoprotein and guiding miRNA to the RNA 
induced silencing complex (RISC) (Van Kouwenhove et al., 2011; Wilker et al., 
2010). DDX20 is involved in apoptosis and cellular proliferation, and is deficient 
or not functional in many diseases such as cancer, and motor neuron diseases 
such as spinal muscular atrophy (Guo, Zhang, Zhao, Li, & Li, 2011; Shpargel & 
Matera, 2005; X. Sun et al., 2010; van Kouwenhove et al., 2011; H. Yang et al., 
2008). Increases of DDX20 transcription are observed in murine fibroblasts 
exposed to ultraviolet radiation acquiring consequent DNA lesions (Garinis et al., 
2009). Interestingly, these irradiated fibroblasts also exhibit growth hormone and 
IGF signaling deficits reminiscent of Ames dwarf mice. DDX20 is definitely 
differentially expressed in dwarf mice at the protein level but not at the 




were seen in Ames dwarf mouse liver at 3, 12, and 24 months of age 
corresponding with our cross-sectional studies of decreased DNMT1 protein at 
all of these ages.  
We next investigated whether miRNA 140-3p was basally overexpressed in 
dwarf mice, since DNMT1 protein was so diminished compared to wild type mice 
(Figure 17). Surprisingly, miRNA 140-3p levels were lower at three months of age 
in dwarf mice, and increased at 12 months of age, though not statistically 
significant at that age. When we investigated miRNA 140-3p at 24 months of age, 
we found significantly diminished levels. We observed that 5S rRNA levels were 
decreased (indicated by increased Ct counts in RT-PCR), which would indicate 
that 24-month-old dwarf mice have a lowered expression of this transcript. This is 
an unexpected finding and may have implications for overall translational function 
of dwarf liver cells. One possible explanation for this change is the overall 
decrease in total mRNA in aging mice which has been recently documented (De 
Cecco, Criscione, Peterson, et al., 2013). This may be a product of increased 
transcriptional expression of interspersed repeats. However, the only transcript we 
noted as being increased in dwarf mice at 24 months, compared to wild type mice 
was SINE B1. In many studies, transient induction of SINE B1 had no effect on 5S 
rRNA abundance and was used as a control, however, both are transcribed by  
RNA polymerase III (T. Li et al., 1999; Liu et al., 1995).  Chronically induced SINE 
B1 transcription, could affect RNA polymerase III levels available for ribosomal 
RNA transcription, and thereby inhibit translational processes. However, there is 




translation by forming complexes with other proteins acting as trans regulatory 
factors (Häsler & Strub, 2006). In aging Drosophila, increased ribosomal RNA 
transcription is associated with the loss of heterochromatin, which might be 
differently affected in mammals, where there is a gain of heterochromatin in 
C56BL/6 mouse liver with aging (De Cecco, Criscione, Peterson, et al., 2013; 
Kreiling et al., 2011; Larson et al., 2012). 
Metallothioneins are free radical scavengers and respond to many cellular 
stressors. Metallothioneins 1 and 2 are prevalent in most tissues and decreased 
protein expression is associated with hepatocellular carcinoma. Treatment with the 
DNMT inhibitor 5-azacytidine restored MT1 expression and tumor regression in rat 
hepatomas (Majumder et al., 2002). DDX20 and miRNA 140-3p purportedly 
suppressed DNMT1 translational repression and thereby increased metallothionein 
(MT) expression via loss of methylation in CpG regions of the MT gene in 
hepatocytes. Interestingly, it is documented that Ames dwarf mice exhibit increased 
basal expression of MT1 and MT2. We observed that liver MT1 expression is age-
related decreasing in both dwarf and wild type mice after 3 months of age. However 
the expression of MT1 and MT2 is greatest in difference between wild type and 
Ames dwarf mice at 3 months of age. Therefore, since DNMT1 levels and 
methylation of the MT promoter drive mRNA expression, we studied the promoter 
regions of MT1 and 2 at 3 months of age in dwarf and wild type mouse liver (Figure 
19). Metallothionein 1 showed less methylation in dwarf mice in an area of CpG 
methylation that resides between exons 1 and 2 of this gene, rather than 




for this area of the MT-1 gene (TFSearch), several potential transcription factors 
including GATA-2 and Ik-2, which are both implicated in controlling the senescence 
protein marker-30 in aging rat liver were found and could be potential regulators 
(Heinemeyer et al., 1998; Rath, Pandey et al., 2008). Normal metal response 
element transcription binding areas of MT1 were not differentially methylated in 
dwarf mice compared to wild type mice. However, methylation in these areas of 
transcription are induced by the presence of heavy metals such as zinc, ischemia, 
and hypothermia, MTF-1, and metal response elements (MREs) (Majumder et al., 
2006; Park et al., 2013).  In addition, preliminary qualitative analysis of whole 
genome bisulfite sequencing of young dwarf liver compared to wild type liver is 
consistent with dwarf mice exhibiting more methylation differences within gene and 
promoter regions (Brown-Borg and Adams, unpublished data). The MT2 gene was 
highly unmethylated and methylation-specific PCR provided no evidence of 
differential methylation in this region.  
Since DNMT1 expression is increased by growth hormone administration, 
we thought perhaps that DDX20 would be decreased and miRNA 140-3p might 
show decreased expression, in line with what was seen in hepatocellular 
carcinoma cultures (Takata et al., 2013). Unexpectedly, we observed DDX20 
protein expression significantly increased in the dwarf liver after one week of 
growth hormone administration (Figure 20). Previously, we showed that GH 
administration increased DNMT1 translational expression in dwarf mice; 
however, protein levels were not rescued to wild type levels. This increase in 




as part of a negative feedback loop disallowing a full rescue of DNMT1 to wild 
type levels. This lack of rescue of GH treated dwarf mice to wild type phenotypes 
has been observed in other studies as well. For instance, Ames dwarf mice did 
not reach body weights of wild type mice even when exposed to as much as 6 
weeks of GH treatment, nor were wild type levels attained in the expression of 
proteins, or activation of pathways, regulated by GH such as IGF1 and 
phosphorylation of STAT3 respectively (Louis et al., 2010; Panici et al., 2010). 
Whether DDX20 expression modulates or associates with these pathways is 
currently unknown. Further study is required to elucidate the response of DDX20 
expression to long-term GH administration. Interestingly, there was no change in 
miRNA 140-3p in response to GH treatment indicating that in normal liver miRNA 
140-3p expression is either tightly controlled, or other pathways may influence its 
expression (Figure 21).  
Growth hormone administration decreased global DNA methylation in 
dwarf mouse liver (Figure 14) and because there are significantly higher 
metallothionein mRNA expression levels, we investigated whether there were 
methylation changes in the metallothionein gene region. Changes in DNA 
methylation of this region at 6 months of age in dwarf liver were not significant. In 
addition there were no differences between methylation in MT1 methylation at 
base pairs covering the area between exons 1 and 2 in dwarf mice with the 
administration of growth hormone (Figure 22). The loss of statistical methylation 
difference in dwarf liver may be an age-related change that coincides with a large 




CpG methylation was not significantly different in areas common to metal 
transcription factor 1 (MTF-1) or the family of metal response elements (MREs) 
probed in Figure 18 between young dwarf and wild type mice. However, GH 
administration greatly increased methylation in this area. This increase in 
methylation should decrease MT1 transcription and yet it does not. This indicates 
the methylation regulation of MT1 is more complex that just the up- or down-
regulation of DNMT1 or global DNA methylation. Because the MT1 gene 
contains many transcription binding factor sites, the increased expression of MT1 
due to GH administration may be at binding sites farther upstream from the 
transcriptional start site, such as sequences associated with STAT. GH 
administration is known to activate JAK/STAT signaling. STAT3 signaling has 
also been implicated in the increase of MT1 expression due to hypothermic 
protection against induced ischemia (Park et al., 2013). To address this question, 
we designed methylation specific primers for the binding sites of STAT and the 
STAT response element (which also is a response element for interleukin-6) 
within the first 150 base pairs of the MT1 gene (Figure 23). However, the 
results were inconclusive for any relative methylation changes in all groups, 
(wild type, dwarf, and dwarf treated with growth hormone) and the STAT 
binding regions all appeared to be highly unmethylated. More sensitive 
measures will have to be undertaken to probe these two methylation sites. 
There is also a possibility that because of the increase of methylation in 




stress induction of MT1, causing a deficiency in the ability to scavenge free 
radicals and heavy metals decreasing oxidative stress resistance. 
At any rate, GH associated changes in methylation of the MT1 gene do 
not appear to be simply a consequence of global methylation changes caused 
by increased DNMT1 as suggested in previous literature, but specific to 
regulatory areas of the MT1 gene and promoter regions. Metallothionein 
expression due to GH administration may be a transient response that may be 
down-regulated during long term GH treatment such as has been indicated in 
one study through a six-week treatment of GH in 7-month-old Ames dwarf 
mice (Swindell et al., 2010).  
 To summarize, in contrast to the findings of Takata et al (2013), in our 
mice, miRNA 140-3p expression does not appear to be the key factor in 
regulating DNMT1 expression. DDX20 protein levels however, still could be 
important to DNMT1 regulation if this pathway is a major regulator. High levels 
of DDX20 protein may still be regulatory by selectively bringing miR-140-3p to 
the RISC complex and therefore offset the much higher transcription of Ames 
dwarf mice as seen in our previous work, however, we feel it is unlikely for 
several reasons. Firstly, manipulation of DNMT1 expression through DDX20 
could involve many different miRNA transcript partners. For instance, only one 
of many possible miRNA partners for DDX20 could include miR-148a, which 
has been predicted to negatively regulate DNMT1 and is involved in 
maintaining the differentiation of hepatocytes and repressing hepatocellular 




expression has been noted to change with age in murine tissues and is 
responsive to calorie restriction, which is a well-known intervention that 
increases life span in mice (Dhahbi et al., 2013). Also miR140-3p may be 
more important for tissues other than the liver for the suppression of other 
pathways such as IGF-1 (Yuan, Shen, Xue, & Fan, 2013).  Other factors may 
regulate DNMT1 as well, and miRNA regulation may only be a minor player in 
regulation. For example, DNMT1 is also regulated in cis by unique RNA 
molecules expressed by gene regions (Ruscio et al, 2013).  Several other 
factors have also been shown to modulate DNMT expression and activity and 
include PCNA, PKA, PKB (Akt), PKC, and GSK3β.  GH treatment of dwarf 
mice increased liver phosphorylated Akt protein and  phosphorylated GSK3β 
protein levels when compared to wild type mice or untreated dwarf mice 
(Masternak et al., 2010; Miquet et al., 2010; Panici et al., 2010).  GSK3β 
regulates pAkt activity and can stabilize DNMT1 affecting its expression and 
activity (Sun et al., 2007). PI3K and pAkt are known to be involved in cell 
proliferation and aging. Since liver DNMT activity is higher in the dwarf at 3 
months and lower at 24 months, there may be additional regulation by PKA, 
PKB (Akt), PKC, and other pathways where Ames dwarf mice exhibit 
increased responses to GH treatment in the liver. If the increase of DDX20 
protein expression is significant in DNMT1 post-transcriptional regulation, 
more studies are needed to identify the ways in which DDX20 may be working 
with one or several miRNA transcripts to post-transcriptionally regulate 




expression and represent potential avenues of investigation for post-
transcriptional regulation of DNMT in the liver of Ames dwarf mice and in 
aging studies, in general. Growth hormone deficiency in the Ames dwarf 
mouse may contribute to epigenetic stability by decreasing DNMT1 protein 
through a variety of aging-associated pathways, and increasing DNMT3a 
protein at young ages. We have data indicating differences between 
genotypes in global DNA methylation and preliminary results showing 
differences in specific gene regions (Brown-Borg, unpublished data).  
Furthermore, GH signaling may also be important to differences in tissues 
other than liver such as muscle and fat.  The results of this study do not 
exclude potential IGF-1 effects on DNMT expression. DNMT1 also has DNA 
methylation independent actions that may be different in dwarf mice and 
contribute to cell cycle regulation (Milutinovic et al., 2004).  
 
Specific Aim 3- to examine histone H3 and H4 marker s associated with 
aging 
 Histone methyltransferases also use S-adenosylmethionine from the 
methionine pathway as a substrate. Therefore these methyltransferases may well 
be affected by methionine pathway alterations similar to GNMT and DNMTs. Methyl-
deficient diets are known to cause alterations in SAM, methionine, and the 
expression of methionine enzymes (Pogribny et al., 2009). Alterations in the 
methionine pathway due to nutritional alterations, or enzyme loss, such as GNMT 
knockout mice, have been shown to prolong life (methionine restriction) or cause 




Fenech, 2012; Martínez-Chantar et al., 2008). These factors are also known to alter 
the DNA and histone methylation in mice (Davis & Uthus, 2004; Pogribny et al., 
2009). As stated earlier, histone methylation has also been linked to aging in a 
variety of species (Figure 36). We found profound changes in histone abundance 
and distribution between Ames dwarf and wild type mice during our cross-sectional 
studies (Figures 24 and 25). First was the discovery that total H3 was not expressed 
similarly between wild type and dwarf mice in liver histone extracts. However when 
compared within genotype, dwarf mice showed more stable expression of this 
protein through all three age groups, while wild type mice showed a progressive 
increase in total histone H3 which led to differences in expression between the two 
genotypes at different ages (Figure 25). One of the first studies to note changes in 
histone H3 was in Drosophila, and showed that histone H3 decreases with age, 
which as stated earlier, suggests a loss of heterochromatin with age (Larson et al., 
2012). In rodents however, heterochromatin increases with age as evidenced by 
studies in mice and increases in H4K20me3 in rat liver (De Cecco et al., 2013; Sarg 
et al., 2002).  In addition, in mice exposed to early life stressors that trigger abnormal 
emotive behavior, total H3 is responsive to pharmaceuticals, showing this marker to 
be dynamic and impacted by environmental events and chemical interventions 
(Levine et al., 2012).  
 We studied one histone methylation marker associated with transcriptionally 
active areas of the genome, H3K4 tri-methylation (H3K4me3). Dwarf mice 
compared to wild type mice have altered total expression of this marker at 12 and 24 




2011).  In humans, losses or gains of this marker are associated with cancer 
progression and with hepatic steatosis (Blair & Yan, 2012; Jun, Kim, Hoang, & Lee, 
2012). Of note, it has been shown that the loss of this H3K4me3 is associated with a 
higher activity of DNMT3a; this might be important as dwarf mice exhibit less 
DNMT3a protein and more H3K4me3 at 24 months of age (Kuzumaki et al., 2010b; 
Ooi et al., 2007). This could be associated with resisting the gain of methylation in 
gene regions during aging as our mice demonstrate less global methylation changes 
over all in whole genome bisulfite sequencing (Brown-Borg, unpublished data).  
 The facultative repressive marker histone H3K27me3, is also diminished 
in dwarf mice compared to age-matched wild type mice at 12 months of age, and 
increased at 24 months of age, similar to H3K4me3 abundance. When examined 
in proportion to total histone H3 expression however, less histone H3 is 
methylated at lysine 4 at 3 months of age (similar to H3K4me3). Since 
H3K27me3 is purportedly decreased in abundance with aging in C. elegans, and 
in cells from patients with Hutchinson–Gilford Progeria Syndrome (HGPS) it is 
interesting to note that dwarf mice resist this change at 24 months of age (S. Han 
& Brunet, 2012; Shumaker et al., 2006).  
 The constitutive heterochromatin marker H3K9me3 has also been found 
to be reduced with age in cells taken from patients with HGPS (Shumaker et al., 
2006). However it increases with age in Drosophila (Han & Brunet, 2012). Dwarf 
mice had higher total levels of this marker at 3 months of age and similar levels 
at 12 and 24 months of age. However when normalized to total H3 protein at 12 




and 24 months of age. Therefore, dwarf mice may be allocating most of the 
histone H3 resources into retaining areas of constitutive heterochromatin at this 
age. Our studies did not indicate that H3K9me3 was especially altered between 
the two genotypes at 24 months of age either in overall abundance or in total 
histone H3 distribution. Coupled with the high DNA methylation status in dwarf 
mice and the resistance to DNA methylation changes, it appears that areas of 
constitutive chromatin are well maintained in dwarf mice compared to wild type 
mice even with fluctuations in total histone H3. Locations of these markers may 
be more informative in determining their impact on the aging phenotype. 
 In a preliminary experiment, we noted some changes in methylation 
enzymes related to H3K9me3 and H3K4me3 in 3 month old dwarf mice 
compared to their wild type counterparts (Table 5). The lysine demethylase 
Kdm5 (also known as Jarid1b) is known to participate in cellular senescence, and 
its expression affects longevity in c. elegans and cancer in humans, making its 
expression important as a possible aging target. Also, the histone 
methyltransferase Setdb2 is a marker that hasn’t been identified as an aging 
related protein yet, thus this may be a novel finding that warrants further 
investigation. 
Specific Aim 4- To examine global DNA methylation a nd DNMT expression 
and growth hormone expression mutants.  
 For our last specific aim, we began investigations to validate some of the 
epigenetic methylation differences that we observed in Ames dwarf mice in other 
GH mutant mice. We focused on growth hormone receptor binding protein 




it due to a mutated receptor. Global DNA methylation in these mice did not differ 
from their age-matched wild type counterparts, but an age-related effect was 
nearly significant (Figure 28). For mice overexpressing growth hormone however, 
differences were noted at 10 months of age, where aged GH Tg mice display 
~50% higher levels of DNA methylation compared to age-matched wild type mice 
(Figure 32). This is interesting as these mice live only to approximately 12 
months of age and express premature aging phenotypes by six months of age. It 
is possible that result may show they accumulate a large increase in 
heterochromatin at a younger age, which has been shown in normally aging 
mice. However, heterochromatin markers have yet to be studied in this model. 
 For the methylation assessment of interspersed repeats, some similarities 
and differences were noted in GHRKO, GH Tg, and dwarf mice when studied 
cross-sectionally. Both long-living GH signaling deficient mice (Ames, GHRKO) 
showed some resistance to the hypomethylation of IAP-LTR repeats, although at 
different ages (Figures 8 and 29). GH Tg mice however, displayed more 
hypomethylation at younger ages, while their wild type counterparts maintained 
similar levels of methylation (Figure 33). For wild type mice this could be 
expected since the wild type mice from our two other long-lived strains showed 
differences at 12 months of age. However, we may have missed potential 
changes in methylation as we didn’t look past 12 months of age in the wild type 
controls of the GH Tg line. Excitingly, the hypomethylation of IAP-LTR may be a 




of methylation in GH Tg mice for IAP-LTR may have huge implications for 
genetic instability and chromatin structure in these mice.  
 In addition, GHRKO mice express more IAP-LTR at 3 months of age than 
their wild type counterparts. Though it was not statistically significant, Ames 
dwarf mice showed an increase in transcription at this age as well. The GH Tg 
mice showed less IAP-LTR transcription at 10 months of age compared to their 
wild type counterparts where expression was unchanged with age. This altered 
transcription occurred at an age when the premature aging phenotype is already 
apparent and there is a large increase of genomic DNA methylation in these 
animals. This repeat appears to have some important function in relation to the 
aging epigenome and requires further investigation.  
 LINE-1 was more hypomethylated at 24 months of age in wild type mice 
than in the age-matched mutant GHRKO mice. The longer-lived mutant mouse 
was able to maintain consistent methylation of this repetitive element.  
Interestingly, methylation changes in this repeat in the wild type mice might be 
strain specific when they are compared to the wild type mice of the Ames dwarf 
strain. LINE-1 hypomethylation during aging has been somewhat controversial as 
mentioned earlier. LINE-1 hypomethylation is not always apparent in normally 
aging human cells, but is more apparent in cancer, where the knockdown of 
expression can abrogate cellular proliferation or metastases (Chalitchagorn et al., 
2004; Oricchio et al., 2007; Takai et al., 2000). In GH Tg mice, LINE-1 




at 6 months methylation loss in its wild type counterpart. The six month increase 
is surprising, and will have to be investigated in other mouse lines to see if this is 
consistently observed. The transcription of LINE-1 in both lines of dwarf mice is 
age-related regardless of genotype, however whereas Ames dwarf mice exhibit 
no genotypic differences in expression, GHRKO mice exhibit higher levels of 
expression. GH Tg mice exhibit lower amounts of transcription compared to wild 
type counterparts. This may be an important factor specific to growth hormone 
signaling. These results are somewhat contrary to the current literature where 
LINE-1 expression appears to be deleterious with age and promotes cancer. 
However, as LINE-1 is usually found in A-T regions in gene-poor regions, loss of 
expression in GH Tg mice might be a result of increased heterochromatin 
formation at an early age.  
 SINE B1 GH Tg mice did not show any significant changes in 
hypomethylation due to age or genotype. Only the GHRKO line appeared to have 
an interactive effect between age and genotype that altered expression of SINE 
B1. This is most likely a strain specific difference. SINE B1 transcription however, 
showed very interesting results. Just as its transcription was increased in dwarf 
mice at 24 months of age, its transcription was increased in GHRKO mutants at 
12 and 24 months of age when compared to age-matched controls. In GH Tg 
mice, there was no genotype difference between the mice though it decreased 
with age. The fact that SINE B1 transcription is higher in two long-living mutants, 
and not in short-living GH Tg mice, raises the possibility that the transcription of 




later ages. Further study will be required to assess whether GHRKO mice have 
reduced amounts of translation or RNA splicing differences at these older ages 
which could be protective mechanisms in the aging of these rodents.  
 For SINE B2, the rodent specific repeat, hypomethylation assays showed 
age-related differences in all three strains of mouse. In the GHRKO and Ames 
dwarf mouse lines the hypomethylation was increased with age in both wild type 
and mutant mice. Only the Ames dwarf showed resistance to hypomethylation of 
this repeat that may or may not be growth hormone associated. In GH Tg mice 
both the wild type and mutant mice gain methylation (lost hypomethylation) with 
age, however, since this cross-sectional study does not include wild type mice 
older than 10 months of age, hypomethylation of this repeat may yet occur. Age-
related transcriptional differences were only seen in the Ames dwarf line, while 
there were genotype differences in GHRKO mice, and no differences between 
GH Tg and respective age-matched wild type mice. Differences in transcription 
appear to be strain specific for the mice overall.  
 Examination of DNMT transcription yielded fascinating results when 
comparing all three lines of mice. DNMT1 transcription was significantly 
increased in GHRKO mice compared to their wild type counterparts. At 12 
months of age, DNMT3a was also 2-fold higher than wild type transcription 
levels. However, Ames dwarf mice showed greater transcription levels of DNMT1 
and DNMT3a at 3 months of age. At first this seems as if it may not correlate, 
however, earlier reports from our lab showed that methionine pathway gene 




12 months of age, and are not as large in magnitude as Ames dwarf mice 
(Brown-Borg et al., 2009). The 2-fold increase in DNMT1 and DNMT3a RNA 
expression observed at 12 months of age in GHRKO mice is mirrored by the two-
fold increase in MAT1a and GNMT expression, two important enzymes in the 
production and regulation of SAM in the methionine pathway (Brown-Borg et al., 
2009). This substantiates our finding that DNMT1 and DNMT3a transcription 
coincide with methionine pathway differences in both strains of long-living dwarf 
mice. DNMT1 transcription in both the GHRKO and GH Tg lines of mice 
decreased with age, in agreement with the literature that examined DNMT1 
transcription in T cells mentioned earlier (Ray et al., 2006). Both GHRKO and GH 
Tg are laboratory inbred strains, as are the DNMT1 deficient mice used in the T 
cell study, which unlike the Ames dwarf mouse line which is bred on a 
heterogenous background. DNMT1 was not altered in transcription in GH Tg 
mice compared to wild type mice at any age. DNMT3a however did show 
genotypic differences, however the increase in DNMT3a expression did not 
approach the magnitude of change detected in the dwarf mouse lines. DNA 
methyltransferase 3b was not different between genotypes in GHRKO mutants or 
wild type mice at any age, reminiscent of the Ames dwarf line. In contrast, 
transcriptional expression of DNMT3b in GH Tg mice at 3 months of age was 2-
fold higher compared to wild type controls. Age-related differences were noted 
between all three strains of mice however, DNMT3b mRNA increased with age in 
the Ames dwarf line, while both the GHRKO and growth hormone transgenic 




DNMT3b differences in transcription of the GH Tg mice had confounding effects 
of age and genotype, which frequently reoccurs in all the mouse lines when 
studying these transcripts in a cross-sectional manner.  
 Interestingly, we found background genetics alters the wild type pattern of 
expression or hypomethylation, supporting the idea that epigenetic mechanisms 
are at least partially controlled through genetic background. However, there is 
plasticity in epigenetic expression that can be permanently altered by chronic or 
early life events. Strain differences in aging are well-documented and should be 
expected when comparing different mutant strains of mice (Yuan et al., 2011). 
However, when commonalities between diverse genetic background strains are 
discovered due to a lack of hormone signaling, the findings become an even 
more potent discovery. 
 A few other preliminary studies were accomplished to further elucidate the 
epigenetic characterization of the GHRKO and GH Tg mutants. Since GH 
modulates differences in DNMT expression of Ames dwarf mice, we decided to 
see if Insulin-like growth factor-1 administration would alter liver DNMT levels 
(Figure 31) in GHRKO mice. IGF-1 administration to Ames dwarf, GH Tg and 
age-matched wild type hepatocyte cultures induced significant differences of 
expression in  enzymes responsible for oxidative stress response, including 
glutathione peroxidase, a transulfuration enzyme which is connected to the 
methionine pathway (Brown-Borg et al., 2002). IGF-1 also has feedback effects 
on growth hormone secretion, cellular proliferation, mediating many of the 




(Bartke et al., 2013; Miller et al., 2005). IGF-1 receptors are not expressed in 
liver; however, IGF-1 is able to stimulate insulin receptors, illustrating some 
promiscuity in signaling. Interestingly, DNMT1 and DNMT3a mRNA expression 
were responsive to IGF-1 injections in the liver of GHRKO mice (Figure31). 
Surprisingly, in this genetic background, GHRKO mutant mice at 6 months of age 
showed decreased expression basal expression of DNMT3b that remained 
unchanged upon IGF-1 treatment. GH, IGF-1, and insulin signaling in the liver 
are interconnected. While DNMT1 showed no effects when insulin was applied to 
hepatocellular carcinoma cells, differences in insulin signaling between 
hepatocellular carcinoma cells and normal liver may have accounted for the 
differences (Chiang et al., 2009). The increase in DNMT3a is likely due to the 
ability of IGF-1 to influence insulin receptor signaling, similarly to what has been 
seen in hepatocellular carcinoma cells. Also IGF-1 signaling through insulin 
receptors had no effect on DNMT3b transcription, similar to the literature. 
However, IGF-1 has a much smaller affinity for insulin receptors than its own 
receptors, therefore applications or injections of insulin would be expected to 
produce more drastic alterations in these transcripts, and would be an excellent 
future study. More DNA methyltransferase protein studies will be forthcoming 
subject to tissue availability. 
 We also began preliminary studies based on tissue availability for the 
expression of DNMT proteins in transgenic mice (Figure 35). For this study, we 
expected DNMT1 protein to be higher in these mice since one week of GH 




months of age DNMT1 protein appeared to be slightly increased, low samples 
sizes may have left any results statistically non-significant (n=5-6). However 
there was decreased expression in DNMT1 in 10 month old GH Tg mice 
compared to wild type counterparts. This coincided with a large increase in global 
methylation. Also DNMT3a protein at every age is significantly lower in 
expression in GH Tg mice, a dramatically different expressional profile than 
Ames dwarf mice, which showed an increased protein expression at 3 months of 
age. DNMT3b protein expression results are still forthcoming, as are replication 
of these studies with larger sample sizes when tissue availability allows. From 
this data, it appears DNMT3a expression is a vital enzyme to longevity and 
possibly delays hepatocellular tumorigenesis as predicted from methyl-deficient 
dietary studies (Pogribny et al., 2009). DNMT3b may play an opposing role in 
longevity based on the transcriptional studies of GH Tg mice, however further 
study of epigenetic methylation mechanisms of GHRKO and GH Tg mice are 
warranted. 
 In conclusion, it has been proposed that epigenetic mechanisms can 
contribute greatly to the aging phenotype and genetic instability.  DNA 
methylation plays a significant role in development and likely in responses to 
early life events, either of which may avert or exacerbate the aging phenotype.  
However, due to the lack of GH signaling, Ames dwarf mice remain able to resist 
and delay many pathologies of aging such as the hepatocellular carcinoma found 
in their wild type siblings (Ikeno et al., 2003). GHRKO mice are also long-lived 




features of DNMT mRNA expression and interspersed repeat methylation or 
transcription with Ames dwarf mice. Our study demonstrated that Ames dwarf 
mice, GHRKO, and GH Tg mice exhibited significant differences in DNMT 
expression that change with age. We also demonstrated that GH administration 
can have a significant impact on the methylation mechanisms and global DNA 
methylation of the Ames dwarf. Similarly, IGF-1 has some transcriptional effects 
on methylation enzymes for GHRKO mice as well. The differential expression of 
both de novo and maintenance DNMTs between Ames dwarf, GHRKO, and GH 
Tg mice, compared to their wild type counterparts affects the methylation of 
repetitive elements and specific genes and therefore contributes to epigenetic 
stability, or instability in the case of GH Tg mice.  Also Ames dwarf mice showed 
differences in histone methylation that can offer further clues for chromatin 
structure and organization. Continuing studies of these proteins and enzymes in 
GH signaling mutant mice are extremely valuable tools to elucidate the changes 
of the epigenetic landscape during aging. These novel findings have initiated a 
new line of inquiry and contributed to our understanding of the mechanisms 
underlying the relationships between GH, longevity and epigenetic stability 
associated with aging and aging pathologies.  
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